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 Abstract  
Asymmetric synthesis is a very important tool to the synthetic chemist. With 
many pharmaceutical targets often having at least one stereocenter within the 
compound, methods of asymmetrically synthesizing such targets is becoming 
increasingly important.  
Pharmaceutical target molecules often have at least one, if not more, chiral centre, 
creating different enantiomers and diastereoisomers of the target compound. 
Different enantiomers and diastereoisomers of compounds may, potentially, have 
very different chemical and pharmaceutical properties. Consequently, asymmetric 
synthesis has achieved a lot of attention.  
One particular asymmetric method is asymmetric epoxidation. Epoxides are three-
membered rings that contain an oxygen and two carbon atoms. Epoxides are very 
reactive to nucleophilic attack due to strain in the three-membered ring system. 
This strain means epoxides are prone to ring opening when attacked by a 
nucleophile to restore the ideal tetrahedral bond angle. This reactivity is utilised in 
asymmetric epoxidation as it is an important method of obtaining an alcohol 
group stereospecifically.  
One method of asymmetric epoxidation is by the use of organocatalysts such as 
iminium salts. Asymmetric iminium salt epoxidation catalysts have been found to 
have a high enantioselectivity to some substrates. However, their full potential has 
not yet been realised.  
This research project focused on identifying further substrates and natural 
products for which the group's asymmetric epoxidation catalysts could be used. 
New method based applications where also investigated.  
Dihydroquinoline, chromene, 3,4-dihydropyran and their enamine analogues were 
all investigated.  
It was found that iminium salt catalysts did not work well with dihydroquinoline 
based substrates, probably due to an interaction between the oxaziridine on the 
catalyst and the nitrogen on substrate. Some protecting groups were investigated 
but no epoxidation could be achieved. Future research will investigate alternative 
methods of protecting the nitrogen.  
Chromene based compounds were found to be easily epoxidised, achieving high 
enantioselectivites. Due to the high enantioselectivities achieved this substrate 
was then used to investigate the potential of iminium salt catalysts in kinetic 
resolution. A large number of chiral chromene compounds were synthesized and it 
was found that those with large substituent's at the C2 position gave both high 
enantio- and diastereoselectivity, enabling the first iminium salt based kinetic 
resolution to be achieved.  
The chiral chromene based natural products (-) lomatin and trans-khellactone 
were synthesized using the group's iminium salt catalyst, with very high 
enantioselectivities being achieved.  
 Synthesis of epigallocatechin gallate (EGCG), using the newly developed kinetic 
resolution was also attempted, but synthesis of the chromene core proved difficult 
and research is continuing.  
Unfortunately, neither the 3,4-dihydropyran or enamine analogue proved to be 
good epoxidation substrates.  
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List Of Abbreviations  
 
Abbreviation Chemical Name Chemical Structure 
Ac acetyl 
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NA 
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De diastereoisomeric excess  NA 
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3,4-dihydro-2H-pyran 
 
O
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Al
H
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NO
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S
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NA 
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H hours 
 
NA 
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O
I
O
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M meta 
 
NA 
 
Min minutes 
 
NA 
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Me methyl 
 
CH3
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NA 
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NA 
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2KHSO5·KHSO4·K2SO4 
 
P para 
 
NA 
 
Ph phenyl 
 
 
 
Py (pyr) pyridine 
 
N  
 
r.t. room temperature 
 
NA 
 
TEA triethylamine 
 
N
 
 
TFA trifluoroacetic acid 
 
F3CCOOH 
 
TFAA trifluoroacetic anhydride 
 
O
OF3C
O
CF3
 
 
TPPP tetraphenylphosphonium 
monoperoxysulfate 
 
NA 
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1.0 Introduction  
 
The epoxide functional group is one of the most useful intermediates in organic 
synthesis.1 Epoxides are three-membered rings that contain an oxygen and two 
carbon atoms.2 Epoxides are very reactive to nucleophilic attack due to strain in the 
three-membered ring system. The ring strain in epoxides originates from the angle 
between the bonds in the three membered ring, which has to be 60° instead of the 
ideal tetrahedral angle of 109°. This strain means epoxides are prone to ring opening 
when attacked by a nucleophile to restore the ideal tetrahedral bond angle. This 
reactivity is utilised in organic synthesis as it is an important method of obtaining an 
alcohol group stereospecifically, such as in the synthesis of Levcromakalim (Scheme 
1). 
NC
O
O Pyrrolidine-2-one
NaH, DMSO
r.t. 4h. 52oC
NC
O
NO
OH
 
 
Scheme 1: Conversion of 6-cyano-2,2-dimethylbenzopyran to Levcromakalim. 
 
It is also thought that epoxides are involved in the carcinogenic activity of aromatic 
hydrocarbons. Oxidation by cytochrome P450 can result in epoxidation of the 
hydrocarbons,3 which facilitates nucleophilic attack by DNA, resulting in the 
alkylation and mutation of the DNA. Interestingly, this effect has conversely been 
utilised to fight cancer, in a class of anti-tumour compounds such as the manumycin 
family of antibiotics,4 for example manumycin A (1), and the epothilones (2).5 
 
 
 
 
 
          1      2 
 
 
 
O
O O
R
OH
OH
O
S
N
Epothilone A (R = H)
Epothilone B (R = Me)
O
O
ON
H
O
OH
OH
H
N
O
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Because of these and other important biological compounds, synthetic methods of 
asymmetric epoxidation have received a great deal of attention over the past forty 
years, with the first widely used epoxidation technique being that of Prilezhaev using 
organic peroxides.6 However, this technique was not asymmetric, and it was not until 
Sharpless in 1980 that the first highly successful chiral epoxidation technique was 
documented.7  
 
This was an important step forward in organic synthesis as Emil Fischer had 
previously documented in 1894 that the configuration of the substrate had an effect 
on the activity of enzymes. Fischer wrote: To use a metaphor, I would say that 
enzyme and substrate must fit together like lock and key in order to exert a chemical 
effect on each other. In any case, this notion becomes more likely and its value for 
stereochemical research increases when the phenomenon itself is transferred from the 
biological to the chemical realm. In other words, chemical stereospecificity is of the 
utmost importance during chemical reactions in the body.8 Consequently, methods of 
synthesising biologically active compounds in a stereospecific manner are very 
important; mistakes can be costly as was seen with the drug Thalidomide.9 Although, 
in the case of Thalidomide, it is now known that blood pH causes the in-vivo 
racemisation of this drug, so the side effects could never have been avoided. 
 
N
O
O
NH
H
O
O (R)-thalidomide
N
O
O
NH
O
O
H (S)-thalidomide
 
 
Figure 1: The two configurations of Thalidomide. 
 
1.1 Sharpless Epoxidation 
 
As noted previously, the need for enantiomerically pure or optically active chiral 
epoxides has increased with the development of biologically active natural products 
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that contain the epoxide functional group or where the group is used in the 
compounds synthesis.  
 
Sharpless discovered the first practical method for the asymmetric epoxidation of 
allylic alcohols using (+)- or ()-diethyl tartrate and a titanium tetraisopropoxide 
reagent (Ti(OiPr)4).7 He noted that it gave uniformly high asymmetric inductions 
throughout a range of substitution patterns, and that the enantiomer of the tartrate 
complex used delivered the oxygen from the same side of the olefin regardless of the 
substitution pattern (Figure 2), with generally greater than 90% enantiomeric excess 
(ee). 
 
 
 
 
 
 
 
 
 
Figure 2: Sharpless epoxidation. 
 
The effectiveness of this system was further exemplified using the synthesis of the 
three epoxides (3), (4) and (5), which are key intermediates in the synthesis of 
methymycin, erythromycin and leukotriene C-1 respectively.7  
O
OH OH
O
OH
O
COOCH3
 
   3   4   5 
Figure 3: The three epoxide intermediates synthesized by Sharpless used in the synthesis of 
methymycin, erythromycin and leukotriene C-1 respectively. 
 
The area of metal-based catalysis has since grown exponentially, with many new 
methods being developed. Two of the most well known are the manganese based 
catalytic methods of Jacobsen10 (Scheme 2) and Katsuki11 (Scheme 3).  
R2
R3
OH
R1
(-)-tartrate
(+)-tartrate
Ti(OiPr)4, tBuOOH
4   molecular sieves
- 20 oC
DCM
Å
O
OHR1
R3R2
70 - 87% yield
90% ee
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N N
HH
OO
Mn
Cl
6
Catalyst (6) (5 mol%)
DCM
MePhPh Me NaOCl (aq)
81% yield
92% ee
1S, 2R
O
 
 
Scheme 2: Jacobsens manganese based epoxidation. 
 
N N
OO
Mn
7
Catalyst (7) (9 mol%)
PhIO (2 eq.)
DCM 12% yield
50% ee
1R, 2R
Ph Ph
AcO-
H H
Ph Ph
Ph
Me
Ph
Me O
 
 
Scheme 3: Katsukis manganese based epoxidation. 
 
Both Jacobsen and Katsuki utilise manganese N,N-
ethylenebis(salicylideneaminato)(salen) complexes in combination with a 
stoichiometric oxidant.  At present, although a number of different catalyst structures 
have been prepared, Jacobsens catalyst (6) tends to perform the best, with the 
highest ee values (up to 98%) being achieved using cis alkenes.10 
 
The mechanism of action still remains a topic for debate. Kochi12 proposed in 1986 
that the active species was an OMnV (salen) complex. This was later proved to be 
correct when Plattner13 showed, using ESI MS, that the addition of the MnIII (salen) 
complex to a dispersion of PhIO in MeCN afforded an OMnV (salen) species. 
However, discussions of the mechanism of oxygen transfer have led to two different 
routes being proposed depending on the substrate used, with the epoxidation of 
acyclic conjugated cis alkenes resulting in the formation of both cis and trans 
isomers.13 The formation of products with a trans stereochemistry points to a 
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stepwise oxygen transfer mechanism involving a radical intermediate which could 
ultimately lead to products (13a and b), whereas products with a cis stereochemistry 
point to a concerted mechanism which would result in only product (13c) being 
observed.13  
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Two proposed mechanisms for oxygen transfer. 
 
In these reactions the stoichiometric oxidant is typically iodosylbenzene (PhIO) or 
sodium hypochlorite. Recently, however, Jacobsen has developed a non-aqueous 
system using m-CPBA and NMO, which has allowed for the use of lower 
temperatures. This new system has also resulted in some high enantioselectivities 
being observed for terminal alkenes, which are typically poor substrates, with the 
epoxidation of styrene (14) yielding the epoxide (15) in an 88% yield and 86% ee at 
 78 °C (Scheme 4).14 
 
Ph
m-CPBA (2.5 eq)
Catalyst (6) (5mol%)
NMO (5 eq)
DCM
- 78 oC
Ph
O
88% yield
86% ee
14 15
 
 
Scheme 4: Epoxidation of styrene (14) using Jacobsens non-aqueous conditions. 
 
However, although these metal-based epoxidation techniques work well, with high 
ee values being achieved, the reagents are often expensive. They also have to be used 
Mn
N
O
N
O Cl
[O]
Mn NO
N
O ClPh Ph
Mn NO
N
O Cl
Mn
N
O
N
O Cl
Mn
N
O
N
O Cl
Ph
O
Ph
O
O
Ph
O
O
Ph
O
Ph
Radical-based mechanism Concerted mechanism
collapse
rotation
then
collapse
8
9
10 10
1112
13a
13b
13c
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under special anaerobic conditions and the metals used are, in some cases, toxic to 
the environment. This has led to an increased interest in the use of organocatalysts. 
 
Organocatalysis is the acceleration of chemical reactions through the addition of a 
substoichiometric quantity of an organic compound.15 Organocatalysts often have the 
advantage of being inexpensive, more stable and being able to be used in an aerobic 
atmosphere with wet solvents. Most organocatalysts used currently are bifunctional 
with a Brønsted acid and a Lewis base centre.15 This enables them to both activate 
the donor and acceptor, resulting in an acceleration of the reaction rate. The large 
majority of organocatalytic reactions used currently are amine-based, proceeding 
through an enamine cycle or as charge accelerated reactions through the formation of 
imonium intermediates (Scheme 5).15  
 
 
 
 
Scheme 5: Electrophilic or nucleophilic activation of a carbonyl group by a secondary 
amine. 
 
Such methods of organocatalytic epoxidation are discussed here as well as other 
current organocatalyst-based methods of epoxidation, such as those using 
polypeptides, those using dioxirane-based structures, and those using oxaziridine-
based precursors.  
1.2 Polypeptide Catalysis 
 
The use of polypeptide-catalysed epoxidation was pioneered by Julià16 in the 
epoxidation of , unsaturated ketones, using poly-(L)-alanine. More recently, 
Roberts et al. have developed the first organically soluble version of the Julià-
Colonna catalyst (Scheme 6), using a polyethylene glycol (PEG)-bound poly-(L)-
leucine as catalyst in THF. The percentage of conversion to the epoxide at 1 h was 
around 35%, however this increased to between 58-80% when the reaction was left 
for 24 h depending on the catalyst used, with the highest conversion of 80%, being 
achieved for catalyst (16) (Scheme 6).17 It is broadly believed that the mechanism of 
O
N
H
R2R1
+H+
N+R
1 R2 -H+ N
R1 R2
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this type of Julià-Colonna system proceeds via fast reversible addition of 
hydroperoxide, followed by slow, intramolecular displacement of hydroxide.18 The 
presence of the poly-(L)-leucine is thought to provide the origin of the 
enantioselectivity seen in the reaction by providing binding points for the chalcone 
within its á-helical structure. The combination of the helical structure and hydrogen 
bonding wraps the poly-(L)-leucine around the chalcone shielding one of the faces of 
the alkene â-carbon atom, resulting in attack of the hydroperoxide occurring at the 
other face. 
 
Ph Ph
O
H(L-Leu)3.9NHCH2CH2(OCH2CH2)71NH(L-Leu)3.9H (16)
Urea-H2O2,
DBU, THF, 0 oC Ph
O
80% conversion
98% ee
O
Ph
17 18
 
 Scheme 6: Epoxidation of chalcone (17) to epoxychalcone (18) using PEG-bound 
poly-(L)-leucine (16) as catalyst. 
1.3 Amine Catalysis 
 
In 2000, Aggarwal reported that simple amines (as shown in Table 1) could be used 
as epoxidation catalysts when using Oxone®/NaHCO3, with the standard procedure 
shown in Scheme 7.19  
 
 
 
                            
 
Scheme 7: Aggarwals standard amine-catalysed epoxidation procedure. 
 
 
 
 
 
 
 
Ph Ph
O
amine (1eq.)
Oxone    (2eq.)
MeCN:H2O (95:5)
NaHCO3 (10eq.)
O oC

19 20
 16 
Amine Conversion (%) Epoxide (%) Diol (%) 
Et2NH 40 36 4 
pyrrolidine 100 90 10 
piperidine 90 87 3 
pyrrolidinone 2 2 0 
pyridine 1 1 0 
pyrrolidine (10%) + 
pyridine (0.5eq) 
100 95 4 
 
Table 1: The amines used by Aggarwal in the standard amine catalysed epoxidation. 
 
The study was originally investigating iminium salt catalysts, but the group found 
that simple amines could also epoxidise the test substrate, 1-phenylcyclohexene (19) 
to racemic 1-phenylcyclohexane oxide (20) (Table 1). Primary amines were found to 
be ineffective in the epoxidation of 1-phenylcyclohexene (19), but secondary and 
tertiary amines catalysed rapid conversion to the epoxide. Secondary amines gave the 
highest yields, for example, when using pyrrolidine, a 90% yield of 1-
phenylcyclohexane oxide (20) was obtained (Table 1, second entry). Further 
investigations showed that substituted pyrrolidines, such as (S)-2-
(diphenylmethyl)pyrrolidine (21), were more effective for a broader range of alkenes 
than pyrrolidine itself, showing a maximum ee value of 57% with 1-
phenylcyclohexene (Table 2). 
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N
H Ph
Ph
21
 
Table 2: Comparison of epoxidation substrates using pyrrolidine and (S)-2-
(diphenylmethyl)pyrrolidine (21). 
 
When investigating the mechanism, it was found that pyrrolidine was oxidized to the 
corresponding hydroxylamine (10%), nitrone (60%) and N-hydroxylactam (2-3%), 
but none of these were found to act as oxygen transfer agents or catalysts in the 
reaction. Aggarwal reasoned, however, that as asymmetric induction is observed, the 
amine must be involved in the oxygen transfer process, possibly by a radical cation 
reaction (Scheme 8).19  
 Pyrrolidine (S)-2-(diphenylmethyl)pyrrolidine (21) 
Alkene 
Conversion 
(%) 
Epoxide 
(%) 
Diol 
(%) 
Conversion 
(%) 
Epoxide 
 (%) (ee %) 
Diol  
(%) 
1-phenyl-
cyclohexene 
59 56 3 100 
96 
(57) 
4 
Styrene 30 27 2 100 
93 
(9) 
6 
trans-stilbene 2 2 0 6 6 0 
cis-stilbene 6 6 0 9 9 0 
1-methylcyclohexene 100 90 10 100 
90 
(15) 
7 
Indene 29 19 10 31 
20 
(25) 
11 
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N
H
N
H
N
R4
R1 R2
R3
R4
R1 R2
R3
N
H H
R2
R4
R1
R3O
KHSO5KHSO4
+
R4
R1 R2
R3O
O2
auto-
decomposition KHSO5
SETSET
Ph
Ph
Ph
Ph
Ph
Ph
Ph
Ph
 
 
Scheme 8: Proposed mechanism for amine catalysed epoxidation. 
 
In an attempt to determine the mechanism of the epoxidation, Aggarwal carried out a 
series of competition experiments. In these experiments, structurally similar alkenes 
were subjected to either 1) electrophilic epoxidation, using m-CPBA or H2O2/MTO, 
or 2) a radial cation mediated epoxidation using a Ar3N+·SbCl6− method developed 
by Bauld and Mirafzal.20 The selectivities were then compared to those observed by 
Aggarwal when using the amine catalysed epoxidation. In view of the close 
similarity in selectivity of the amine catalysed epoxidation to the selectivities 
observed when using Ar3N+·SbCl6−, Aggarwal concluded that a radical cation 
mediated process was responsible for the amine catalysed epoxidation. However, 
Aggarwal later found both the competition experiments and Bauld and Mirafzals 
original radical cation mediated epoxidation to be inconsistent and often 
irreproducible, which makes the radical cation mechanism as originally proposed less 
likely.21  
 
Aggarwal also found the enantiomeric excesses achieved to be relatively variable, 
from 32 to 38% ee, when using the standard test reaction (Scheme 9).  
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N
H Ph
Ph
Ph Ph
amine (21) (10 mol %)
Oxone    (2eq.)
NaHCO3 (10eq.)
MeCN:H2O (95:5)
0 oC
O
100% conversion
32 to 38% ee
 
 
 
 
 
 
 
Scheme 9: Aggarwals standard test conditions using amine (21). 
 
Aggarwal solved this problem by using the hydrochloride salt of the amine, and 
incorporating pyridine to reduce the amount of epoxide hydrolysis. This method also 
gave higher enantiomeric excess values and shorter reaction times (Scheme 10).  
 
Ph
N
H
Ph
Ph21
Oxone     (2 eq
NaHCO3 (10 eq)
Pyridine (0.5 eq)
Amine (21) HCl (0.1eq)
MeCN:H2O (95:5) (0.5 ml)

N N
O
Ph Ph
Ph
O- O-
22 23
 
 
Scheme 10: The fate of the amine and pyridine after the epoxidation reaction. 
 
Further investigation into the mechanism of the reaction showed that at the end of the 
reaction only the oxidation products were observed, with the starting amine (21) and 
pyridine completely oxidized to the nitrone (22) and N-oxide (23) respectively 
(Scheme 10). This led Aggarwal to pose the question that if the amine and pyridine 
are both oxidized, how are they involved in the epoxidation process?.21 Aggarwal 
attempted to answer this question by repeating the reaction and then quenching it 
after five minutes. The reaction mixture showed that despite substantial epoxidation 
occurring, the amine was un-oxidized at that time and only a small amount of the 
pyridine had been oxidized to the N-oxide (23).  
 
This provided evidence that the alkene is oxidized at a faster rate than the amine, 
enabling the pyridine to act as a proton carrier during the epoxidation process, with 
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the amine being protected from oxidation by protonation. Only when all of the 
alkene has been consumed is the free base of the amine (which is present in 
equilibrium with the protonated salt form) slowly oxidized to give the nitrone (22).  
 
N+
HH
Ph
Ph
HSO5-
 
24 
Figure 5: The suggested active ammonium salt. 
 
Later, isolation of the active oxidizing species showed that it was ammonium salt 
(24) (Figure 5) that was the key oxidant in the reaction, providing evidence that the 
reaction mechanism occurs between a nucleophilic alkene and electrophilic oxidant, 
not the radical reaction previously suggested.21 
  
During studies into chiral iminium salt catalysis, Yang also found that amines were 
able to promote epoxidation under slightly acidic conditions.22 Inspired by the 
previous work by Aggarwal, the group decided to investigate further into the effect 
the amines and their substituents have on epoxidation and, from this, ultimately 
confirm the mechanism of action. Their investigation found cyclic secondary amines 
to be better catalysts than either primary or secondary amines, and that 2-substituted 
pyrrolidines gave higher conversions and yields than pyrrolidine itself, with amine 
(25) bearing the bulky CPh2OH group giving a 78% yield and a 33% ee.  
 
Further investigations into these catalysts showed that substituents in the 4-position 
on the ring exert a strong effect on substrate conversion to the epoxide, with 
hydroxyl and methyoxymethyl ether groups showing the greatest effect. When 
investigating the effects of different substituents positioned â to the amino group, it 
was found that a fluorine atom positioned at this point gave the highest catalytic 
efficiency, with 100% conversion and a 50% ee. This was improved further (56% ee) 
when the reactions were conducted at 0 °C to −20 °C, with the advantage that no 
epoxide hydrolysis occurred. The highest enantiomeric excess (61% ee) was found 
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with catalyst (26), a secondary amine bearing a fluorine atom at the â-position 
relative to the amino group (Scheme 11). 
 
92 % yield
61% ee
5 mol% catalyst (26)
Oxone    (2 eq)  
NaHCO3 (5 eq)
CH3CN/H2O (1:1)
N
H NH F
R
R
25 26 R = Me

Ph
Ph
OH
Ph Ph
O
 
Scheme 11: Yangs cyclic amine catalysed epoxidation. 
 
The results also showed that, as noted by Aggarwal, the oxidation products of the 
amines were not involved in the epoxidation process, and that under the acidic 
conditions of the experiment it was likely that the catalyst was indeed converted into 
its corresponding ammonium salt, confirming the proposal by Aggarwal that the role 
of the amine is to act as a phase transfer catalyst and Oxone® activator. 
1.4 Chiral Amines Developed by Jørgensen and Cordova 
 
Direct asymmetric epoxidation of á,â-unsaturated aldehydes using organocatalysts 
has been a challenge to achieve. Jørgensen and co-workers reported the first 
asymmetric organocatalytic epoxidation of á,â-unsaturated aldehydes using a range 
of peroxides, such as H2O2, as the oxidant.23 Jørgensen envisioned utilising the 
properties in chiral amines (27) to create an in-situ formation an iminium ion (29) 
when reacted with an á,â-unsaturated aldehyde substrate (28). The peroxide oxidant 
reacts at the electrophilic â-carbon atom forming a carbon-oxygen bond, leading to 
enamine intermediate (30). The resulting nucleophilic enamine carbon atom then 
forms the epoxide by nucleophilic attack on the electrophilic peroxygen atom. 
Finally hydrolysis of the epoxy-iminium (31) results in the epoxy-aldehyde (32) and 
the regenerated chiral amine (27) (Scheme 12). 
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N+
R1 R2
O HRO
N
R2R1
ORO
OTMS
Ar
Ar
OTMS
Ar
Ar
N+
R2R1
O
OTMS
Ar
Ar
H2O
N
H
OTMS
Ar
Ar
H2O
O
R1 R2
O
R1 R2
O
RO-
27
28
29
30
3132
 
 
Scheme 12: Proposed mechanism of epoxidation of á,â-unsaturated aldehydes by Jørgensen. 
 
The initial development of the reaction involved the screening of conditions for the 
epoxidation of cinnamaldehyde (33). Hydrogen peroxide (35% w/w in H2O) was 
found to be the most efficient oxidant when combined with chiral amine (34) in a 10 
mol% loading, with full conversion to the epoxide (35) being reached in 2 hours, 
with a high diastereomeric ratio of 94:6 and an ee of 96% (Scheme 13).  
 
O
Ph
O
Phcatalyst (34) (10 mol%)
H2O2, CH2Cl2
r.t. 2h
dr = 94:6
96% ee
N
H
OTMS
F3C
CF3
CF3F3C 34
33 35
O
 
 
Scheme 13: Epoxidation of cinnamaldehyde using chiral amine (34). 
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This synthetic methodology has since been used to synthesize the sex pheromone 
from an acaric mite, where epoxidation of citral (36), under the conditions noted 
previously, gave the sex pheromone (37) in a 73% yield and 85% ee (Scheme 14). 
 
O OO
73% Yield
85% ee
catalyst (34) (10 mol%)
H2O2, CH2Cl2, 
r.t., 4 h.36 37
 
 
Scheme 14: Epoxidation of citral using catalyst (34). 
 
At this time Córdova was starting his own investigations into this area.24 The group 
also screened a variety of amines to act as catalysts, using cinnamaldehyde as the test 
substrate and hydrogen peroxide (50% wt%, aqueous solution, 1.2-7 eq.) as the 
oxidant. Similar results to Jørgensen were observed, with chiral pyrrolidine 
derivatives showing the best reaction profiles. The best enantioselectivity was 
observed with amines (38) and (39), with 66% and 97% ee respectively.  
N
H N
O
N
H OTMS
38 39
 
Figure 6: Córdovas most enantioselective catalysts. 
 
Once the catalysts with the best reaction profiles were determined, these catalysts 
((38) and (39)) were then tested under various different conditions. Córdova found 
that temperature had little effect on enantioselectivity when either catalyst was 
employed. However, catalyst (39) was found to show high diastereoselectivity and 
enantioselectivity for the epoxidation of cinnamaldehyde when a range of different 
oxidants was used. With the highest values being achieved at 4 °C in CHCl3 using 
both H2O2 (95:5 dr and 98% ee) and sodium percarbonate (SPC) (84:16 dr and >95% 
ee), respectively. A further range of substrates was also tested with both catalysts 
(38) and (39), with the highest ee of 98% being observed when catalyst (39) was 
used in the epoxidation of fumaraldehyde monoethylester. 
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1.5 Ketone Catalysis 
 
Dioxiranes are three membered rings containing two oxygen atoms and a carbon 
atom. Their reactivity stems from the fact that O-O bonds are weak, and dioxiranes 
are therefore prone to nucleophilic attack by even weak nucleophiles like olefins to 
give epoxide products. Dioxiranes are usually generated in-situ from ketones (chiral 
or achiral) and an oxidant such as Oxone® (potassium peroxomonosulfate) as shown 
in Scheme 15.25   
 
 
 
 
 
 
 
 
Scheme 15: General route for the generation of dioxiranes from chiral ketones. 
 
The two main limiting factors of this method are (i) the competing Baeyer-Villiger 
reaction, which decreases the effectiveness of the dioxirane catalyst used (Scheme 
16), and (ii) the high catalyst loadings required.26  
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 16: Competition from Baeyer-Villiger oxidation during the generation of dioxiranes 
in Shis fructose derived ketones. 
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1.5.1 Yangs Dioxirane Mediated Epoxidation 
 
The first highly enantioselective system to utilise dioxiranes was developed by 
Yang27 using a C-2 symmetric dioxirane generated from the corresponding C2-
symmetric ketone (40) and Oxone®.  
O
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O
O
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O
O
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40 41
 
Figure 7: Yangs C2-symmetric ketones. 
 
The system was developed from the BINAP ligand, which was already known for its 
enantioselective properties in asymmetric hydrogenation28 and many other processes. 
Using this system, Yang achieved moderate enantioselectivities, with the best 
substrate being trans-4,4-diphenylstilbene, giving ee values of up to 87%. The 
selectivity of the catalyst was further improved when X-ray analysis showed that 
positions H3 and H3 were the closest in proximity to the dioxirane ring, indicating 
that this position could be exploited to provide more steric control during the oxygen 
transfer process. This lead to the synthesis of catalyst (41), which gave a 95% ee for 
the highly hindered alkene, trans-4,4-di-tert-butylstilbene. 
 
1.5.2 Denmarks Fluorinated Ketones 
 
Denmark showed that dioxirane-mediated epoxidation accomplished with 1-dodecyl-
1-methyl-4-oxopiperidinium triflate (42) gave high reactivity and yields, with the 
success of this ketone thought to be due to the ability of nearby electron-withdrawing 
groups to increase the reactivity of the carbonyl group towards nucleophiles.29 
Additionally, it had been reported that á-fluorine substituents tremendously increase 
the reactivity of the carbonyl in dioxirane-mediated epoxidations. On the basis of 
these observations, Denmark designed catalysts (43) and (44),30 with catalyst (43) 
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bearing a fluorine atom and catalyst (44) also fluorinated but utilizing the ketone 
backbone originally designed by Yang.  
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The á-fluorinated ketone (43) showed excellent catalytic activity with ee values 
ranging from 6 to 58%, with all the reactions complete within 12 h and a catalyst 
loading of 10 mol%. Cyclic difluoro ketone (44) also showed good asymmetric 
induction, although the ee values ranged from 12 to 94% (Table 3). Denmark 
reasoned this could be due to the two fluorine groups not providing sufficient 
activation for the carbonyl group or that the actual conformation of the ketone may 
somehow restrict the activity.  
 
 
Table 3: Catalytic activity achieved with Denmarks catalysts (43) and (44) on a range of 
olefins. 
 
The reaction conditions were then investigated to see if optimal conditions could be 
found. Shi had reported earlier that changing the buffer solution to potassium 
Catalyst (43) Catalyst (44) 
Substrate 
Yield 
of 
epoxide  
(%) 
Enantiomeric 
Excess (%) 
Substrate 
Yield 
of 
epoxide 
(%) 
Enantiomeric 
Excess (%) 
Me OBn
 
97 6 Me OBn
 
72 68 
MePh
 
85 35 MePh
 
80 88 
PhPh
 
79 58 PhPh
 
46 94 
 
78 14 
 
67 12 
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carbonate resulted in an increase in the reaction rate;31 Denmark reasoned that this is 
because at higher pH the concentration of the peroxymonosulfate dianion is higher, 
and so the concentration of the conjugate base would also be higher which would 
facilitate the formation of the dioxirane (Scheme 17).29 Increasing the pH, by 
changing the base used from NaHCO3 to K2CO3 resulted in a 55% conversion of the 
alkene after 8 h, using 10 mol % of the catalyst. 
Scheme 17: Generation of the Dioxirane. 
 
1.5.3 Armstrongs Fluorine-Containing Ketones 
 
It has been suggested that the presence of a fluorine-containing substituent can 
increase or decrease the reactivity of the dioxirane as a catalyst, depending on the 
orientation of the fluorine.32 Armstrong demonstrated that á-fluoro-N-
carbethoxytropinone (45) was a stable catalyst that resisted decomposition through 
Baeyer-Villiger reaction.33 The first substrate to be investigated was trans-stilbene, 
and good ee values, 76% from an 88% conversion, were obtained at room 
temperature with a 10% catalyst loading. Importantly, as dioxiranes are generally 
regarded as electrophilic oxidants, the successful epoxidations of trans-ethyl 
cinnamate, 64% from a 51% conversion, and trans-chalcone 54% ee from a 94% 
conversion, were encouraging. 
O
F
CO2Et
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Figure 8: Armstrongs á-fluoro-N-carbethoxytropinone ketone (45). 
 
Armstrong believed that this increased stability for the fluorine-containing compound 
(45) was due to the á-fluoro group exerting a stabilising and directing effect in the 
spiro transition state.33 
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1.5.4 Cavellos Investigation into the Fluorine Effect 
 
Cavello32 further investigated the effect of fluorine on dioxirane epoxidation by 
examining the rigid trans-decalone ketones, 46, 47 and 48, as chiral catalysts for the 
epoxidation of trans-olefins (such as stilbene, â-methylstyrene and p-methoxy 
cinnamate).  
O
O
O
O
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Me
F
Me
Me H
F F
MeMe
46 47 48
           
Figure 9: Cavellos trans-decalone ketones. 
 
These particular catalysts were used as they are unable to undergo chair-chair ring 
inversion; hence they can be used to probe the importance of ring inversion and 
fluorine orientation. The formation of the resulting dioxiranes showed (i) that 
dioxiranes with an equatorial á-fluorine (such as (47) and (48)) on the dioxirane ring 
are less reactive and provide lower ee values than dioxiranes with an axial fluorine 
(such as (46)) and having otherwise the same chirality and (ii) that an axial methyl 
group gives significantly lower conversions and ee values than an axial á-fluorine.  
 
When suggesting reasons for why this effect was observed Cavello considered 
several different things; 1) the effect of the fluorine on activation energy, 2) 
electrostatic interactions, and 3) the approach of the alkene. 
 
In all cases it would be expected that the inductive effect of the fluorine atom would 
lower the activation energy. Cavello reasoned therefore, that the increased reactivity 
of catalyst (46), which contained an axial fluorine atom, must be due to interactions 
occurring during the epoxidation reaction itself.  
 
Cavello noted that when considering the approach of the alkene to the dioxirane for 
catalysts (46  48), there are interactions in all possible approach routes when 
catalysts (47) and (48) are used (Figure 10). These interactions, however small, 
would result in a decrease in the reactivity of the catalysts. However, when catalyst 
(46) is used (Figure 11), interactions would only be expected in the A1 route (due to 
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Me/Ph repulsion) and the E2 route (due to F/Ph repulsion), resulting in a more 
reactive catalyst. 
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Figure 10: Cavellos explanation of the epoxidation reactivity seen in the epoxidation of 
trans-stilbene using catalysts (47) and (48). 
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Figure 11: Cavellos explanation of the epoxidation reactivity seen in the epoxidation of 
trans-stilbene using catalyst (46). 
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Cavello also noted that if the alkene approaches the dioxirane equatorially, and the 
fluorine is in an axial position, the fluorine is anti to the dioxirane oxygen that is not 
transferred. Cavello reasoned (based on previous calculations by Armstrong)34 that 
this arrangement would minimise electrostatic interactions between the oxygen with 
greater the developing negative charge and the fluorine atom. In catalysts where the 
fluorine is in an equatorial position this interaction in unavoidable, thereby 
decreasing reactivity of the catalyst.  
 
When combined, each of these factors point to catalysts with an axial fluorine (such 
as catalyst (46)) being more reactive, and this was seen to be the case. 
 
1.5.5 Shis Fructose-Derived Ketones 
 
More recently, the fructose-derived ketones developed initially by Shi have been 
found to show considerable reactivity, particularly in the catalytic epoxidation of E 
configured and tri-substituted olefins,26 with a 95% ee for trans-stilbene being 
achieved when using catalyst (49), shown in figure 12. 
 
 
 
 
 
Figure 12: Shis fructose derived ketones. 
 
However, the main drawback of Shis system is that if the epoxidation proceeds 
slowly, the catalyst is prone to decomposition via Baeyer-Villiger oxidation. 
Experimentation showed that this could be minimised by raising the pH from the 
typical pH of between 7.0 and 8.0 for an epoxidation reaction using Oxone® to a pH 
of 10.5. This increase resulted in an enhanced effect on catalyst activity, with the 
conversion of trans-methylstyrene using 20 mol% catalyst increasing from less than 
10% at pH 7-8, to around 80% at pH 10.5. Importantly the enantioselectivity 
remained high at 90-92% ee.35 
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The highly enantioselective epoxidation of á,â-unsaturated esters using fructose 
based catalysts still remained a challenging problem, due to the electrophilic catalyst 
reacting slowly with the electron deficient substrates. However, Shi found that 
catalyst (50), the acetate analogue of (49), provided a highly active and 
enantioselective catalyst for the epoxidation of á,â-unsaturated esters, with a 73% 
yield and 96% ee being achieved in the epoxidation of ethyl trans-cinnamate.  
1.5.6 Bile Acid Dioxiranes 
 
Bile acid dioxiranes from bile acid ketones (51) have been reported in the 
epoxidation of cinnamic acids. The structure of the bile acids is characterised by a 
rigid and robust skeleton, which limits conformational changes, and so maintains any 
steric factors in the ketone after its conversion into the dioxirane.36 
 
R R1
R2
COOH
51
      
  
 
Figure 13: Bortolinis bile acid ketones. 
 
The ketones can be obtained from commercial sources or can easily be prepared from 
bile acids. The epoxidation reaction is performed in an aqueous NaHCO3 solution at 
0 oC in the presence of an excess of Oxone® (Scheme 18). 
 
COOH Bile AcidOxone/NaHCO3
H2O/EDTA, 0oC
COOHO
 
 
Scheme 18: Bortolinis bile acid epoxidation method. 
 
Epoxidation ee values varied from 95% using catalyst 51a to zero when catalysts 
51b, c and d were used. The conclusion was that the use of bile acid inducers which 
Compound R R1 R2 
51a O OH OH 
51b H H O 
51c OH H O 
51d OH OH O 
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have a carbonyl function at carbon three (R group), as well as specific and 
stereochemically appropriate carbon seven (R1 group) and carbon twelve (R2 group) 
substituents, has a large effect on the reactivity and stereoselectivity during 
asymmetric epoxidations with Oxone®. 
1.6 Oxaziridines in Asymmetric Epoxidation  
 
Oxaziridines are the nitrogen analogues of dioxiranes, and can also act as oxygen 
transfer agents.37 Lusinchi et al. first highlighted the use of oxaziridines as 
epoxidation agents in 1976.38  However, Davis was the first to show examples of 
epoxidation using oxaziridines and 2-benzenesulfonyl-3-aryloxaziridines, in 1981. 
Davis showed that the similarity between oxygen transfer systems in heteroaromatic 
N-oxides and enzyme-catalysed oxidations made the photolysis of such 
heteroaromatic systems a useful model for potential synthetic epoxidation 
reactions.39 The first chiral epoxidation used chiral 2-sulfonyloxaziridine 
diastereoisomers, however, the ee values were still low, with a highest figure of 40% 
ee being achieved by (-)-(S,S)-2-(ä-á-bromo-ð-camphorsulfonyl)-3-(2-chloro-5-
nitrophenyl)-oxaziridine (52) for 1-phenylcyclohexene oxide (Scheme 19).40 
 
N
OS
NO2
Cl
O
O
Br
H O
52
 
 
Ph PhO
70% yield
40% ee
(+)-1R,2R
oxaziridine (52) (100 mol%)
chloroform
60 oC, 4h.
 
Scheme 19: Daviss first chiral oxaziridine asymmetric epoxidation. 
 
Greater ee values were later achieved,37 but the main drawback was the lack of 
reactivity of oxaziridines towards most alkenes, and this has led to the investigation 
of using oxaziridinium salts for asymmetric epoxidation. 
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1.6.1 Use of Oxaziridinium Salts  
 
Oxaziridinium salts are the quaternised analogues of oxaziridines, and as such are 
more electrophilic and able to transfer oxygen more efficiently to nucleophilic 
substrates, with epoxidation rates decreasing as the olefin becomes increasingly 
nucleophilic.40 
 
Lusinchi was the first to show that oxaziridinium salts could be used as reactive 
intermediates in the epoxidation of olefins.38 The presence of the two nucleophilic 
centres appeared to be the basis of the oxaziridine reactivity in epoxidation reactions. 
The salt was based on a conanine steroidal pyrrolinic imine skeleton, which was 
oxidized using peracid and then quaternised using methyl fluorosulfonate (FSO3Me). 
This salt is rather unstable and rapidly decomposes to the iminium salt, and it is 
during this decomposition that the oxygen is thought to be transferred to the olefin. 
(Scheme 20).41 
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Scheme 20: Lusinchis first example of an oxaziridium salt catalyst. 
 
Further work in this area resulted in the first enantiomerically pure oxaziridinium 
salt, prepared from (1S,2R)-(+)-norephedrine (Scheme 21), with ee values of 33% in 
the epoxidation of trans-stilbene using iminium salt (53) when carried out in the 
presence of trifluoroacetic acid, being observed in preliminary experiments.42 An 
exciting prospect was the possibility of a catalytic system being developed from the 
side product of the reaction, which was a regenerated iminium salt.  
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Scheme 21: Synthesis of Lusinchis first enantiomerically pure oxaziridinium salt. 
 
This was achieved using Oxone® in a similar system to that developed for dioxiranes, 
though less pH control is required as there is no competitive Baeyer-Villiger 
oxidation. From this initial research, many other catalytic oxaziridinium salt systems 
have been proposed; a few are considered here. 
1.6.2 Armstrongs Oxaziridinium Salts 
 
Armstrong was drawn to the aforementioned work of Lusinchi and Hanquet with 
oxaziridinium salts, in which one of the ring oxygens is replaced with a nitrogen 
atom. However, Armstrong felt that previous systems, in which the iminium part is 
bonded as part of a ring (endocyclic iminiums), were limited in the number of chiral 
salts that could be synthesized and evaluated as epoxidation catalysts. Hence, he 
examined iminium salts (54a-f) derived from intermolecular condensations from 
separate amines and carbonyl compounds (Scheme 22).43  
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Scheme 22: Armstrongs first exocyclic iminium salt catalysts. 
 
Epoxidation reactions were performed using the system described by Lusinchi and 
Hanquet (Oxone®/CH3CN/H2O). The iminium salts derived from pyrrolidine and 
aromatic aldehydes with electron-withdrawing substituents in the para- or 
(particularly) the ortho-position were by far the most reactive catalysts (54d) and 
(54e), with the latter giving an 89% yield in the epoxidation of trans-stilbene. The 
exact reason for the increased performance of the ortho-isomers is not known, but 
Armstrong believed it may be related to the reduced tendency for the aromatic ring to 
adopt planarity with respect to the iminium bond, thus resulting in a loss of 
conjugation. However, extension to the use of more hindered, chiral amines was 
unsuccessful possibly due to hydrolysis of the iminium salts and / or the low 
reactivity of the oxaziridiniums.43 
 
N+ N+Cl CF3
TfO- TfO-
54d 54e
         
    
Figure 14: Armstrongs most successful exocyclic iminium salts. 
 
Armstrong then went on to investigate intramolecular epoxidation as a way of 
maintaining regio- and stereochemistry. Armstrong was able to show that highly 
stereoselective intramolecular epoxidation of 98% ee was possible when using (S)-á-
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methylbenzylamine (55) and an unsaturated aldehyde (56a-c). In this procedure, the 
imine is oxidized with Oxone® to produce two separable diastereoisomers (4:1 ratio) 
(Scheme 23). Each diastereoisomer was dissolved in DCM and treated with MeOTf 
in the presence of 2,6-di-t-butylpyridine, leading to highly enantiopure epoxy-
aldehydes. However, despite the high selectivity observed with these types of 
substituents, it was noted that if the chain between the imine and alkene was more 
than three atoms a loss of selectivity occurred.44 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 23: Armstrongs intramolecular epoxidation. 
 
Substrate 
Ratio of 
60:61 
de % ee % Yield % de % ee % Yield % 
56a 4:1 90 93 35 90 92 47 
56b 3:1 83 81 60 90 94 40 
56c 3:1 90 98 55 n/a 84 70 
 
Table 4: Results achieved by Armstrongs intramolecular epoxidation on substrates 56a-c. 
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1.6.3 Yangs Exocyclic Iminium Salt  
 
Yang has also developed an exocyclic iminium salt system, using salts that are 
generated in situ from amines and aldehydes under slightly acidic conditions, 
oxidized with Oxone® and then used to epoxidise olefins (Scheme 24).45 This in situ 
method avoids the intrinsic problems associated with the usual preparation and 
isolation of the unstable iminium salts. The results from the initial test conditions are 
shown in Table 5. 
Ph
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Ph
Ph
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Scheme 24: Wong and Yangs initial test conditions investigating exocyclic iminium salt 
epoxidation using an exocyclic iminium salt generated in situ from amines (62a-e) and 
hexanal. 
 
Amine 
Conversion 
(%) 
Yield 
(%) 
Enantiomeric 
excess (%) 
N
H 62a 
77 84 - 
N
H 62b 
32 99 - 
N
H 62c 33 48 - 
N
H
AcO
HN
O
62d 
95 99 30 
N
H
OO
N
H
N
H 62e 
63 92 40 
 
Table 5: Results of Wong and Yangs asymmetric epoxidation of trans-stilbene. 
 
 38 
Encouraged by the results obtained using amines (62d) and (62e), Wong and Yang 
then tested a range of aldehydes and found the best ee values were obtained using 
amine (62d) and aldehyde (63) (Scheme 25) with values of around 50% ee. 
Unfortunately, the major limitation for this system is that the catalyst loading needs 
to be 50 mol% to obtain an efficient rate of reaction. 
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Scheme 25: Wong and Yangs catalytic epoxidation using amine 62d and aldehyde 63. 
 
1.6.4 Komatsus Exocyclic Iminium Salts. 
 
Komatsu et al.46 also decided to examine exocyclic iminium salts for asymmetric 
epoxidation. Initially, achiral salts were synthesized by the simple condensation of 
cyclic amines with cyclic ketones under Dean Stark condition. The catalyst which 
was found to display the best reactivity was catalyst (64) which was prepared from 
pyrrolidine and cyclohexanone. This basic structure was then used in the preparation 
of a chiral version (65) using L-prolinol and cyclohexanone. The resulting catalyst 
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was then used in the epoxidation of cinnamyl alcohol giving a 70% yield and 39% ee 
(Scheme 26).  
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Scheme 26: Komatsus exocyclic epoxidation conditions using catalyst (65). 
 
1.6.5 Bohés Improved Iminium Catalyst 
 
In 2001 Bohé reported the groups investigations into the factors which lower the 
catalytic efficiency of the epoxidation process when using oxaziridinium salts.47 The 
group reported that there were two main factors which result in the reduction of 
catalytic efficiency: hydrolysis of the iminium salt in the reaction, and the loss of 
oxygen from the active oxaziridinium intermediate, in a reaction that does not result 
in the regeneration of the iminium salt. This loss of oxygen occurs by the irreversible 
base catalysed isomerisation of oxaziridinium salts containing protons in the á 
position to the nitrogen atom (Scheme 27).47 
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Scheme 27: Loss of oxygen resulting in rearomatisation of the iminium salt. 
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Bohé postulated that this loss of oxygen could be reduced if a 3,3-disubstituted-
dihydroisoquinolinium salt was used as the oxaziridinium catalyst.41 The most 
successful iminium salt was found to be iminium salt (69), which was synthesized 
from the commercially available tertiary alcohol; the active oxaziridinium was then 
prepared from this salt by an oxidation pathway using Oxone® and NaHCO3, but 
unlike previous iminium catalysts, this salt is unable to re-aromatise. This is shown 
in Scheme 28, where (66) and (67) show the previous method, with the possibility of 
re-aromatisation occurring to give (68). However, in the new method, shown by (69) 
and (70), this cannot occur due to the lack of an available proton, resulting in a faster 
and high yielding reaction.  
 
 
 
 
 
 
 
 
 
 
 
 
     
 
 
          
 
Scheme 28: Bohĕs new racemic catalytic epoxidation method in comparison to the old. 
 
The epoxidation of trans-stilbene involving salt (69) was observed to be much faster 
than the reference salt (66), and because the actual intermediates of both species are 
likely to be very similar the only likely explanation is that the exclusion of the 
aromatisation pathway allows improved catalytic turnover.47 Overall good yields 
were observed for trans-stilbene and di- and tri-substituted alkenes (72-92%); 
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however, for the less reactive terminal double bond of the undecylenic methyl ester 
(71) epoxidation resulted in only a 28% yield.48 
 
O
O
71
 
Figure 15:  Undecylenic methyl ester (71). 
 
However, Bohé noted that this base catalysed method of destruction is not observed 
in all iminium salt epoxidations. He felt that this may be due to the reactivity of the 
catalyst, which would favour the nucleophilic pathway over the base catalysed 
isomerisation and that further catalytic enhancement could be achieved by increasing 
the probability of the catalyst favouring the nucleophilic pathway. 
 
Bohé decided to examine this by looking at ways to increase the electrophilicity of 
the catalyst, this consisted of reinforcing the ratio of electrophilicity to acidity, which 
would consequently favour the nucleophilic pathway over the acid-base degredation 
pathway (Scheme 29).47  
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Scheme 29: The nucleophilic and acid-base pathways. 
 
To test this strategy, which allows the based catalysed aromatisation to remain in 
action whilst reinforcing the nucleophilic pathway, Bohé placed an electron 
withdrawing group on the aromatic ring, though not in conjugation with the imine 
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bond. This resulted in the preparation of iminium salt (72) where a nitro group is 
present on the C-7 position. Having reported earlier that iminium salt (69) was a 
more efficient catalyst than (66) due to the absence of protons á to the nitrogen, it 
was postulated that the synergistic effect between these two systems could be utilised 
resulting in the synthesis of iminium salt (73). This resulted in a highly efficient 
catalyst for the oxaziridinium-mediated epoxidation of olefins by Oxone®, with 
100% conversion being obtained after 1.5 hours with only 5 mol% catalyst loading 
(Table 6) required compared to 10 mol% for catalysts (66) and (69). However, to 
date, no chiral versions have been reported. 
N+
R1
R1
R
F4B-
Iminium salt     R     R1
66                     H     H
69                     H     Me
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Figure 16: Bohés improved iminium salt catalysts. 
 
Olefin 
Catalyst 
loading 
(mol%) 
Time 
(h) 
Conversion 
(%) 
74 10 6 92 
75 10 6 85 
76 10 6 89 
77 10 6 85 
78 5 2 100 
79 5 4 100 
80 5 4 100 
81 5 4 100 
82 5 2 100 
83 5 6 100 
84 5 2 100 
 
Table 6: Conversion rates achieved by Bohés optimised catalyst (73). 
 
R
74 R = (CH2)7CO2Me
75 R = Ph
76 R = (CH2)7CH2OH
O
4
77
Ph
O
Ph
Ph
CO2Et
CO2Et
R OH
HO
78 79 80
81
82 R = Ph
83 R = nC8H17
84
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N+ Ph
Ph
85 86
BPh4-
1.6.6 Pages Unique Iminium Salt Catalysis 
 
Page demonstrated in 1997 that if the iminium salt derived from a 
dihydroisoquinoline and primary amine had a chiral exocyclic nitrogen substituent, 
this could be used to achieve catalytic asymmetric epoxidation with Oxone®, with ee 
values of up to 73% (with catalyst (85) and alkene (86)), in clean reactions carried 
out at 0 oC with catalyst loading as low as 0.3 mol% (Scheme 30).49, 50     
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
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Scheme 30: General scheme of Pages asymmetric iminium salt epoxidation using iminium 
salts derived from primary amines (89-98). 
 
It was reasoned that attachment of the controlling asymmetric centres to the iminium 
nitrogen atom makes the system more selective than the Lusinchi-Hanquet system 
because the positioning of the asymmetric centre was closer to the reacting centre.  
 
Along these lines, a range of catalysts was easily prepared by condensation of a 
range of enantiomerically pure primary amines (89-98) with 2-(2-
bromoethyl)benzaldehyde (88), which itself is prepared from treatment of 
isochroman (87) with bromine in carbon tetrachloride. The condensation between the 
amine and aldehyde furnishes the dihydroisoquinolinium bromide salt, however 
these are often oils and can be difficult to purify. This problem was alleviated by 
doing a simple counter ion exchange with NaBPh4, yielding crystalline iminium salts 
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(30-80%) (Scheme 31). This method is advantageous as a wide range of catalysts can 
be derived quickly from a large variety of readily available chiral primary amines. 
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Scheme 31: General scheme of the preparation of the iminium salt catalysts. 
 
As noted previously, it was found that this route provided a large variation of 
catalysts, as the chirality was only present in the amine component, although more 
hindered amines were found to give inferior conversions, typically 25-30%, possibly 
due to an increased tendency to act as bases rather than nucleophiles. Using the 
above method, the primary amines (89-98) were converted to their corresponding 
iminium salt catalysts. The catalysts were then used in the epoxidation of 1-
phenylcyclohexene under the standard conditions (Scheme 30). Out of this selection 
of catalysts, the one derived from N-isopinocamphenyl (93) showed the best reaction 
profile giving up to 40% ee and 68% yield. Even better results were obtained using 
trans-stilbene as substrate where a 73% ee and 78% yield were obtained when using 
10mol% catalyst. Although steric hindrance near the reaction site appears to be 
important, as shown with the N-isopinocamphenyl (93) salt, the more sterically 
demanding systems such as the steroidal (98) salt, showed a decrease in 
enantioselectivity, with a maximum 14% ee for 1-phenylcyclohexene, although the 
overall conversion rate was similar with a 47% yield. 
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Amine in catalyst 
Compound 
No. 
Catalyst 
loading 
(mol%) 
Yield (%) Enantiomeric 
excess (%) 
NH2
  
89 5 54 0 
NH2
  
90 5 70 0 
HN
Ph NH2
 
91 1 39 25 
H2N
 
92 0.5 63 19 
NH2
  
93 5 68 40 
NH2  
94 0.5 66 12 
NH2
 
95 0.5 45 32 
NH2
  
96 0.5 60 18 
NH2
  
97 0.5 58 8 
HO
 
98 0.5 47 14 
 
Table 7: Catalytic asymmetric epoxidation results using amines (89-98) in the epoxidation 
of 1-phenylcyclohexene under the standard conditions.. 
 
 46 
However, these systems are complicated by the possibility that two diastereoisomeric 
oxaziridinium salts may be formed depending on whether the nucleophilic attack of 
the oxidant occurs on the front or back face of the iminium species.51  
 
Page then set about optimising the reaction conditions using the N-isopinocamphenyl 
derived catalyst (93)52.  It was felt that the counter ion, solvent system temperature 
and catalyst loading may all have a bearing on the reactivity and selectivity of the 
catalyst, so these were examined in turn.  
 
To examine the change in counter ion, the corresponding perchlorate, 
hexafluorophosphate, tetrafluoroborate and periodate salts were prepared and used in 
the epoxidation of 1-phenylcyclohexene, executed under the standard conditions 
(Scheme 32). The tetraphenylborate and periodate salts gave similar ee values (40% 
and 35% respectively), but the fluoride containing salts and perchlorate salt gave 
significantly lower ee values (28% and 20% respectively), though all gave the same 
enantiomer of the epoxide product (R,R) and all were complete within 45 minutes.  
 
Ph Ph
catalyst (93) (10 mol%)
Oxone (2 eq.)
Na2CO3 (4 eq.)
CH3CN:H2O (1:1)
0 oC
O
 
 
Scheme 32: The Page groups standard epoxidation conditions using catalyst (93). 
 
The solvent system used in the standard epoxidation conditions (Scheme 32), is a 1:1 
ratio of acetonitrile and water, however an increase in the water to acetonitrile ratio 
was found to result in an increase in the reaction rate, with the effect being greater 
the smaller the quantity of catalyst used. The N-isopinocamphenyl derived catalyst 
showed 30% conversion after 1 hour when a 1:1 ratio of solvents was used, this 
increased to an essentially quantitative yield, after the same time, when the ratio was 
increased to 2:1 (water:acetonitrile). However, it was noted that the change in solvent 
composition had no influence over the enantioselectivity of the reaction with ee 
values of 18 to 20% seen whether a 1:1 ratio or a 2:1 ratio of solvents was used. This 
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increase in reaction rate is most likely due to an increase in Oxone® solubility, 
resulting in an increase in nucleophilic attack by the persulfate species on the 
iminium species.  
 
Page also looked at the effect of co-solvent polarity, which could provide insight into 
the reaction mechanism and the factors that control enantioselectivity. The co-
solvents were selected to provide a range of dielectric constants (å, given in 
brackets): dichloromethane (8.9), trifluoroethanol (26.7), acetonitrile (37.5), water 
(78.4) and formamide (111). The epoxidation was performed as shown in Scheme 32 
using both the perchlorate and tetraphenylborate N-isopinocamphenyl derived 
catalysts (10 mol%), with the co-solvents and water in a 1:1 ratio. Both salts showed 
quantitative conversion after 30 minutes when using trifluoroethanol and ee values of 
26%, but interestingly the perchlorate salt was also reactive in dichloromethane 
giving a 33% ee in 3 hours, where the tetraphenylborate salt was completely 
unreactive. The perchlorate and tetraphenylborate catalysts were both unreactive in 
formamide, and Page felt this was probably due to the iminium species being too 
well stabilised/solvated. Acetonitrile remained the best co-solvent with an ee of 40% 
when using the tetraphenylborate N-isopinocamphenyl derived catalyst. 
 
The effect of temperature is fairly limited when using Oxone® as oxidant, due to the 
instability of Oxone® under alkaline conditions, which increases at higher 
temperatures and the necessity to have water for Oxone® solubility which restricts 
the reactions to a minimum of 0 °C. When the epoxidation of 1-phenylcyclohexene 
was performed at − 10 °C, using catalyst (93) under standard conditions, low 
conversion was observed. This is most likely to be due to the limited solubility of 
Oxone® and sodium carbonate at this temperature, and was resolved by changing the 
ratio to 3:1 (water:acetonitrile), which gave complete epoxidation and 35% ee, 
though this was still lower than when the reaction was performed at 0 °C. Higher 
temperature reactions resulted in negligible conversion, presumably due to the auto-
decomposition of Oxone® at higher temperatures. 
 
The effect of catalyst loading was expected to be an important parameter in the 
reaction system in relation to conversion and, possibly, enantiomeric excess. Again 
using the N-isopinocamphenyl derived catalyst (93), a graph of catalyst loading 
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versus ee % could be compiled. Using 1-phenylcyclohexene as substrate, the results 
showed that enantioselectivity does increase with catalyst loading, but only to a 
point, with the maximum ee value being obtained at 2 mol% catalyst loading.  
 
 
Figure 16: Graph showing the relationship between catalyst loading and enantiomeric 
excess using catalyst (93). 
 
After the optimization trials, the Page groups attention refocused on the role of the 
catalyst structure within the epoxidation reactions in a continued effort to develop a 
catalyst capable of mediating the highly enantioselective epoxidation of alkenes. 
Various amine groups were considered (Figures 17 to 20) containing alcohol, ether 
and acetal functionalities, with the idea that the polar groups within these type of 
structure may act as a directional aid, by either controlling the persulfate attack on 
the iminium or the alignment of the alkene with the oxaziridinium. 
 
The catalysts prepared from chiral 1,2-aminoalcohols that contained a primary 
hydroxyl group (99-102) were found to produce (almost) racemic 1-
phenylcyclohexene oxide when used in the epoxidation procedure under Pages 
standard conditions (Scheme 32), and the reactions proceed much slower than 
catalysts that lack the hydroxyl group.  
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Figure 17: Pages catalysts derived from primary alcohols. 
 
Page believed this to be because of an equilibrium between the ring open iminium 
salt (active) (103) and the ring closed oxazolidine (inactive) (104) forms of the 
catalyst under the slightly alkaline conditions used (Scheme 33). 
 
-BPh4
103 104
 
 
Scheme 33: The proposed ring open and ring closed equilibrium. 
 
The catalysts prepared from 1,2-aminoalcohols (105-107), which contained a 
secondary hydroxyl group, were formed equally as readily and showed improved ee 
values on testing, with catalyst (105), a (1S,2R)-norephedrine derivative, giving a 
30% ee when catalysing the epoxidation of 1-phenylcyclohexene. This improved 
selectivity was at the cost of the catalyst loadings, which were higher, with at least 5 
mol% required for complete oxidation of 1-phenylcyclohexene in 1 h compared with 
2 mol% of catalyst which contained a primary hydroxyl group. Unfortunately, 
catalysts containing a tertiary hydroxyl group could not be prepared. 
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Figure 18: Pages catalysts derived from secondary alcohols. 
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It was also not possible to prepare catalysts from aminodiols, and the catalysts 
prepared from aminoether precursors proving to be difficult to isolate, with the 
(1S,2S)-2-amino-3-methoxy-1-phenylpropanol-derived salt only being isolated in 
low yield. In an attempt to increase the yield, simpler amino-ethers were used, 
resulting in the catalysts (108-110), but despite good conversions being achieved, 
these catalyst gave poor ee values.  
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Figure 19: Pages catalysts derived from amino ethers. 
 
It was found that the catalysts derived from aminoacetal precursors gave the best ee 
values, with catalyst (111) giving an enantioselectivity of up to 59% ee when using 
the standard epoxidation conditions (Scheme 32), compared to catalyst (93) which 
only gave a 40% ee at its highest under the same conditions. These results 
demonstrate that this catalyst, in general, induced much higher enantioselectivity in 
the asymmetric epoxidation than the previous catalysts.                            
 
   
 
Figure 20: Pages catalyst (111) derived from amino acetal precursors and the previous best 
enantioselective catalyst (93). 
The amino acetal derived catalyst (111) also provides some interesting features such 
as the cis relationship between the nitrogen heterocycle and the phenyl group, 
implying that the one group must be axial for the dioxane to retain the chair 
conformation. 1H NMR spectroscopy supports the chair conformation of the 1,3-
dioxane ring and on the basis of this and single-crystal X-ray analysis, Page 
postulated two possible reasons for the catalyst adopting this conformation. The first 
N+
-BPh4
93
N+
O
O
Ph111
-BPh4
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was that conformer (112) may be more favoured due to a possible interaction 
between the oxygen loan pairs and the electron depleted carbon atom of the iminium 
salt (Figure 21). The second is the lack of 1,3-diaxial interactions when the catalyst 
adopts this conformation, which is the most likely explanation for the observed 
conformation.  
 
 
 
Figure 21: Possible influence of oxygen lone pairs on the chair-conformation of catalyst. 
This conformational analysis also provided a possible explanation of the higher 
enantioselectivities observed when using catalyst (111) when compared to catalyst 
(93). In catalyst (93) both conformers are equally favoured, resulting in attack by the 
oxidant coming from both faces of the iminium salt decreasing its asymmetric 
epoxidation capabilities. However for salt (111), in its more stable conformer, the 
phenyl substituent is positioned such that it may hinder the attack of the oxidant from 
that side, making the other side more accessible. This leads to the possibility of 
major and minor diastereoisomeric intermediates existing (Scheme 34).  
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Scheme 34: The two possible diastereoisomeric oxaziridinium intermediates of catalyst 
(111). 
 
Page has also reported more reactive catalysts where the dihydroisoquinolinium 
moiety has been replaced with a biphenyl (113)53 and binaphthalene (114)54 
structures.   
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Figure 22: Pages biphenyl (113) and binaphthalene (114) based asymmetric epoxidation 
catalysts. 
 
Epoxidation of most alkenes with catalyst (113) proceeded within 10 minutes, 
making it the most reactive catalyst at that time. The enantioselectivities ranged from 
10-60% ee. 
 
Binaphthalene-derived iminium salts have been reported previously by Aggarwal to 
achieve enantiomeric excesses of up to 71% ee.55 Page has also developed a range of 
azepinium salt catalysts containing the binaphthalene backbone. The most successful 
of this series proved to be catalyst (114), which when employed in epoxidation 
reactions gave ee values of up to 95%. Interestingly, unlike previous catalysts, 
decreasing the catalyst loading did not result in a loss of enantioselectivity. As such, 
a loading of just 0.1 mol% was used to achieve complete epoxidation of 1-
phenylcyclohexene in 88% ee, compared to 91% ee when using a loading of 5 mol%. 
 
It was felt that the remaining limitation in the Page groups system was the range of 
temperatures at which the epoxidation can be performed (0 oC  room temperature) 
using the conditions reported by Page previously.49-54,56 This is because Oxone® 
decomposes relatively quickly in the basic medium used at room temperature, but the 
aqueous medium used freezes at about 10 oC. 
 
Page felt the enantioselectivity could be enhanced if the reaction could be carried out 
at lower temperatures and so sought non-aqueous reaction conditions. After testing a 
range of oxidants, Page reported the first non-aqueous epoxidation system mediated 
by iminium salt catalysts using tetraphenylphosphonium monoperoxybisulfate 
(TPPP) as the oxidant, and acetonitrile as the solvent.56 The oxidant TPPP has 
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previously been reported by Di Fura, where it was used to transfer oxygen to 
manganese porphyrins and is prepared by simple cation exchange between Oxone® 
and tetraphenylphosphonium chloride. In contrast to the Oxone® system, no base is 
required, in fact the addition of amine bases was found to be harmful for the 
epoxidation reaction. The optimum temperature was found to be − 40 °C and under 
these conditions the biphenyl catalyst (113) performed the best, giving 100% 
conversion in 3 minutes with 67% ee for 1-phenylcyclohexene.  
 
Recently Page has developed this non-aqueous system further by using chloroform as 
the solvent in the epoxidation of cis-alkenes. Using iminium salt (115), ee values of 
67% for trans-stilbene, 70% for cis--methyl styrene and 82% for 
dihydronaphthalene were observed; these were superior to those obtained under 
either aqueous conditions or non-aqueous conditions with acetonitrile as the solvent.  
 
Results were equally promising when benzopyran substrates were used, with the 
epoxidation of 6-cyano-2,2-dimethylbenzopyran achieving the highest ee to date 
with a 97% ee in 59% yield. This was particularly important due to its possible use in 
the synthesis of levcromakalim (116) an antihypertensive agent which acts through 
the opening of K+ channels. This synthesis was subsequently achieved by the Page 
group as shown in (Scheme 35) .57 
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Scheme 35: Pages synthesis of levcromakalim. 
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1.7 The Use of Epoxidation in Kinetic Resolution 
 
Although numerous methods are known for the synthesis of enantioenriched 
compounds, one of the major drawbacks is that they can consist of rather lengthy 
procedures.   
 
In selecting a method for the synthesis of enantioenriched compounds there are many 
different alternatives to consider, with the main three approaches being 1) using a 
starting material from the available chiral pool, 2) enantioselective synthesis or 3) 
resolution of enantiomers by chemical or physical means. 
 
Resolution itself can be classified in to three broad groups: 
 
1) The use of a chiral resolving agent to form a diastereomeric pair, enabling the 
diastereoisomers to be separated either by chemical or physical means, due to 
their different properties. 
2) The use of chiral chromatography. 
3) Kinetic resolution. 
 
Kinetic resolution is defined as the achievement of partial or complete resolution by 
virtue of unequal rates of reaction of the enantiomers in a racemate with a chiral 
agent (reagent, catalyst, solvent, etc.).58, 61  
 
The major drawback of kinetic resolutions is that the maximum theoretical yield of 
enantiomerically pure recovered starting material is 50%. However, if the product is 
the desired compound, it is sometimes possible to racemise the starting material in 
situ, allowing the isolation of enantiomerically pure product in 100% yield starting 
from racemic starting material. This process is known as dynamic kinetic 
resolution.59 In other cases it is possible to racemise the remaining enantiomer of the 
starting material after isolation.  
 
However, regardless of the drawbacks, there are also advantages to using kinetic 
resolution. For example, despite the fact that in most cases the maximum yield will 
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be 50%, the racemates are often less than half as expensive as their enantiomerically 
pure counterparts.60 
 
Another attractive feature of kinetic resolutions from a practical point of view is that 
even with a relatively low selectivity, the unreacted substrate can be obtained with 
high ee simply by carrying the reaction to high enough conversion.  
 
Jacobsen,60 proposed that kinetic resolution can be considered a viable resolution 
method providing certain conditions are met: 
 
1) The racemate is cheap and/or readily available and no satisfactory 
enantioselective, chiral pool, or classical resolution route to the product 
exists. 
2) The catalyst is highly selective for one enantiomer and is effective at low 
loadings. 
3) The catalyst is inexpensive and/or it can be recycled efficiently. 
4) The reaction is economical and safe: inexpensive stoichiometric reagents, no 
undue dangers associated with the reagents, high volumetric throughput, and 
a minimum of waste generated. 
5) The resolved starting material and converted product are easily separated. 
6) In the ideal case, both the product and resolved substrate are valuable and 
recoverable in highly enantioenriched form. 
1.7.1 Sharpless Kinetic Resolution. 
 
The first example of a successful kinetic resolution using a chemical catalyst, 
although in stoichiometric amounts, was published in 1981 by Sharpless et al.,62 
where the groups previously reported procedure7 for the catalytic asymmetric 
epoxidation of allylic alcohols, was adapted to the kinetic resolution of chiral allylic 
alcohols (Scheme 36).  
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Scheme 36: Sharpless kinetic resolution. 
 
Using this kinetic resolution technique, Sharpless was able to obtain enantiopure 
allylic alcohols in up to 96% ee depending on the substrate used. Sharpless found 
that the enantioselectivities could further be improved by modification of the alkyl 
groups present in the tartrate ester, with the best values being achieved using (+)-
diisopropyl tartrate (DIPT). Sharpless reasoned that this was due to the larger alkyl 
group further retarding the rate of reaction of the slower reacting enantiomer.  
 
The impact of the Sharpless kinetic resolution was very important, as although 
enzyme based resolutions were well known, there had been very little work done 
with respect to synthetic catalysts. This has lead to other synthetic catalysts being 
investigated for use in kinetic resolution reactions, two of which are discussed in 
more detail below.  
1.7.2 Jacobsens Application of Kinetic Resolution Mediated by (salen)Mn 
Based Catalysts. 
 
Jacobsen realised that the (salen) Mn-catalysts ability to epoxidise prochiral 2,2-
dimethylchromans, with high enantioselectivity, could be exploited for use in the 
kinetic resolution of chromenes bearing a quaternary stereocentre next to the 
oxidizable olefinic moiety.61                      
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Figure 23: Jacobsens model substrate. 
 
Compound (117) was first evaluated as a model substrate using catalyst (118), and at 
full conversion showed high enantioselectivity for both diastereomers. Importantly 
for a kinetic resolution when the reaction was stopped at partial conversion a 
preference for the trans-diastereomer (119) was shown (Scheme 37).  
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Scheme 37: Evaluation of compound 117 at full conversion. 
 
Jacobsen had found previously that enantioselectivity in the chromene substrates is 
sensitive to the presence of electron-donating groups on the catalyst. Using this 
knowledge Jacobsen was able to improve selectivity still further by the use of the 
electron rich and sterically hindered catalyst (121).  
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On the substrates themselves it was noted that selectivity increased with increasing 
steric demand from the alkyl substituent. This kinetic resolution methodology was 
then utilized in the synthesis of (+)-Teretifolione B. 63 
1.7.3 Shis Application of Kinetic Resolution Mediated by Dioxirane 
Based Catalysts. 
 
At present the only known organocatalytic kinetic resolution has been reported by 
Shi using his dioxirane based catalysts.64 In the examples explored by Shi, the 
substrates were based on cyclic olefins with the chiral center at the allylic position. 
Initially 1,6-disubstituted cyclohexenes were examined, using (±)-1-phenyl-6-
(trimethylsiloxy)cyclohexene (122) as the test substrate. Shi postulated that the 
proposed spiro transition state would favour the formation of the trans-epoxide and it 
was found that this was indeed the case, with the reaction giving a 95% ee of the 
trans-epoxide at 49% conversion in a >20:1 ratio of trans/cis. Analysis of the 
recovered starting material showed the enriched S isomer at a 96% ee, reinforcing the 
transition state proposal. 
OTMS
Ph
OTBS
Ph
122 123
 
             
Shi then investigated 1,3-disubstitued cyclohexenes with the TBS ether of 3-phenyl-
2-cyclohexenol (123) as the test substrate. Although it was found that the selectivity 
of trans to cis was less at 4:1, the unreacted starting material had an ee of 99% at 
70% conversion, showing that the kinetic resolution of such compound is at least 
feasible. 
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1.8 Conclusion 
 
This introduction has briefly reviewed the fast developing area of asymmetric 
epoxidation that is mediated by organocatalysts. As can be seen, many methods have 
been implemented and some have ultimately been more successful than others. The 
Page group is now interested in looking at further applications of their highly 
successful enantioselective epoxidation techniques, such as in kinetic resolution and 
in the synthesis of other natural products, such as enediyne antibiotics and 
epogallocatechin-3-gallate (EGCG). This is the aim of this research project and will 
be discussed below. 
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2.0 Results and Discussion  
 
The main aim of this project was to further the use of the groups asymmetric 
catalysts in the synthesis of some natural products. Previously within the group the 
asymmetric epoxidation methodology had been applied to the synthesis of 
Levcromakalim,57 an antihypertensive drug based on a chromene-type structure 
(124). Many other natural products contain this core structure, and the similar 
dihydroquinoline structure (125). The chromene-type structure had previously 
yielded very good enantioselectivites, and, as no research had previously been 
attempted on compounds containing nitrogen we decided that the project would 
initially concentrate on dihydroquinoline-based structures, especially as this core 
structure is found in a range of natural products, such as dynemicin A, which is part 
of the enediyne family of antibiotics (126).65                                         
 
 
 
 
 
 
 
Figure 24: Previous (124) and potential future (125-126) asymmetric epoxidation targets. 
 
The catalyst (132) had provided the best enantioselectivity to date with the 
chromene-based structures, so it was decided that this catalyst would be used to 
investigate the epoxidation of the dihydroquinoline-based structures. The catalyst 
was prepared using the procedure described by Norden and Thomas.66 (1S,2S)-(+)-
Thiomicamine (127) was protected with methyl formate, then the diol closed to form 
the six membered ring (128) using dimethoxypropane and p-TSA, both in good 
yields. The sulfide was then oxidized to the sulfone (129) using m-CPBA, followed 
by removal of the protecting group with aqueous hydrazine. The resulting amine 
(130) was then stirred with 2-(2-bromoethyl) benzaldehyde (131) in ethanol 
overnight to yield, on reaction with sodium tetraphenylborate, the required catalyst 
(132) (Scheme 38). 
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Reagents and Conditions : i: MeOCHO, MeOH, r.t.; ii: 2,2-DMP, acetone, CSA, r.t.; iii: m-CPBA 
(2.2eq.), DCM/CHCl3, 0 °C, iv: H2NNH2.H2O, Ä; v: EtOH, 0 °C-r.t.; vi: NaBPh4, MeCN 
 
Scheme 38: Synthetic route for the formation of the catalyst. 
 
An examination of the literature provided a relatively simple route to the basic 
dihydroquinoline structure (137) by Hamann et. al.,67 and in such a way that various 
analogues could easily be synthesized by alteration of the aniline (135) used (Scheme 
39).  
 
The dihydroquinoline compounds were prepared in three steps according to Scheme 
39, with 2-methyl-3-butyn-2-ol (133) being converted to 2-methylbut-3-yn-2-yl 
acetate (134) using acetic anhydride, and then being heated under reflux with the 
appropriate aniline (135) and 10 mol% CuCl in dry THF for 3 hours, at which point 
the intermediate product (136) was isolated and used in the next step of the reaction 
without further purification. The intermediate structure was confirmed by crude IR 
and 1H NMR spectroscopy, which clearly indicated the formation of the secondary 
amine from the primary amine, the loss of the acetate group and the presence of the 
alkyne group. The intermediate (136) was then reacted under similar conditions, with 
11 mol% CuCl, for 14 hours resulting in the required cyclised product (137), which 
could be easily purified using column chromatography.    
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Reagents and Conditions: i: Alkyne (1.3 eq), Ac2O (1.5 eq), Et3N (1.4 eq), DMAP (5 mol%), r.t.; ii: 
CuCl (10 mol%), aniline (1 eq), THF,  Ä; iii:  CuCl (11 mol%), THF, Ä. 
 
Scheme 39: Synthetic route for the formation of the dihydroquinoline substrate (137). 
 
The reaction depicted above in Scheme 39 was also attempted without the 
intermediate (136) being isolated, with the addition of the 11 mol% CuCl being 
performed after 3 hours without stopping the reaction. The reaction was then 
continued in the same manner as when the intermediate was isolated and left 
overnight.  However, although the reaction was found to proceed to the fully cyclised 
product, far lower conversions were achieved than when the intermediate was 
isolated.  
 
Initially, problems were encountered using this reaction system with low conversions 
being recorded, and we thought that this maybe due to the acetate leaving group not 
being sufficiently active. We felt that a sulfonyl group on the alcohol might provide a 
more active leaving group, and as such reaction of the alcohol with mesyl chloride 
was attempted (Scheme 40), but unfortunately the desired product (138) could not be 
isolated. The literature also reported a similar reaction being carried out using 3-
chloro-3-methyl-but-1-yne (139), 68 so we felt that perhaps this might provide a more 
successful pathway to the required product. However, the isolation of this compound 
proved difficult at that time (Scheme 41), and this approach was abandoned. 
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Reagents and Conditions: Et3N (1.2 eq), Mesyl chloride (1.1 eq), DCM, r.t. 
 
Scheme 40: Attempted preparation of the sulfonyl protected of 2-methyl-3-butyn-2-ol. 
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                  139 
Reagents and Conditions: CaCl2 (1 eq), hydroquinone (10 mol%), HCl (5 eq), r.t. 
 
Scheme 41: Attempted route for the deoxychlorination of 2-methyl-3-butyn-2-ol. 
 
 
Table 8: Optimised conditions for the formation of product 137. 
 
The original paper by Hamann et.al., 67 stated that dry conditions were to be used and 
we considered it possible that the failure of the reaction could be due to the THF 
being used in the reaction not being sufficiently dry enough. To examine this, a test 
Reaction Type Temperature 
Time Taken 
(Hours) 
Overall yield of 
compound 137 (%) 
Aniline + 2-methylbut-
3-yn-2-yl acetate 
Room 
temperature 
96 46 
Aniline + 2-methylbut-
3-yn-2-yl acetate 
60°C 48 51 
Aniline + 2-methylbut-
3-yn-2-yl acetate 
Reflux (80°C) 17 83 
Aniline + 2-methylbut-
3-yn-2-yl acetate 
Reflux (80°C)  
THF left 2 hours 
17 54 
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reaction was performed in THF which had been directly distilled from the sodium 
benzophenone ketyl radical before being used, and the reaction was found to proceed 
well. Following on from this a series of reactions was carried out to determine the 
optimum reaction conditions, and these were found to be when dry THF was taken 
directly from the still and the reaction heated under reflux at 80 °C (Table 8). We 
found that if the reaction temperature was too high the reaction mixture appeared to 
decompose to give unidentifiable products, and if the reaction temperature was too 
low then the reaction proceeded very slowly, with a large amount of starting material 
remaining even after 96 hours. We also noted that if the THF was left to stand for 
even a couple of hours the reaction proceeded less efficiently, resulting in a much 
lower overall yield. 
 
With the reaction conditions now optimized, a selection of the dihydroquinoline 
substrates were prepared using five different anilines (Table 9), with some examples 
found to proceed in good overall yields. However, it was found that when the 
synthesis of the para-nitroaniline (147) and para-cyanoaniline (149) compounds was 
attempted, it was not possible to obtain the fully cyclised product, probably due to 
the electron-withdrawing nature of the groups reducing the overall nucleophilicity of 
the aniline. As previous research within the group had found that epoxidation 
reactions tended to proceed better with electron rich alkenes,49,50,56 it was decided to 
continue this investigation with the dihydroquinoline compounds containing 
electron-donating groups without further attempts to synthesize the dihydroquinoline 
compounds containing the electron-withdrawing groups. 
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Table 9: Dihydroquinoline intermediates and products formed. 
 
With a selection of dihydroquinoline substrates and the required catalyst synthesized, 
it was then necessary to prepare the required oxidant, and as such 
tetraphenylphosphonium monoperoxysulfate (TPPP) was prepared according to the 
literature procedure (Scheme 42).53,69 The TPPP oxidant was then isolated and stored 
in the freezer to be used as required. 
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Ph4P+ Cl- + Oxone® (2KHSO5:KHSO4:K2SO4)                                    Ph4P+(HSO5)- 
 
Scheme 42: Preparation of tetraphenylphosphonium monoperoxysulfate. 
 
Before commencing reaction on the dihydroquinoline substrates we decided to test 
that both the oxidant and catalyst were working. A test reaction was performed using 
6-chloro-2,2-dimethyl-2H-chromene (150). As this substrate had been previously 
epoxidised within the group, it would enable an easy comparison to be made. The 
reaction was performed as shown in Scheme 43 and the required epoxide (151) was 
formed in 81% yield. A racemic epoxide was then prepared to enable the 
enantiomeric excess (ee) to be determined by chiral HPLC. For this 6-chloro-2,2-
dimethyl-2H-chromene was reacted with 2.2eq of m-CPBA in DCM (Scheme 44).  
The ee value was then determined by chiral HPLC using a 99:1 mixture of hexane 
and isopropyl alcohol. The racemic epoxide was run first to provide standard peaks 
for the two enantiomers, followed by the chiral racemic epoxide, and the peaks 
compared. Using the standard enantiomeric excess equation (major - minor / major + 
minor) x 100%, the ee value was determined, which was found to be in this case 85% 
ee. This compared well to the 93% ee achieved previously in the group, 49,50,56 
showing that the catalyst and oxidant were both of suitable quality for further 
epoxidations on the new substrates to be attempted. 
 
TPPP (2eq)
Cat (132) (10mol%)
Chloroform
-40oC 24hours
O
Cl
O
Cl O
150 151
 
 
Scheme 43: Chiral expoxidation of 6-chloro-2,2-dimethyl-2H-chromene 
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Scheme 44: Racemic expoxidation of 6-chloro-2,2-dimethyl-2H-chromene 
 
The same reaction procedure as previously described in Scheme 43, was then 
performed on the corresponding nitrogen based dihydroquinoline (143). 
Unfortunately, epoxidation of this compound did not occur; surprisingly however, 
analysis of the reaction mixture showed no formation of the possible N-oxide 
product. Instead, all of the original starting material had disappeared and only an 
unidentifiable mixture remained.  
 
We thought that this maybe due to an interaction between the catalyst and the 
nitrogen lone pair, and therefore, we felt that the reaction might proceed better if the 
nitrogen was protected in some way. Acetate protection was attempted first, as it was 
postulated that the carbonyl group might withdraw electron density away from the 
nitrogen, making the catalyst more reactive to the olefin. The acetate protection of 
the aniline based dihydroquinoline compound (141) and the chlorodihydroquinoline 
compound (143) was achieved efficiently by dissolving the compounds in DMC, 
with acetyl chloride and DMAP and stirring the reaction mixture overnight at room 
temperature. Both reactions were found to proceed well, with yields of the acetate 
protected compounds (152) and (153) of 74% and 72% respectively. 
 
Disappointingly, however, when epoxidation of the acetate protected 
chlorodihydroquinoline compound (153) was attempted using the TPPP conditions 
above, only starting material was retrieved from the reaction (Table 10, entry 6), and 
this continued to be the case when the epoxidation was attempted with the other 
acetyl-protected dihydroquinoline compound (152) (Table 10, entry 4).   
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Table 10: Attempted epoxidations of various protected dihydroquinolines. 
 
Previous research within the group49,50,52,56 had shown that electron-rich alkenes 
underwent epoxidation better than electron-poor ones, and in the case of the acetate 
protected dihydroquinolines it was possible that the acetate group may have been 
pulling too much electron density out of the alkene bond making it less reactive to 
the oxaziridinium. It could also be that the low temperatures used in the TPPP 
reaction may result in a further decrease in epoxidation reactivity.  
 
To test the first of these hypotheses the reaction was attempted using the acetate 
protected chloro-dihydroquinoline compound (153) and m-CPBA (Scheme 45), and 
this was found to proceed well (Table 10, entry 5), resulting in the desired epoxide 
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(155) in a near quantitative yield. This indicated that it may indeed be the case that 
the acetate group is decreasing the reactivity of the olefin to the oxaziridinium, which 
would make epoxidation all the more difficult when coupled with the low reaction 
temperatures used in the TPPP reaction.  
 
N
O
Cl
N
O
Cl Om-CPBA (2 eq)
DCM
0 oC
155
93% yield
153
 
Scheme 45: Reaction of the acetate protected chloro-dihydroquinoline compound (153) with 
m-CPBA. 
 
To assess the implication of the reaction temperature on reactivity it was decided to 
attempt the reaction using both the groups original Oxone® conditions, where the 
reaction is carried out at 0 °C (Scheme 46) and the TPPP conditions, also at 0 °C 
instead of -40 °C.  
 
Both TLC and 1H NMR analysis showed slight epoxide formation (ca. 5%) in the 
Oxone® system after 24 hours. The reaction was then stopped at this point, as the 
likelihood of any further epoxidation occurring was unlikely due to decomposition of 
the Oxone® oxidant. Disappointingly, there was still no epoxide spot present in the 
TLC from the corresponding TPPP reaction. 
N
O
Cl
N
O
Cl O
Oxone  (2eq),
Na2CO3 (4eq)
Cat (132)(10mol%)
0 oC
MeCN/H2O

 
   153      155 
 
Scheme 46: The standard epoxidation conditions using Oxone®. 
 
These results indicated that although epoxidation did appear to be possible, it was 
likely that a less electron-withdrawing protecting group would be required for the 
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reaction to proceed in a high yield. We decided that the use of a more electron rich 
protecting group, such as a benzyl or methyl protecting group, may provide a more 
reactive substrate and potentially provide better results. Both benzyl protection 
(Scheme 47) and N-methylation (Scheme 48) were attempted. 
 
N
H
Cl
N
ClNaH (1.1eq)BnBr (1.1eq)
DMF (20ml)
 
   143      154 
Scheme 47: Reaction conditions used for the benzyl protection of compound (143). 
 
N
H
Cl
N
ClK2CO3 (1.3 eq)MeI (1.2eq)
DCM (20ml)
r.t - 24 hours
 
 
   143       
Scheme 48: Reaction conditions of the attempted methylation of compound (143).  
 
The benzyl protection of the chlorodihydroquinoline compound (143) proceeded well 
yielding the benzyl protected compound (154) in an 80-85% yield. Unfortunately, 
despite repeated attempts, methylation of the chlorodihydroquinoline compound 
(143) proved impossible. The methylation was initially attempted using MeI, 
however this only yielded starting material. Methylation was also attempted using a 
range of bases, such as n-BuLi and NaH, and different methylating reagents such as 
dimethyl sulfate, but even with repeated attempts the reactions all still only yielded 
starting material. 
 
Further disappointment followed, as despite a less electron-withdrawing protecting 
group being present, the epoxidation in the TPPP system at −40 °C, 0 °C or room 
temperature still did not occur with the benzyl protected compound (154), with the 
reactions still yielding only starting material. The epoxidation reactions were 
repeated with the Oxone® system and even this system also showed no epoxidation 
product. At this point we felt that the nitrogen may be unavoidably interacting with 
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the catalyst and inhibiting its activity completely. This proposal is supported by the 
fact the epoxidation can occur with m-CPBA, where no catalyst is used, even with a 
very electron-withdrawing group in place on the nitrogen.  
 
As mentioned above, other research within the group had focused on prochiral 2,2-
dimethylchromenes (124), and had shown that these particular substrates could be 
epoxidised with very high enantioselectivties.57 Following on from this initial 
research, we felt that it would be interesting to examine whether chiral 2-substituted 
chromenes would display the same high enantioselectivities. If this was found to be 
the case then the epoxidation could possibly be used in a kinetic resolution-based 
synthesis of a natural product, such as had been reported by Jacobsen,63 where he had 
looked at the use of enantioselective epoxidation as a form of kinetic resolution, and 
applied this to the synthesis of (+) teretifolione B (Figure 25). 
 
O
O
O
OH
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N N
O O
Cl
t-But-Bu
t-But-Bu
H H
 
 
Figure 25: (+) Teretifolione B and the (salen)Mn catalyst used by Jacobsen. 
 
Even more importantly, if it was found that the groups epoxidation system could be 
used as a kinetic resolution technique, then this would be the first example of kinetic 
resolution performed using an oxaziridinium salt-based catalyst. 
 
To test the possibilities of kinetic resolution we began looking for a possible natural 
product target of which the synthesis of a basic analogue of the target could be used 
to obtain an idea on the epoxidation rate and enantioselectivity of that type of 
substrate. Due to the previous work within the group we felt that the best target 
would be one based on a similar structure to the prochiral 2,2-dimethylchromenes 
tested previously, and examination of the literature led to a paper by Schram70 
describing the synthesis of epigallocatechin gallate (EGCG). Due to EGCGs 
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chromene-based structure we felt it could be considered as a potential natural product 
target. 
Epigallocatechin gallate (EGCG) (156) is a natural product found in green tea and it 
is thought to be the responsible agent for the antioxidant properties of green tea.71 
Antioxidants have received a considerable amount of attention in the media recently 
because of their alleged ability to counteract cancers, thought to be made possible by 
the antioxidant mopping/scavenging up some of the radicals that cause cells to 
become cancerous in the first place. The presence of such radicals may be caused by 
such environmental factors as smoke, pollution, radiation and some herbicides.71 
Epigallocatechin gallate (EGCG) has a chromene-based core structure and we 
envisaged that a selective epoxidation of the chiral 2-substituted chromene (157), and 
kinetic resolution, as shown below in the proposed retrosynthetic route (Scheme 49), 
could provide a simple route to its synthesis. We decided that it would be easiest to 
synthesize an EGCG analogue, with the alcohols protected to lessen the probability 
of side reactions occurring. 
 
 
 
 
     
 
 
 
 
     
 
Scheme 49: Possible retrosynthetic route to EGCG. 
 
A review of the literature found several routes to basic chiral 2-substituted chromene 
structures (158). Norths procedure,72 in which a phenol is cyclised with an á,â-
unsaturated acetal (Scheme 50), was thought to be a simple route which could easily 
be modified by varying both the phenol and acetal used to produce various chromene 
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analogues, which would be useful when examining the potential application to 
kinetic resolution.  
 
R
O
R
OR1
O R
R2
OR1i(a) or i(b)
OH
R2
ii
R = Me, Pr, i-Pr, Ph
R1 = Me, Et
R2 = CN, Me, NO2, Cl
158
        
Reagents and Conditions: i(a): (R1O)3CH (1.2 eq), NH4NO3, ethanol (50ml), or i(b): R1OH (10 eq,), 
Et3N (0.5 eq), TiCl4 (0.25 eq.); ii: phenol (2 eq), 3-picoline (0.25 eq), p-xylene (40ml), reflux. 
 
Scheme 50: Formation of the chromene by acetalization and cyclization. 
 
The á,â-unsaturated acetals were initially prepared using a method by Clerici et al. 
which involved reacting the corresponding aldehyde under nitrogen, with a dry 
alcohol (ethanol or methanol), in the presence of a catalytic amount of TiCl4 to form 
the corresponding alcohol-derived acetal (Scheme 50, ib).73 However, this reaction 
proved both very capricious, with yields varying from quantitative to as low as 30%, 
and very time consuming, as it required dry glasswear, an inert atmosphere and a 
very slow addition of TiCl4 due to the volatility of the reaction. This led to a more 
reliable reaction being sought. A paper by Mori et al.74 provided an ideal alternative, 
where a mixture of the aldehyde, triethyl orthoformate and a catalytic amount of 
ammonium nitrate in ethanol stirred at room temperature yielded the required á,â-
unsaturated acetal in a quantitative (and reproducible) yield (Scheme 50, ia), with no 
special considerations being required. Using this improved technique it was possible 
to synthesize four different á,â-unsaturated acetals, which would provide a good 
variety of substitution at the 2 position (Table 11). The acetalisation reaction was 
also attempted with methanol as the alcohol. However, despite also giving a 
quantitative yield of the acetal, the acetal (163) itself was found to be less stable. 
 
 
 
 
 74 
 
Starting Aldehyde Acetal 
Conversion 
(%) 
Yield of 
Acetal (%) 
O
 
EtO
OEt
     
159 100 92 
O
 
EtO
OEt
 
160 100 95 
O
 
OEt
EtO
  
161 100 91 
O
 
OEt
EtO
 
162 100 96 
O
 
OMe
MeO
 
163 100 91 
 
Table 11: Acetalisation of aldehydes. 
 
With a selection of acetals synthesized it was then possible, using the procedure 
developed by North,72 to react the acetals with some chosen phenols to form the 
corresponding cyclised chromene compounds (Scheme 50).  
 
The cyclisation reaction was attempted first using 4-cyanophenol and 3,5-
dimethoxyphenol, and the acetal derived from cinnamaldehyde (162), with both 
proceeding in good yields (>80%). These particular phenols and acetal were chosen 
first for three main reasons, 1) the acetal used would result in a similar group at the 
2-position as in the natural product, 2) 3,5-dimethoxyphenol could be used in the 
natural product analogue and 3) para-cyanophenol was used in the synthesis of 
Levcromakalim, which gave the groups highest ever ee.57 Advantageously, upon 
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purification by column chromatography, 2-phenyl-2H-chromene-6-carbonitrile (164) 
spontaneously crystallized straight from the column fractions, enabling a crystal 
structure to be obtained of this new chromene species.  
 
O
NC
164
 
 
Figure 26: Diagram and crystal structures of 
2-phenyl-2H-chromene-6-carbonitrile. 
 
It was also found that by increasing the 
number of equivalents of the phenol 
used compared to Norths original 
procedure, higher and purer yields of the 
chromenes could be produced. This is 
because whereas the acetal and the 
cyclised product have a similar polarity on silica, the phenol is much more polar. 
With an excess of phenol present the reaction is driven forward until all the acetal is 
reacted. Then during purification the polar phenol elutes at a much slower rate than 
the cyclised product, resulting in both high yields and pure compounds.  
 
Once these two chromene compounds had been synthesized, it was then possible to 
attempt epoxidation of the compounds.  
 
We felt that the 2-phenyl-2H-chromene-6-carbonitrile compound (164) would be 
best to start with, as it was both the purest and the easiest compound to synthesize 
and purify. A racemic m-CPBA epoxidation was attempted first, using 4 equivalents 
of m-CPBA, as shown in Scheme 51. 
 
 76 
O
NC
Ph O
NC
O
NC
PhPh
O O
trans cis85:15165 166
m-CPBA (4 eq.)
DCM
0 oC164
 
 
Scheme 51: Epoxidation of 2-phenyl-2H-chromene-6-carbonitrile (164) using m-
CPBA. 
 
The reaction proceeded well, yielding the corresponding racemic epoxide in a 
quantitative yield. Interestingly the reaction also proved to be diastereoselective, with 
major (165) and minor (166) epoxides being produced in a 85:15 ratio. We felt that 
the major epoxide was likely to be the trans-isomer as this would be more favoured 
due to the approach of the m-CPBA towards the opposite side to the phenyl 
substituent as this would be least hindered, thus favouring the trans-epoxide 
formation. Luckily, a crystal of the major product (as determined by 1H NMR) was 
obtained, and subsequent crystal structure analysis of the major product showed that 
the trans-product was indeed the major product formed in the reaction. 
 
 
 
 
 
 
 
 
 
Figure 27: Crystal structure of the major trans-epoxide (165). 
 
The diastereoisomeric mixture containing the epoxides (165) and (166) was purified 
by column chromatography and an HPLC trace obtained using a chiral column. The 
trace below (Figure 28) shows the minor diastereoisomeric product at 16.120 and 
19.907 minutes and the major at 17.533 and 23.263 minutes. 
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Figure 28: HPLC trace of the diastereoisomeric mixture containing the epoxides 
(165) and (166). 
UV Results  
Retention 
Time 
Area Area % Height Height % 
Major or Minor 
Diastereoisomer 
16.120 11386400 5.26 341325 10.89 Minor (166) 
17.533 92241012 42.63 2244114 47.03 Major (165) 
19.907 13493320 8.06 278414 5.83 Minor (166) 
23.263 95325378 44.05 1729502 36.25 Major (165) 
Totals 212446110 100.00 13958291 100.00  
 
For a kinetic resolution using a chiral epoxidation, we decided that the Oxone® 
conditions would be attempted first (Scheme 52), as we felt that although these 
conditions are generally less enantioselective, the higher reactivity would mean it 
would be easier to gauge the potential of a kinetic resolution on these type of 
substrates, which could then perhaps be further enhanced with the use of lower 
temperatures with the TPPP conditions.  
 
 
 
 
 
 
Scheme 52: Kinetic resolution of 2-phenyl-2H-chromene-6-carbonitrile (164) using 
Oxone® conditions. 
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This first asymmetric epoxidation reaction also proceeded well, with the experiment 
being stopped when a 1H NMR spectrum of the crude reaction mixture showed that 
the reaction contained roughly half the epoxide product and half the original alkene 
starting material. As shown by the racemic epoxidation, the trans-diastereoisomer 
(165) was already known to be formed in preference to the cis-diastereoisomer (166), 
however, for a kinetic resolution to have good potential it is necessary that the 
preferential diastereoisomer be formed at a much faster rate than the other, so that at 
an approximate 50% conversion it would be the only diastereoisomer formed. It is 
also be important that one enantiomer of the preferred diastereoisomer should also be 
formed with high enantioselectivity.  
 
Purification of the epoxide product from the Oxone® epoxidation and subsequent 
HPLC analysis showed both a good diastereoselectivity at 50% conversion and some 
selectivity between the enantiomers, when compared to the racemic HPLC trace. As 
can be seen from Figure 29, the Oxone® trace shows the same epoxide peaks, but 
with an enhanced selectivity for the peak at 19 minutes compared to that at 16 
minutes for the minor product, and for the peak at 17 compared to that at 23 minutes 
for the major product. Analysis of the peak areas gave ee values of 98.6% for the 
minor epoxide and 60% for the major epoxide.  
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Figure 29: HPLC trace of the diastereomeric mixture containing the epoxides (165) and 
(166) from the Oxone® epoxidation reaction. 
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UV Results  
Retention 
Time 
Area Area % Height Height % 
Major or Minor 
Diastereoisomer 
16.183 94189 0.08 3258 0.12 Minor (166) 
17.510 71979014 60.65 1712652 65.68 Major (165) 
19.817 23069777 19.44 452298 17.34 Minor (166) 
23.300 23527579 19.83 439498 16.85 Major (165) 
Totals 118670559 100.00 2607706 100.00  
 
The results obtained from this Oxone® epoxidation were encouraging and showed 
that a kinetic resolution using an oxaziridinium based catalyst is at least feasible. 
Using the TPPP epoxidation system, which enables the reactions to be carried out at 
lower temperatures, should enhance the reaction even further as it is these conditions 
which have given the best enantioselectivities to date.  
 
Unfortunately, both the attempted m-CPBA (Scheme 53, conditions i) and Oxone® 
epoxidation (Scheme 53, conditions ii) of the dimethoxy-chromene compound (167) 
only yielded an unidentifiable mixture.  
 
O Ph
OMe
MeO O Ph
OMe
MeO
Oi) m-CPBA (1 eq.), 
   DCM, 0 oC
ii) Catalyst (132) (10 mol %),
    Oxone (2 eq.)
    Na2CO3 (4 eq.)
    MeCN:H2O (1:1)
    0oC
167
   
Scheme 53: Attempted epoxidation of the dimethoxy-chromene (167). 
 
Previously within the group, an attempted epoxidation of the para-methoxy 
chromene compound (168) had also failed to result in the epoxidised product. It was 
postulated that due to the presence of the electron-rich methoxy group, the olefin was 
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very reactive and therefore prone to over oxidation, an effect which would be even 
more pronounced in a compound where two methoxy groups were present.  
 
O
MeO
168
 
 
However, despite the initial disappointment of the reaction not resulting in the 
epoxidised product, we felt that an important lesson had been learned, and that for 
the synthesis of the natural product it would be necessary to use alternative 
protecting groups. 
 
Encouraged by the initial results from the epoxidation of the cyanochromene (164) 
for the potential kinetic resolution, a range of chromene based substrates were 
synthesized to enable a full picture of the applicability of an oxaziridinium based 
kinetic resolution to be obtained (Tables 12a and 12b). The variety of chromene 
substrates were chosen to enable both steric and electronic effects to be examined. 
 
Compound Acetal Phenol Product Yield 
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Table 12a: The range of chromene substrates synthesized. 
 81 
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Table 12b: The range of chromene substrates synthesized. 
 
 82 
In the case of investigating steric effects, methyl, propyl and iso-propyl were chosen 
as alternative 2-substituents, as we felt that they would provide a progressive 
increase in the amount of steric hinderance represented by the group. It would also be 
interesting to examine the effect a straight chain group has when compared to its 
branched equivalent as in the case of the straight chain propyl and branched iso-
propyl groups. Also, in the case of the compounds with a methyl substituent, 
previous racemic epoxidation of the cyanomethyl chromene (169) by Buckle75 had 
shown that this was produced as a 1:1 ratio of diastereoisomers, which is very 
different from the 85:15 ratio obtained from the phenyl-substituted compound, and 
we therefore felt that it would be interesting to see what level of enantioselectivity (if 
any) could be obtained from the methyl substituted compounds.  
 
When looking at what effects changes in electronic properties would have, we felt 
that para-nitro, cyano, methyl and chloro groups would provide an interesting range 
of effects, in comparing electron-withdrawing substituents to electron-donating ones. 
Previous research within the group had shown that similar compounds containing a 
chloro substituent on the aromatic ring were more reactive substrate compared to 
both cyano and nitro, all of which could prove important when attempting 
epoxidation using the TPPP system. 
 
After synthesis and subsequent purification by column chromatography, each 
compound was epoxidised using m-CPBA in order to obtain a racemic HPLC trace 
and 1H NMR standard of the product epoxide to compare to future chiral 
expoxidations. It was interesting to note that all racemic compounds containing the 
methyl substituent were obtained as the expected 1:1 mixture of trans:cis 
diastereoisomers, whereas the propyl substituent gave roughly a 60:40 ratio, and the 
phenyl and isopropyl substituents a 85:15 ratio.  
 
To gauge the reactivity and selectivity of the TPPP epoxidation on the chromene 
substrates, a test chiral epoxidation using the TPPP conditions was attempted on the 
methyl substituted cyanochromene (169) (Scheme 54).  
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Scheme 54: Test TPPP epoxidation using chromene (169). 
 
It was felt that this compound was best as an initial test substrate for the TPPP 
reaction as the compound was less sterically hindered than the previous test substrate 
(164) and due to TPPP being a less reactive oxidant, the epoxidation reaction was 
more likely to proceed when using a compound with minimal steric hindrance than in 
the case of the epoxidation of a compound which was more sterically hindered.  
 
Unfortunately, it was found that no reaction occurred when the TPPP epoxidation of 
the methyl substituted cyanochromene (169) was performed at − 40 ºC, so the 
reaction was re-tried at − 20 ºC. Pleasingly, the reaction proceeded well at this 
temperature with the reaction running to 65% conversion (as determined by 1H NMR 
spectroscopy) after 2 days, though it was interesting to note that even if the reaction 
was left for more than 3 days, it never reached completion, probably due to 
decomposition of the oxidant. 
 
Purification of the TPPP epoxidation product (181) of the methyl substituted 
cyanochromene (169) enabled analysis by chiral HPLC, thereby allowing a 
comparison to be made with the trace of the racemic epoxide product run previously. 
The trace of the racemic epoxidation product (Figure 30) showed four equal peaks at 
26, 32, 42, and 44 minutes. It is important to note that this particular HPLC had to be 
run in 90:10 hexane:isopropyl alcohol due to the peaks co-eluting when run at 80:20, 
which is the value that was used for the epoxidation products obtained from the 
epoxidation of the phenyl cyanochromene (164). 
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Figure 30: Trace of the product (181) of the racemic epoxidation of compound (169). 
 
The trace of the asymmetric epoxidation reaction product (Figure 31) appeared to 
show some selectivity, but as can be seen from the HPLC trace of the racemate 
(Figure 30), due to the racemic epoxidation reaction resulting in a 1:1 mixture of 
diastereoisomers (i.e. there were no major and minor products formed), it was not 
possible to determine which peaks related to which diastereoisomer from the trace of 
the racemate alone.  
 
This was unlike the previous epoxidation example of the phenyl substituted 
cyanochromene (164) where there were obvious major and minor diastereoisomeric 
products in the racemic reaction, enabling quick identification of which peaks 
corresponded to which diastereoisomer. Therefore, to establish which peaks related 
to which diastereoisomer for the methyl substituted cyanochromene (169), a 
preparative HPLC was run on the racemic epoxide. This showed two peaks at 65 and 
70 minutes when run in 90:10 hexane:isopropyl alcohol. These fractions were 
collected and run using the chiral HPLC, showing that the peaks at 26 and 33 
minutes were from one diastereoisomer and the peaks at 42 and 45 minutes from the 
other. From this, ee values of 66% and 47% respectively were calculated, with a 
diastereoisomeric ratio of 3:1.  
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Figure 31: Trace of the epoxidation product (181) from the asymmetric epoxidation 
reaction. 
 
UV Results  
Retention 
Time 
Area Area % Height Height % 
Major or Minor 
Diastereoisomer 
26.853 298317 3.72 6810 5.75 Minor 
33.317 1949413 24.28 32908 27.79 Minor 
42.623 4139333 51.55 57686 48.71 Major 
45.310 1641132 20.44 20941 17.68 Major 
Totals 8029241 100.00 118435 100.00  
 
These results were really promising, as the enantioselectivity was good and even the 
diastereoselectivity was reasonable considering that the reaction had run to 65% 
completion, whereas an optimum kinetic resolution would typically require the 
reaction to be stopped at or below 50%.  
 
Asymmetric epoxidations using the TPPP system at − 20 ºC were then performed on 
all the substrates, as shown in Table 13, this time attempting to stop the reaction at or 
before 50% conversion.  
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Compound Product Conversion (%)b 
Major 
Enantiomer 
ee (%)c 
Recovered 
Starting 
Material 
ee (%)c 
 
Diastereo- 
isomer  
Ratio 
(cis:trans)d 
 
 
O
R
 
 
O
R O
 
    
 R =  CN  (169) R =  CN  (181) 48 76 69 15:1 
 NO2 (170)  NO2      (182) 45 63 nae  20:1 
 Cl (171)  Cl  (183) 52 75 57 10:1 
 
O
R
 
 
O
R
 
    
R =         NO2 (174) R =  NO2 (184) 42 81 79 25:1 
 Cl (175)    Cl (185) 53 80 nae 14:1 
 
O
R
 
 
O
R
 
    
R =         CN (164) R =  CN (186) 42 72 nae 24:1 
 NO2 (176)          NO2 (187) 20 naf  nae na 
 Cl (177)          Cl (188) 48 78 nae 20:1 
 
O
R
 
 
O
R
 
    
R =         CN (178) R =         CN (189) 26 naf nae naf 
 Cl (179)          Cl (190) 45 82 nae 26:1 
 NO2 (180)   NO2 (191) 20 naf nae naf 
 
a
 All reactions were carried out with substrate (1 equiv.), catalyst (10 mol%) and 
tetraphenylphosphonium monoperoxysulfate (TPPP) (4 equiv.) in CHCl3 at − 20 °C. The 
temperature was then slowly raised to − 10 °C overnight. 
b
 Conversion was determined by NMR analysis of the crude reaction mixture. 
c
 Enantioselectivity was determined using a Chiralcel ODH column, with the chiral traces 
being compared to those obtained for the racemic compound and starting material. 
d
 The diastereomeric ratios were determined from the chiral HPLC trace. 
e
 It was not possible to separate the diastereomers to obtain an ee value. 
f
 These compounds proved too unreactive to be used in the kinetic resolution. 
 
Table 13: Kinetic resolution of olefins using asymmetric epoxidation mediated by catalyst 
(132).a 
 
In all cases, it was found that the compounds containing the chlorosubstituent on the 
aromatic ring were the most reactive and although this slightly affected the 
diastereoselectivity, with ratios of around 10:1 to 15:1, the enantioselectivities 
remained relatively high with ee values at around 75 to 85%. The highest 
 87 
diastereoselectivities were observed using those compounds containing electron-
withdrawing groups, with the nitro containing chromene yielding diastereoisomeric 
ratios of around 20:1 to 25:1.  
 
Increasing the size of the group at the C2 position does seem to effect a small 
increase in both diastereo- and enantioselectivity, probably due to this group 
restricting access to one face of the chromene, and therefore enhancing trans-
diastereoselectivity. Although this effect is also observed in the racemic 
epoxidations, with the propyl, phenyl and isopropyl groups showing preference for 
the trans-epoxidation product in 1.5:1, 4:1 and 9:1 ratios respectively, the effect is 
enhanced even further when using the TPPP epoxidation system. In fact this steric 
effect is so pronounced that in the case of the isopropyl compounds, only the chloro 
substituted example (179) was sufficiently reactive to provide a high enough 
conversion to assess the kinetic resolution for that substrate; all the remaining 
compounds in that group showed little or no conversion to the epoxide after 4 days, 
and even raising the reaction temperature to 0 °C had no effect on conversion.  
 
As kinetic resolution reactions are terminated at approximately 50% conversion, the 
reaction also results in the resolution of the remaining starting material. In order to 
establish the degree to which the kinetic resolution using the epoxidation reaction on 
the chromene substrates had resulted in the resolution of the starting material, we 
obtained HPLC traces of both the racemic starting material and the starting material 
remaining after the asymmetric epoxidation reactions were performed. As can be 
seen from the results in Table 13, in some cases it was not possible to separate the 
starting material enantiomers by HPLC, despite varying the ratio of eluents and the 
elution rate.  Separation by gas chromatography was also attempted on the more 
volatile substrates; unfortunately it was still not possible to separate the enantiomers 
resulting in the determination of an ee being impossible. However, in the cases where 
it was possible to separate the enantiomers, it can be seen that the reaction indeed led 
to resolved starting material, with ees of up to 71%. 
 
With a kinetic resolution now feasible using the TPPP epoxidation system, we felt 
that the methodology should be applied to the synthesis of epigallocatechin gallate 
(EGCG) as previously proposed. EGCG (156) is a poly-hydroxylated compound, so 
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in order to decrease its polarity and minimize the possibility of side reactions with 
the free hydroxyl groups, a protected version would need to be synthesized, with the 
protecting groups being removed at the end of the synthesis. To synthesize a 
protected chromene which could be used as the EGCG precursor it was decided to 
test potential routes using easily available and cheap starting materials. Although, as 
noted previously, alternative protecting groups would need to be used, the simplest 
initial route appeared to be to cyclise commercially available 3,5-dimethoxyphenol 
with the acetal (192), as shown in Scheme 48, using the procedure developed by 
North,72 which had proved so efficient previously. This would result in the methoxy-
protected chromene (193) product as shown (Scheme 55). 
 
 
 
 
 
 
 
Scheme 55: Possible route to a close EGCG analogue. 
 
As the acetal (192) was not commercially available and neither was the 
corresponding aldehyde, the first step of the potential synthetic route was to prepare 
this compound, either directly or indirectly through the aldehyde.  
 
A review of the literature showed that the only known routes to the acetal were 
through the aldehyde. The synthesis of the aldehyde was attempted by following part 
of the literature procedure shown in scheme 56,76 where 3,4,5-
trimethoxybenzaldehyde  (196) is converted to the á,â-unsaturated ester (197) and 
then reduced to the aldehyde (198). To obtain 3,4,5-trimethoxybenzaldehyde (196), 
3,4,5-trimethoxybenzoic acid (194) was converted to the alcohol (195) using a 
LiAlH4 reduction, a subsequent PDC oxidation then provided the aldehyde (196) in 
excellent yield. Later, to save time, these steps were replaced by buying 3,4,5-
trimethoxybenzaldehyde. The aldehyde was then converted to the 3-(3,4,5-
trimethoxyphenyl)acrylic acid ethyl ester (197) using a Horner-Wadsworth-Emmons 
reaction also in a good yield. Unfortunately this route proved to be ultimately 
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unsuccessful, as despite repeated attempts the reduction of the ester (197) to the 
aldehyde (198) using DIBAL proved futile. The reaction did not even yield the 
alcohol, which would have resulted if over-reduction of the ester had occurred. 
Analysis of the H1 NMR spectrum showed only an unidentifiable mixture. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Reagents and Conditions: i: LiAlH4 (1.1 eq), THF, -78 °C, (95%); ii: PDC (0.75 eq), DCM, 4A 
molecular sieves, (86%); iii: OP(OEt)2CH2COOEt (1.2 eq), NaH (1.2 eq), THF, -78 °C, (80%), iv: 
DIBAL (1.1 eq), toluene, -78 °C. 
 
Scheme 56: Formation of 3-(3,4,5-trimethoxyphenyl)acrylic acid ethyl ester. 
 
Knowing how capricious DIBAL reductions can be, a LiAlH4 reduction was also 
attempted (Scheme 57), with the thought that if the ester (197) could be reduced 
down to the alcohol (199), it would be possible to oxidize it back to the aldehyde 
(198) using the PDC method employed in the previous oxidation of the alcohol (195) 
to the aldehyde (196). However, analysis of the reduction product showed only an 
unidentifiable complex mixture, and none of the expected alcohol product.  
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Scheme 57: Attempted routes to 3-(3,4,5-trimethoxyphenyl)propenal (198). 
 
Another method found in the literature showed a route to the aldehyde straight from 
the ester, this time using LiAlH4 and diethylamine.77 The paper proposed that during 
the reaction, the amine coordinates to the aluminium, forming an alane-amine 
complex with AlH3, leaving only one hydride equivalent available for the reduction. 
However, attempts using this route also led to an intractable mixture with no 
identifiable products being isolated. 
 
At this point we decided that other routes to the chromene precursor which did not 
require the acetal, should also be explored. A further examination of the literature for 
other potential routes to a suitable chromene precursor led to the discovery of a paper 
by Chassaing et al.78 This paper showed the formation of a flavylium salt skeleton 
from an aryl ethynyl ketone and phenol and we thought that once the salt (200) had 
been synthesized, it could then be reduced to yield the required chromene for the 
natural product EGCG (193) (Scheme 58).  
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Scheme 58: Possible reduction of flavylium salt (200) to yield the EGCG precursor (193). 
 
To form methoxy flavylium salt (200), it was first necessary to synthesize the 
required aryl ethynyl ketone (202). This was achieved by reacting 3,4,5-
trimethoxybenzaldehyde (196) with ethynyl magnesium bromide to furnish the 
alcohol (201) in good yield. The alcohol was then oxidized to the ketone (202) using 
IBX, also in good yield. The aryl ethynyl ketone and the required phenol, in this case 
3,5-dimethoxyphenol (203), were then placed in a flask and an excess of 
hexafluorophosphoric acid, in the minimum of acetic acid, was added, causing the 
reaction to turn a dark red colour. The reaction mixture was stirred for a further two 
days, after which diethyl ether was added causing a dark red precipitate to form. The 
solid was filtered off and washed, yielding the clean product (200) in good yield with 
no need for further purification (Scheme 59). 
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Reagents and Conditions: i: MgBrCCH (1.1eq), THF, N2, 0 °C, (87%); ii: IBX (1.2 eq), acetone, 
reflux (78%); iii: HPF6 (2 eq), AcOH (0.1 eq), 2 days (89%). 
 
Scheme 59: Synthesis of flavylium salt (200). 
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The methoxy-protected flavylium salt (200) was then reduced using LiAlH4, though 
it was not known at which carbon the hydride attack would occur. We hoped that the 
attack would occur at the C2 carbon to yield the flav-3-ene, but we feared that the 
bulky phenyl group also present at the C2 position would cause the hydride attack to 
occur at the C4 position to yield the flav-2-ene (204), and this indeed proved to be 
the case.  
O
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MeO OMe
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OMe
204
 
 
Despite this it was felt that an epoxidation should still be attempted and accordingly 
a TPPP-mediated epoxidation was performed. Disappointingly, no epoxidation was 
detected by TLC, and workup of the reaction showed no epoxide present in the 1H 
NMR spectrum only an unidentifiable mixture. Two possible reasons were 
postulated; 1) it was felt that the presence of a large number of methoxy groups may 
have made the olefin very reactive and so prone to over-oxidation even in the less 
reactive TPPP conditions, as seen in previous epoxidation attempts on compounds 
containing methoxy groups; or 2) it was also possible that the location of the oxygen 
next to the olefin may have made the epoxide inherently unstable, resulting in 
formation of the alcohol or diol, even though no alcohol or diol were observed in the 
1H NMR spectrum. As this had been a known possible complication, a route to the 
corresponding TBDMS protected ketone (211) had also been started. Chassaing had 
reported in his paper that when reacted with resorcinol (212) using the same 
conditions used in the synthesis of the methoxy-protected compound (200), the acid 
labile silicone protecting groups fell off during the reaction, resulting in the 
formation of the polyphenolic compound (205), which could then be protected using 
whatever protecting groups were required, and so eliminating the potential over-
oxidation resulting from the methoxy protecting groups (Scheme 60).  
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Reagents and Conditions: i: TBDMS-Cl (4 eq), imidazole (4 eq), DMF, r.t. 20 h, (92%); ii:LiAlH4 (1 
eq), THF, reflux, (60%); iii: PCC (1 eq), DCM, 2 h, r.t. (85%); iv:  MgBrCCH (1.1eq), THF, N2, 0 °C, 
(87%); v: IBX (1.2 eq), acetone, reflux (78%); vi: HPF6 (2 eq), AcOH (0.1 eq), 2 days (89%). 
 
Scheme 60: Possible synthesis of polyphenolic flavylium salt (205). 
 
To form the polyphenolic compound (205), methyl gallate (206) was protected using 
tert-butyldimethylsilyl chloride to yield the tri-protected compound (207). This 
compound was then reduced to the alcohol (208) using LiAlH4, before being 
oxidized to the aldehyde (209) using PCC. However, in light of the flav-2-ene being 
produced during the reduction step, it was decided that the synthesis should be halted 
at this point to pursue methods which would lead more directly to the required 
compound. 
 
Whilst attempting the flavylium salt synthesis route, we located another route to 
another potential EGCG chromene precursor (213). 79  
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Figure 32: Potential benzyl protected EGCG chromene precursor (213). 
 
In this synthetic route, a chalcone intermediate structure (220) is formed from 
reaction between a substituted hydroxyacetophenone (219) and a substituted 
benzaldehyde (217); the chalcone (220) is then condensed to form the required 
chromene (213) (Scheme 61).79 We decided that for our synthesis of the EGCG 
chromene intermediate the compounds would be benzyl protected, as this protecting 
group would be easier to remove and is less electron donating than in the previously 
used methoxy protecting group.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 61: Synthesis of the EGCG precursor (213). 
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To obtain the required benzyl protected aldehyde (217), methyl 3,4,5-
trihydroxybenzoate (214) was tri-benzyl protected (215) and reduced to the alcohol 
(216) using LiAlH4, both in good yields. The alcohol was then oxidized to the 
aldehyde (217) using PCC, also in good yield.  The protected acetophenone (219) 
was obtained by di-benzyl protecting 2',4',6'-Trihydroxyacetophenone (218) using a 
method by Kumazawa80 in a good yield. The protected acetophenone (219) and 
aldehyde (217) were then reacted together in an aldol condensation to form the 
chalcone (220). This was followed by reduction and dehydration of the chalcone with 
NaBH4. Unfortunately this final step to the product (213) proceeded in a very low 
yield (~ 20%), with the rest of the starting material remaining un-reacted. Subsequent 
purification by column chromatography reduced this yield even further (<10%). 
Despite this, enough material was collected to enable a test epoxidation to be 
performed, however no epoxide product could be isolated with only starting material 
being obtained after workup of the reaction. Interestingly, TLC of the epoxidation 
reaction had appeared to indicate the formation of an epoxide, with the appearance of 
a spot below the starting material. As epoxides are inherently unstable, during 
workup of the epoxidation reaction it is possible that some of the epoxide present 
will react further or decompose. Due to the small amount of starting material used in 
this epoxidation reaction it was felt that the failure to isolate any epoxide product 
was most likely due to the small amount of epoxide that had formed in the reaction 
decomposing during workup. It was decided to leave the work on EGCG at this time 
and concentrate on other potential natural product targets. 
 
As noted above, the procedure by North72 is an efficient pathway for the formation of 
chromenes, allowing for many different substitution patterns and groups. A brief 
examination into the versatility of this reaction led to some multiple cyclisations 
being attempted; we felt that as well as providing potentially interesting epoxidation 
substrates, an insight into the scope of the cyclisation reaction would also be 
obtained.  For example, the reaction between resorcinol and 1,1-diethoxy-3-methyl-
but-2-ene, resulted in a 65% yield of the 2,2,8,8-tetramethyl-2H,8H-pyrano[3,2-
g]chromene (221). However, steric effects appear to limit the scope of the reaction, 
as an attempted synthesis of 2,8-diphenyl-2H,8H-pyrano[3,2-g]chromene (222) from 
(3,3-diethoxy-propenyl)-benzene yielded only starting material.  
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Figure 33: Interesting double cyclisations 
 
Examination of the literature for further possible natural products which could be 
synthesized using the groups asymmetric epoxidation yielded two interesting 
papers. The first, a paper by Lee et al.81 showed the synthesis of (+)-decursinol from 
xanthelitin using a Jacobsen epoxidation. Knowing the high levels of 
enantioselectivity observed with our catalysts on this type of substrate, it was felt that 
it would be interesting to compare our organocatalytic asymmetric epoxidation with 
that of Jacobsens Mn(salen) based epoxidation.  
 
A search of the literature showed that coumarins are widely distributed in nature, 
both in angular (such as seselin (223)) and linear (such as xanthelitin (224)) form, 
and have been shown to exhibit a broad range of pharmacological profiles.82 Such 
wide-ranging biological effects include anti-bacterial,83 anti-inflammatory,84 anti-
cancer85 and anti-HIV.86 With cancer and HIV posing serious threats to public health, 
the need for new and better treatments is ever more important. Coumarins have also 
been found to be extremely variable in structure due to the many substitution patterns 
that can be incorporated onto the basic skeleton, which in turn can influence 
biological activity.82  
 
Examples of some naturally occurring pyranocoumarins include seselin (223), 
predominantly isolated from Plumbago zeylanica, Naucleopsis caloneura, Carum 
roxburghianum, and Citrus grandis;87 xanthyetin (224) isolated from many sources 
including Zanthoxylum americanum;88 selinidin (225) isolated from Angelica 
keiskei,84 both enantiomers of lomatin (226) isolated from Lomatium nutalli and 
various Umbelliferae,89 (+)-decursinol (227) isolated from Angelica gigas,90 and (+) 
trans-khellactone (228) isolated from the aerial parts of Ligusticum elatun91 with 
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each having shown interesting  anti-inflammatory, cytotoxic and/or antitumour-
promoting activity.  
O O O O OO
O O O
O O O
HO
OR223 224
225 - R = (Z)-COC(CH3)CHCH3
226 - R = OH
227 O O O
OH
OH
228
 
Figure 34: Some naturally occurring pyrano-coumarins. 
 
As well as being interesting synthetic targets in their own right, we felt that an 
enantioselective synthesis of decursinol and its analogues from the xanthyetin core, 
would provide useful information about the ring-opening reaction which would be 
required for the eventual synthesis of EGCG.  
 
As Norths procedure had been shown to be very adaptable, the synthesis of 
xanthyetin (224) was attempted from 7-hydroxycoumarin (229) and 1,1-diethoxy-3-
methyl-2-butene (230), using the conditions described previously (Scheme 62).  
O
O
O OHO
OO O
223
229 230
i
i
OO O
224
 
 
Reagents and conditions: (i) 3-picoline (0.25 eq), p-xylene (40ml), reflux.  
 
Scheme 62: Attempted synthesis of xanthyetin by Norths procedure. 
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However, workup of the reaction yielded not xanthyetin (224) but its angular 
structural isomer seselin (223), in a very good yield. Although unexpected, this 
proved not to be a great problem as this particular core structure is also found in 
many natural products such as lomatin (226) and khellactone (228).  
 
An examination of the literature showed that lomatin (226) has only previously been 
prepared by achiral synthesis, using osthenol (231),92 2,4-dihydroxybenzaldehyde,93 
visnadin (provismine) (232),94 and seselin (223)87 as starting materials, although the 
enantiomers of lomatin have been resolved.87 Racemic trans-khellactone has been 
prepared from seselin (223) using m-CPBA followed by saponification.86 (+)-trans-
khellactone (228) has been isolated alongside the cis isomer in a 1:1 ratio from the 
alkaline hydrolysis of a number of dihydropyranocoumarins, such as peujaponisin 
(233), (-)-visnadin (232), and (+)-anomalin (234).  
 
 
 
 
 
 
 
 
 
 
 
Figure 35: Known synthetic precursors of lomatin (226) and trans-khellactone (228). 
 
To synthesize lomatin (226) the isolated seselin (223) was subjected to both an m-
CPBA and asymmetric TPPP epoxidation (Scheme 63) using the conditions 
described previously. Pleasingly, workup of both reactions yielded the desired 
epoxide (235) in good yields.  
 
O OHO O OO
OR2
OR1
232 - R1 = COCH(CH3)CH2CH3
         R2 = COCH3
233 - R1 = COCH=C(CH3)2
         R2 = COCH2CH(CH3)2
234 - R1 = R2 = COC(CH3)=CHCH3
231
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OO O
OH
228
OH
iii
O O O
i
223
 
 
Reagent and conditions: (i) TPPP (2 eq.), cat (132) (10 mol%), CHCl3, 30 °C, 24 h, 65%; (ii) 
NaBH3CN (1 eq.), BF3.OEt2, THF, 0 °C, 0.5 h, 92%; (iii) 1M aq. H2SO4 (5.5 eq.), acetone (1:2 ratio), 
r.t., 1 h. 
 
Scheme 63: Enantioselective synthesis of (−) lomatin (226) and (+) khellactone (228). 
 
Purification of both epoxide samples enabled a HPLC trace of both to be recorded 
using a chiral column. The trace of the racemate (Figure 36) derived from the m-
CPBA reaction showed the two enantiomer peaks at 15.0 and 21.8 minutes, in a 1:1 
ratio. The trace from the asymmetric epoxidation (Figure 37) reaction showed the 
same peaks at the same times, but with an obvious selectivity for one epoxide 
enantiomer. Subsequent calculation of the ee showed that seselin had undergone 
epoxidation in a 97% ee, which was equal to the highest ee achieved in our group so 
far. Conversion of the epoxide to lomatin (226) was achieved by simple reductive 
cleavage with NaBH3CN at 0 °C in 92% yield. 1H NMR and 13C NMR spectroscopy 
confirmed the formation of lomatin, and optical rotation matched the known data for 
(−)-lomatin,87 enabling the stereochemistry of the epoxide to be determined as the 
(+)-(3′S,4′S)-seselin epoxide.  
 
Acid catalysed ring opening of the epoxide (235) yielded (+)-(3S,4R)-trans-
khellactone (228) in a 95% yield using an acetone/1M H2SO4 mixture.95 
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UV Results     
Retention Time Area Area % Height Height % 
15.047 6291253 50.38 259924 63.79 
21.860 6196574 49.62 147549 36.21 
     
Totals 12487827 100.00 407473 100.00 
 
Figure 36: Chiral HPLC trace of the racemic epoxidation of Seselin. 
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UV Results     
Retention Time Area Area % Height Height % 
15.263 186713 1.69 8440 3.39 
21.893 10837392 98.31 240338 96.61 
     
Totals 11024105 100.00 248778 100.00 
 
Figure 37: Chiral HPLC trace of the enantioselective epoxidation of Seselin. 
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UV Results     
Retention Time Area Area % Height Height % 
29.503 1105171 48.10 14866 50.28 
32.283 1192560 51.90 14701 49.72 
     
Totals 2297731 100.00 29567 100.00 
 
Figure 38: HPLC trace of racemic trans-khellactone. 
 
 
Figure 39: HPLC trace of  (+)-(3S,4R)-trans-khellactone. 
 
UV Results     
Retention Time Area Area % Height Height % 
31.497 17965 1.50 327 2.12 
33.910 1176008 98.50 15097 97.88 
     
Totals 1193973 100.00 15424 100.00 
 
 
The second paper of interest was a paper by Buckle,75 which provided another 
possible epoxidation substrate. Buckle was looking at analogues of the known 
antihypertensive, Levcromakalim, and during the investigations the group had 
synthesized a seven-membered analogue of Levcromakalim (236). As 
Levcromakalim had previously been enantioselectively synthesized within the group 
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using an asymmetric epoxidation, and it had been this epoxidation which had 
resulted in the highest ee using an oxaziridinium based catalyst at that time, it 
seemed both interesting and logical to apply the same epoxidation technique to the 
seven membered ring analogue. A synthesis of the seven membered ring compound 
was proposed using the same route as Buckle, in 7 steps from alpha-tetralone, as 
shown in Scheme 64. 
 
O
O
O
OH
HO
O
R
240a R = H
240b R = Br
240c R = CN
i ii
iii
iv
v
vi
viiO
NC
237 238 239
236
 
 
Reagents and Condition: i: m-CPBA (2 eq), CHCl3, r,t, 5 days, ii: MeMgI, Et2O; iii: PTSA, toluene, 
reflux, iv: Br2, MeCO2H, MeCO2Na, v: CuCN, DMF, reflux, vi: NBS, CCl4, vii: DBN, THF, r.t. 
 
Scheme 64: Route to a seven membered chromene analogue. 
 
This route began with the Baeyer-Villiger oxidation of alpha-tetralone (237) with m-
CPBA, which yielded the required lactone (238) in an 83% yield. The lactone was 
then reacted with MeMgI to yield the hydroxyl phenol (239) in a 96% yield. 
However, attempted dehydration with PTSA did not yield the expected cyclised 
product (240a) only an unidentifiable mess. Consequently, due to time constraints we 
decided to leave the synthesis of this compound to concentrate on other potential 
epoxidation substrates, with the hope of returning to this compound at a later date. 
 
For a continued examination into further possible applications of the asymmetric 
iminium salt epoxidation, we felt that it would be interesting to examine the scope of 
compounds that could be used in the epoxidation reaction, particularly those which 
could then provide simple routes to normally less accessible substrates, such as 
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further chromene-based compounds, hydroxy-pyran based compounds or enamine-
based compounds. In this vain it was decided to examine three other substrates. The 
chromene (241), the 3,4-Dihydro-2H-pyran (242) and the enamine analogue (243). 
 
 
   
           
 
The chromene (241) was chosen as a target because of the potential application of its 
epoxide (244). It has recently been found that replacement of the cis-aminoindanol 
(245), as found in Crixivan (246), with the related cis-aminochromanol (247), affords 
compounds, such as (248) which have been found to have greater potency against 
both the wide-type (NL4-3) virus and PI-resistant HIV strains,96 and although it is 
possible to synthesize the cis-aminoindanol (245) via a Jacobsen epoxidation and 
subsequent Ritter-type reaction,97 the use of the same synthetic route using the 
corresponding chromene (241) results in formation of the coumarin (249).   
 
 
 
 
  245       246 
          
 
 
 
247 
               248  
                                         
 
     249 
 
Previously, the enantioselective synthesis of the cis-aminochromanol (247) has 
required many steps, such as that used by Hansen in 2001 (Scheme 65).98 
O
O
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O O N
H
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Reagents and conditions: (i) NaOCl (aq); (ii) catalyst (A) (6.7 mol%); (iii) KOH, H2O; (iv) AcCl, 
MTBE; (v) Oxalyl chloride, DMF, DCM; (vi) AlCl3, DCM −15 oC; (vii) LiOOH, −15 oC; (viii) 
(NH3OH)SO4, NaOAc, THF/H2O; (ix) H2, Pd/C, HBr, MeOH, 5 oC. 
 
Scheme 65: Hansens synthesis of aminochromanol (247). 
 
We felt that this could be significantly reduced if an epoxidation of the starting 
material could be achieved as suggested in Scheme 66.   
O O
O
O
N
O
O
NH2
OH
          244     
 247 
 
Scheme 66: Potential synthesis of cis-aminochromanol (247) using asymmetric epoxidation. 
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Chromene (241) was synthesized by dehydration of 4-chromanol using p-TSA in 
toluene yielding the chromene in an 86% yield. Epoxidation of the chromene (241) 
was then attempted using the TPPP conditions at  40 °C, whilst being monitored by 
TLC (Scheme 67). After 24 hours another spot appeared on the TLC below the 
original alkene starting material, indicating the formation of the epoxide. Once the 
starting material spot had completely disappeared the reaction was diluted with cold 
diethyl ether to precipitate excess TPPP in the reaction.  The solution was then 
filtered through celite® to remove the precipitated TPPP and the catalyst, and the 
filtrate was then reduced by rotary evaporation to yield the epoxide (244) as a clear 
oil which was immediately submitted for 1H NMR, as it was believed to be likely 
that the epoxide would be highly unstable.  
 
O
OH
O O
O
p-TSA (1 eq.)
hydroquinone (cat.)
toluene
Dean-Stark
TPPP (2 eq.)
catalyst (132) (10 mol%)
CH2Cl2
- 40 oC
241 244
 
 
Scheme 67: Synthesis and subsequent epoxidation of chromene substrate. 
 
Pleasingly, 1H NMR confirmed the formation of the epoxide (244) by the 
disappearance of the alkene protons from 5.87 and 6.53 ppm and the appearance of 
epoxide protons at 3.43 and 3.78 ppm. Work on completing the synthesis of the cis-
aminochromanol (247) is currently being continued within the group. 
 
As mentioned previously, we felt that 3,4-dihydro-2H-pyran (242) would provide 
another interesting initial test substrate, as any epoxide formation would provide a 
selective route to functionalised tetrahydropyran derivatives, which would be very 
advantageous as many natural products have been found which contain 
tetrahydropyran moieties. 
 
The epoxidation reaction was first attempted using the Page groups Oxone®-driven 
conditions (Scheme 68), as these were known to provide more rapid reactions, and 
we felt that using these conditions would enable a quick initial result to be obtained 
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to determine the potential of the reaction. TLC analysis of the reaction mixture 
showed, what appeared to be, full conversion to a new compound after only 3 hours.  
 
 
 
 
         
 
 
 
 
 
Scheme 68: Attempted epoxidation of 3, 4-dihydro-2H-pyran. 
 
However, workup of the epoxidation reaction and subsequent analysis by FT-IR, 1H 
and 13C NMR spectroscopy showed the formation of the diol (259) not the epoxide 
(258). The formation of the diol versus the epoxide is likely to be due to one of two 
reasons, 1) water had added across the double bond in a hydration reaction, or 2) the 
epoxide had indeed formed but was unstable, and ring opened during workup of the 
reaction mixture. 
 
To examine whether water had indeed added to the double bond, it was felt that the 
reaction should be carried out under our non-aqueous TPPP conditions using 
chloroform (Scheme 69, part i). Interestingly, this reaction showed no formation of 
any product by TLC when performed at -40 °C, though this could also be due to the 
TPPP not being reactive enough with this substrate at this low temperature. To 
investigate whether epoxidation followed by subsequent ring opening was 
responsible for the formation of the diol (259), two blank reactions were also carried 
out (Scheme 69 parts ii and iii). One contained only water and solvent, and would 
show if the presence of water was playing a part in the formation of the diol. The 
other was missing the catalyst, and would show if the oxidant alone could be 
responsible for the formation of the diol. Interestingly, neither of these reactions 
showed any reaction, indicating that it was likely that epoxidation, followed by ring 
opening was most likely to be responsible for the formation of the diol. 
O
Oxone (2eq)
NaCO3 (4eq)
Cat (132) (10mol%)
MeCN/H2O
O OH
O
OH
O
242
259
258
Oxone (2eq)
NaCO3 (4eq)
Cat (132) (10mol%)
MeCN/H2O
O
242
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Scheme 69: TPPP epoxidation of 3,4-dihydro-2H-pyran (242), and two blank 
reactions examining the importance of the catalyst. 
 
To further investigate this, two further epoxidation reactions were performed on the 
pyran substrate (242), one under anhydrous conditions with anhydrous acetonitrile in 
place of chloroform in the TPPP-driven reaction at 0 °C instead of −40 °C and one 
under aqueous conditions using a mixture of water:acetonitrile (1:1) as a solvent 
(Scheme 70). Both reactions were monitored carefully and after 12 hours, TLC 
analysis showed the formation of a product in both of the reactions, though the spot 
in the reaction containing the water:acetonitrile as a solvent was lower than that in 
the anhydrous reaction, indicating that in this reaction either the diol had formed 
directly or the epoxide was being ring opened due to the presence of water in the 
reaction. However, subsequent workup of both of the reaction mixtures and 
subsequent analysis by 1H NMR spectroscopy showed only an unidentifiable mess in 
each case.  
 
 
O
TPPP (2eq)
Cat (132) (10mol%)
Chloroform O
242
O
MeCN/H2O
O
242
No catalyst 
or oxidant. 
 
O
Oxone (2eq)
Na2CO3 (4eq)
MeCN/H2O O
242
No catalyst. 
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Scheme 70: Comparison of anhydrous and non-anhydrous TPPP epoxidations performed at 
0 °C. 
 
It was concluded from these investigations that it was most likely that the epoxide 
had indeed formed in the reaction, but was too unstable to be isolated without either 
reaction with water to yield the diol or decomposition to an unidentifiable product. 
 
As a complementary investigation to the 3,4-dihydro-2H-pyran epoxidations, we also 
decided to investigate analogous enamine substrates (243). No exact enamine 
analogues of 3,4-dihydro-2H-pyran were available commercially, but the literature 
provided various routes to the required compounds.  
 
The route of  Hu et al.99 derived a Boc protected enamine compound (261) from a 
simple cyclisation of Boc protected-hydroxycarbamate (260), with an in situ 
oxidation using Dess-Martin periodinane (DMP) (Scheme 71).  
 
 
 
 
   
           260          261 
 
Scheme 71: Hus synthesis of a Boc protected enamine 
 
We felt that due to the instability of DMP, the reaction would be best attempted with 
the DMP precursor IBX. It was at this point that an interesting side investigation 
NH
OH
Boc
1 mmol
DMP (1 eq)
pyridine (2 eq)
CH2Cl2 (10 ml)
r.t. 30 min
N
Boc
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appeared. A recent paper by Vinod100 had shown that IBX could be generated 
catalytically in situ using 2-iodobenzoic acid and Oxone® and used in the generation 
of carboxylic acids and ketones. As our group had recently shown that the oxidant 
tetraphenylphosphonium mono-peroxysulfate (TPPP), which is derived from Oxone® 
by simple counterion exchange with tetraphenyl phosphonium chloride (Scheme 72), 
can act as an Oxone® equivalent in non-aqueous organic solvents,52,53,57 we felt that it 
would be interesting to test TPPP as an oxidant for catalytic IBX production in the 
oxidation of alcohols. The use of TPPP could have possible further implications as, 
unlike Oxone®, it does not require water for solubility in organic solvents. Therefore, 
we hoped that being able to perform the reactions in the absence of water would 
result in only the formation of the aldehyde from primary alcohols, whereas Vinods 
conditions using Oxone® has resulted in production of the acid. 
 
KHSO4:2KHSO5:K2SO4  + Ph4P+Cl
CH2Cl2/H2O
10 °C, 30 min
Ph4P+ HSO5
  
 
Scheme 72:  The formation of TPPP from Oxone®. 
 
It was first necessary to identify the optimum molar ratios of 2-iodobenzoic acid and 
TPPP required to effect complete conversion in the oxidation of alcohols. 
Santagostino had originally reported the use of 1.3 molar equivalents of Oxone® in 
the formation of IBX from 2-iodobenzoic acid.101 For a direct comparison to Vinods 
original paper, acetonitrile was chosen as the reaction solvent, although in this case 
the reaction would be conducted in the absence of water in an attempt to synthesize 
the corresponding aldehydes instead of the carboxlic acids as shown in the original 
paper.  
 
Oxone® (2KHSO5.KHSO4.K2SO4) contains twice the molar active potassium 
persulfate as does TPPP (Ph4P+ HSO5), and with this in mind the intial reaction was 
carried out with 2.6 equivalents of TPPP and 0.5 equivalents of 2-iodobenzoic acid, 
using piperonyl alcohol (262) as the test substrate (Scheme 73). Pleasingly, 
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formation of the corresponding carboxylic acid was not observed, and the reaction 
proceeded to 75% conversion to the aldehyde.  In the presence of 3 equivalents of 
TPPP, the oxidation proceeded to 100% conversion to the corresponding aldehyde, 
again with no trace of the carboxylic acid.  
 
We then decided to reduce the quantity of 2-iodobenzoic acid from 0.5 equivalents to 
0.3 and 0.1 to find the minimum loading that would allow the reaction to proceed 
(Table 14).  
O
O
OH
2-iodobenzoic acid
TPPP, MeCN
O
O
O
262
 
 
Scheme 73: Test oxidation on piperonyl alcohol (262). 
 
2-
Iodobenzoic 
Acid (equiv) 
TPPP 
(equiv) 
Time/h Yield/% 
(Conversion) 
R = H 
Yield/% 
R = OH 
0.5 2.6 24 75 (75) 0 
0.5 3 6 92 (100) 0 
0.3 3 6.5 91 (100) 0 
0.1 3 8 95 (100) 0 
 
Table 14: Oxidation of piperonyl alcohol (262) with varying amounts of 2-iodobenzoic 
acid  
 
The investigation next centred around the optimization of reaction solvents.  Acetone 
and THF were discounted immediately due to previous reports of in-situ dioxirane 
and -butyrolactone formation respectively from oxidation of the solvent.100 Previous 
work within the group has found that TPPP has good solublity in acetonitrile, 
dichloromethane and chloroform;52,53,57 and as such these three solvents were 
investigated first in the oxidation of piperonyl alcohol (262), additionally 1,2-
dichloroethane, ethyl acetate and 4-methylpentan-2-one were also investigated, using 
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2-iodobenzoic acid (0.1 equiv) and TPPP (3 equiv). The results are shown in Table 
15.  
 
 
 
 
 
 
 
 
 
 
Table 15: Effect of solvent variation of the oxidation of piperonyl alcohol (262). 
 
The reaction was found to proceed effectively in acetonitrile and 1,2-dichloroethane 
(1,2-DCE), with 1,2-dichloroethane permitting particularly ready isolation of clean 
product as all reaction by-products were insoluble in the cooled reaction medium. 
Simple addition of diethyl ether to precipitate the excess TPPP, followed by filtration 
through a pad of celite, was sufficient to allow isolation of the products.  
 
The reactions performed in ethyl acetate and 4-methylpentan-2-one proceeded to 
completion only after greatly extended reaction times, perhaps as a result of the poor 
solubility of TPPP in these solvents. As a direct comparison with the previous study 
using Oxone® by Vinod,100 the reaction was also tested in aqueous acetonitrile 
(50:50), and interestingly, was found to proceed well with no formation of the 
carboxylic acid observed, in contrast to the Oxone®-driven process.  
 
Having established optimum conditions for the reaction, a variety of alcohols (262-
268), both primary and secondary, were oxidized by in-situ generation of catalytic 
IBX in the presence of three equivalents of TPPP as stoicheiometric oxidant, in the 
more successful solvents (Table 16). The protocol appears widely applicable, and 
both primary and secondary alcohols are cleanly oxidized to their corresponding 
carbonyl compounds (269-275). Work-up and purification was carried out as 
described above.  
Solvent Time/h Yield/% 
Chloroform 12 89 
Acetonitrile 6 81 
Dichloromethane 8 78 
1,2-Dichloroethane 4.5 89 
Ethyl acetate 16 72 
4-Methylpentan-2-one 15 81 
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Substrate Product Solvent Time/h Yield/% 
MeCN 6 81 
1,2-DCE 4.5 89 
 
O
O
OH
 
 
262 
 
O
O
O
 
 
269 
2-methyl-pentan-4-one 12 71 
MeCN 5.5 85 
1,2-DCE 4 89 OH
 
263 
 
O
 
 
270 
2-methyl-pentan-4-one 16 74 
MeCN 3.5 91 
1,2-DCE 3 93 
 
OH
 
 
 
264 
O
 
271 
2-methyl-pentan-4-one 12 82 
MeCN 7.5 77 
1,2-DCE 6 76 
 
OH
 
 
265 
O
 
272 
2-methyl-pentan-4-one 10 71 
MeCN 8 85 
1,2-DCE 7 87 
 
OH
 
 
266 
 
O
 
 
273 
2-methyl-pentan-4-one - - 
MeCN 11.5 74a 
1,2-DCE 12 79a 
 
OH
OH
 
 
267 
 
O
O
  
 
274 
2-methyl-pentan-4-one - - 
MeCN 5 91 
1,2-DCE 4.5 92 
 
OH
 
 
268 
 
O
 
 
275 
2-methyl-pentan-4-one 11 87 
 
Table 16: Oxidation of a range of alcohols.  
 
A reaction was also performed in the absence of 2-iodobenzoic acid to test any 
background oxidation from the oxidant alone. Interestingly, treatment of piperonyl 
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alcohol (262) with three equivalents of TPPP in a 1,2-dichloroethane solution did 
show slight formation of the aldehyde (ca. 5%) after stirring for three hours (TLC 
monitoring). For comparison, in the added presence of 2-iodobenzoic acid (0.1 
equiv), almost complete conversion was observed after three hours in dichloroethane 
solution.  
 
Hajipour has reported that benzyltriphenylphosphonium peroxymonosulfate is an 
oxidant capable of oxidizing alcohols to their corresponding carbonyl compounds, 
but in that case a Lewis acid is required for the reaction to proceed.102 We found that 
completion of the reaction in the absence of 2-iodobenzoic acid was only achieved 
when more than six equivalents  of TPPP were used, and, even then, the reaction was 
substantially slower, at 10 hours, for piperonyl alcohol as substrate.  
 
We therefore conjectured that during the reaction, 2-iodobenzoic acid is oxidized 
much more rapidly by TPPP, presumably to IBX, than the alcohol is, and that it is the 
IBX so generated which oxidizes the alcohols in the catalytic system (Scheme 74). 
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Scheme 74: Suggested reasoning for the change in reactivity when 2-iodobenzoic acid is not 
present.  
 
Oxidation with TPPP (6 equiv) in the absence of 2-iodobenzoic acid was repeated 
under the same conditions with all of our test substrates, and each showed that, 
although carbonyl formation did indeed occur, the reaction time was roughly double 
that observed when 2-iodobenzoic acid (0.1 equiv) was present (Table 17).  
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MeCN DCE 
Substrate Product Time
/h 
Yield 
% 
Time
/h 
Yield 
% 
O
O
OH
 
262 O
O
O
 
269 10 84 7.5 82 
OH
 
263 O
 
270 9 75 9.5 79 
OH
 
264 
O
 
271 8 81 6.5 87 
OH
 
265 
O
 
272 10 76 10.5 71 
OH
 
266 
O
  
273 8.5 65 8 68 
OH
 
268 
O
  
275 9.5 83 8 79 
 
Table 17: Results of the oxidation of alcohols by TPPP.  
 
Unfortunately, when this new TPPP-mediated catalytic oxidation was attempted on 
the required Boc protected-hydroxycarbamate (260) (Scheme 75), in this case a BOC 
protected 5-amino-pentan-1-ol, the cyclic enecarbamate product was not isolated, 
with only starting material being recovered. We felt that this may be due to IBX not 
being a reactive enough oxidant and that ultimately the reaction may only proceed 
using Dess-Martin Periodinane (DMP). 
 
NH
OHO
ONH2
OH
N
Boc
i ii
260 261
 
 
Reagents and Conditions: i: Boc Anhydride (2 eq), H2O:dioxane (1:1), NaOH (1N, 10 ml); ii: 2-
iodobenzoic acid (0.2 eq), TPPP (3 eq), MeCN, r.t. 
 
Scheme 75: Attempted cyclic enecarbamate formation using the procedure by Hu et al.99 
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Despite this disappointment another paper by Yu103 and co-workers was found, 
which reported a possible route to cyclic enecarbamates (277), this time from lactam 
carbamates (276). The one pot procedure uses Super-Hydride (lithium 
triethylborohydride), followed by diisopropylethylamine (DIPEA), DMAP and 
trifluoroacetic anhydride (Scheme 76).  
i ii
 
Reagents and Conditions: i: LiBEt3H (1.1 eq), PhMe, −70 °C; ii: TFAA/DIPEA, cat. DMAP, −70 °C 
to r.t. 
 
Scheme 76: Yus route to cyclic enecarbamates. 
 
However, despite repeated attempts no cyclic enecarbamate was ever isolated in our 
hands. Therefore, due to time constraints it was decided to leave this work at this 
time with the hope that it could be returned to in the future. 
 
As well as looking into the applications of the iminium salt epoxidation, the research 
project also briefly examined the area of exocyclic catalysts, as opposed to the cyclic 
ones already in use within the group, such as those described by Armstrong43 and 
Komatsu.46 In the past the group has felt that these are unpredictable and 
temperamental, due to the possibility that hydrolysis of the catalyst could occur when 
used under aqueous conditions. Due to our recent development of non-aqueous TPPP 
conditions, it was felt that it would be prudent to re-examine this type of catalyst. 
Both Aggarwal19 and Yang22 have shown that simple amines can promote 
epoxidation under the Oxone® conditions, with pyrrolidine derivatives giving the 
best conversions, acting as phase transfer catalysts and Oxone® activators. We 
therefore felt that exocyclic catalysts based on pyrrolidine could potentially provide 
efficient epoxidation catalysts. 
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Both Armstrong and Komatsu had prepared catalysts from a cyclic amine and a 
carbonyl compound, by simple condensation and we felt this would be the best place 
to start. The simplest catalyst (278) was prepared by Komatsu from pyrrolidine (279) 
and cyclohexanone (280), under Dean Stark conditions, using tetrafluoroboric acid 
(Scheme 77).  
 
 
 
         
               
Scheme 77: Komatsus method for the preparation of exocyclic catalysts. 
 
However, when we attempted to repeat this in a test reaction, it was not possible to 
isolate a stable crystalline product from the reaction. We therefore decided that it 
may be simpler to form the HCl salt of the compound (281) and then perform a 
counter-ion exchange with NaBPh4. This was carried as shown in Scheme 78, and, 
upon addition of diethyl ether, the product (282) precipitated from the reaction as a 
white solid in an 85% yield.  
O
NH
HCl
Toluene
Dean Stark
N+
Cl-
281
NaBPh4 (1.1 eq)
Slow addition of
diethyl ether
N+
BPh4-
282
85% yield
 
     
Scheme 78: Procedure used for the formation of the exocyclic iminium salt catalyst. 
 
As it was possible that the enamine might have been formed instead of the required 
imine, the analytical data was closely examined. Examination of the FT-IR showed 
no enamine peak and 1H and 13C NMR spectrum showed that the structure was 
completely symmetrical with the presence of the expected three CH2 groups on the 
cyclohexanone ring. It was therefore concluded that no enamine was present.  
 
O
NH HBF4
Toluene
Dean Stark Conditions
N+
BF4-
280279 278
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Once the catalyst had been synthesized we then wished to carry out some 
epoxidation reactions. Komatsu had shown his catalyst (278) could epoxidise trans-
stilbene (283) to the corresponding epoxide (284) in an 88% yield, under the 
conditions shown below (Scheme 79).46 
PhPh PhPh
O
Oxone (1 eq)
NaHCO3 (4 eq)
Cat (278) (10 mol%)
H2O/MeCN (1:1)
r.t.
283 284
 
Scheme 79: Komatsus epoxidation conditions using catalyst (278). 
 
As a comparison this reaction was repeated with the newly synthesized catalyst 
(282), giving a comparable 80% yield in 17 hours. The catalyst was then tested under 
the Oxone® conditions used within the Page group,52,53,57 except that the reaction was 
performed at room temperature so as to be comparable to the Komatsu reaction. 
Pleasingly this resulted in the reaction proceeding in a 62% yield in a shorter 8 hour 
time period. Using the same conditions, the temperature was then decreased to the 
usual 0 °C and it was found that the reaction proceeded at a slightly slower rate, 
giving only a 55% yield in the same 8 hour time period.  
 
With this confirmation of catalyst activity, an epoxidation under the TPPP conditions 
was attempted, however when trans-stilbene (283) was used under these conditions, 
none of the epoxidised compound (284) could be detected even after 48 hours. This 
may mean that the reactivity of TPPP at -40 °C is insufficient with trans-stilbene, so 
the reaction was repeated this time using the slightly more reactive 1-
phenylcyclohexene (285) as the substrate (Scheme 80). Pleasingly, the reaction 
proceeded well giving a 55% yield of the epoxide (286) after 8 hours at -40 °C. 
 
PhPh O
TPPP (2 eq.)
Cat. (282) (10 mol%)
Chloroform
- 40 oC
285 286
 
 
Scheme 80: TPPP epoxidation using exocyclic catalyst (282). 
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Although the conditions of the racemic epoxidation still required some optimization 
it was decided to start work on a possible chiral derivative. The most obvious 
structure to use would be similar to the pyrrolidine based catalyst used in the racemic 
epoxidations, as such a catalyst based on L-(−)-proline (287) was chosen.  
 
We decided to attempt the synthesis of chiral catalyst 1-cyclohexylidene-2-
(hydroxydiphenylmethyl)pyrrolidinium tetraphenylborate (290) by taking L-(−)-
proline (287) and converting it to its methyl ester (288) as shown in Scheme 81. A 
double Grignard addition could then be performed (289) with various R groups 
enabling the steric bulk of the catalyst to be varied, which in turn was hoped to 
enable the enantioselectivity to be enhanced. After the Grignard addition, the free 
amine could then be condensed in a similar way as previously with an aldehyde or 
ketone, to give the required catalyst (290) (Scheme 81). 
 
 
 
 
 
 
       
            
 
 
 
 
Scheme 81: Formation of 1-Cyclohexylidene-2-(hydroxy-diphenyl-methyl)-pyrrolidinium 
tetraphenylborate (290). 
 
Unfortunately, despite the conversion of L-proline to the methyl ester proceeding 
well, subsequent Grignard additions all proved unsuccessful, resulting only in the re-
isolation of the starting material. This was probably due to moisture contamination in 
the commercially available Grignard which was used. Future work will use an in-situ 
generation of the Grignard to minimize any moisture contamination. 
 
N+
OH
BPh4-
290
N
H
O
OH
N
H
O
OMe
N
H
OH
R R
N+
OH
R RBPh4-
AcCl (4eq)
MeOH (20ml)
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ie PhMgBr 
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287 288
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It was also decided to look at a possible catalyst based on an azo-bicyclic structure 
which was being examined in the group as a potential catalyst ligand. For the 
synthesis of the azo-bicyclic based catalyst (297) it was decided to start by forming 
the imine (293) from ethyl glyoxylate (291) and (R)-1-phenylethylamine (292), it 
was then envisaged that a Diels Alder reaction could then be performed using 
cyclopentadiene, to give the azo bicyclic structure (294) shown in Scheme 82. A 
review of the literature has shown that this compound could then be hydrogenated 
and converted to the HCl salt (295),104at which point it would then be possible to 
perform a double Grignard addition and remove the protecting group to yield the 
amine (296). This could then be condensed with a ketone or aldehyde to give the 
catalyst (297) (Scheme 82). 
 
 
 
 
 
 
 
 
 
        
 
 
 
 
 
       
 
Scheme 82: Formation of 2-Cyclohexylidene-3-(hydroxy-diphenyl-methyl)-2-azonia-
bicyclo[2.2.1]heptane tetraphenylborate (297). 
 
The initial imine (293) formation between ethyl glyoxylate (291) and (R)-1-
phenylethylamine (292) proceeded well in a good yield, but the subsequent Diels-
Alder reaction with cyclopentadiene proved difficult, with the resulting product 
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being difficult to purify. Future work will look to optimize the Diels-Alder reaction 
to enable enough product to be obtained to continue the synthesis of the amine for 
the catalyst (297). 
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2.1 Conclusions 
 
This research has investigated potential future applications of the Page groups 
asymmetric epoxidation, studying both asymmetric natural product synthesis and 
new methodology to which the groups catalysts and conditions could be applied. 
 
Initially, compounds containing nitrogen were investigated using dihydroquinoline 
based structures. This type of compound was chosen as the basic structure is similar 
to the chromene based compounds which have shown high enantioselectivities when 
epoxidised previously within the group. However, although a range of compounds 
was synthesized, it was not possible to form an epoxide when using the groups 
catalyst, only when using m-CPBA. It was felt that this could be because the nitrogen 
present in the dihydroquinoline compound may interact with the catalyst used in the 
reaction, reducing its reactivity. As such, this work is to be continued within the 
group looking at both different protecting groups on the nitrogen and different 
catalysts.  
 
In view of the high enantioselectivities achieved with the groups catalyst in the 
epoxidation of chromene based compounds, the next area which was investigated 
was the possible use of the groups asymmetric epoxidation in a kinetic resolution.  
To begin with, a range of basic pro-chiral chromenes were investigated to gain an 
overall insight into the potential of a kinetic resolution when using these types of 
compounds. These initial investigations proceeded well, confirming that a kinetic 
resolution could indeed be achieved. Epigallocatechin gallate (EGCG), with its 
chromene based structure, was then chosen as the natural product target to which a 
kinetic resolution could be applied. Several routes were investigated to a core 
structure to which the epoxidation based kinetic resolution could be applied. Work is 
currently being continued on both optimising the synthesis of this core structure and 
the conditions for the kinetic resolution. 
 
The focus of the research project then turned to further natural product targets which 
could be synthesized enantioselectively using the groups asymmetric epoxidation 
conditions.  As it had recently been synthesized by another group using a Jacobsen 
epoxidation, (+)-decursinol was chosen as the natural product target, as this would 
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enable a comparison of the two epoxidation methods to be made. However, when 
attempting the synthesis of the precursor compound xanthyetin using the procedure 
by North, the structural isomer seselin was found to be the product. As such, the 
natural product target was changed from (+)-decursinol to (−)-lomatin and (+)-
khellactone. Epoxidation of seselin was found to proceed well and in a high 
enantioselectivity of 97% ee. The epoxide was then reacted further to yield both the 
natural product targets ((−)-lomatin and (+)-khellactone) in good yields.  
 
Other compounds which were examined during this research project were those the 
epoxidation of which could provide key synthetic intermediates in the synthesis of 
larger biological molecules. Although epoxidation of 2H-chromene was achieved, as 
yet the total synthesis of the cis-aminochromanol has not been achieved and work on 
this area is currently being continued within the group. The epoxidation of 
dihydropyran was found to yield the diol rather than the epoxide, probably due to the 
instability of the epoxide generated. However, it is hoped that this will be 
reinvestigated in the future, looking at the conditions and catalysts used. It was not 
possible to investigate the epoxidation of cyclic enamine based compounds, as at the 
time no suitable substrate could be synthesized. Also, given the results obtained 
when attempting the epoxidation of the dihydroquinoline based compounds, it was 
felt that these types of compound may also prove to be difficult epoxidation 
substrates due to the presence of the nitrogen.  
 
However, an interesting aside appeared when looking at a possible synthetic pathway 
to the cyclic enamine based structures. A simple route to the cyclic enamine based 
compounds was found using an in-situ oxidation and cyclisation of a Boc protected-
hydroxycarbamate using DMP. It was felt that given the instability of DMP, the 
reaction would be attempted using IBX instead. A paper found previously within the 
group reported the in-situ generation of IBX using Oxone® and 2-iodobenzoic acid, 
in the oxidation of alcohols to carboxylic acids. It was felt that by using the oxidant 
TPPP, which could be used under non-aqueous conditions, the reactions could be 
altered to yield the aldehyde instead of the carboxylic acid, when the oxidation of 
primary alcohols was attempted. By using piperonal alcohol as the text substrate this 
was indeed found to be the case. A range of alcohols were then subjected to these 
new reaction conditions showing that the use of TPPP in place of Oxone® resulted in 
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the efficient and simple generation of aldehydes from primary alcohols and could 
also be used in the generation of ketones from secondary alcohols. 
 
The final area of focus for this research project was the re-examination of exocyclic 
catalysts. These had previously been examined within the group using the Oxone® 
conditions. However, such catalysts had not been used with the new non-aqueous 
TPPP conditions. A basic exocyclic catalyst, prepared from pyrrolidine and 
cyclohexanone, was synthesized as the initial test catalyst and this was found to 
epoxidise 1-phenylcyclohexene under the TPPP conditions in a 55% yield in 8 hours. 
As the use of the TPPP conditions is primarily to enable the reaction to be carried out 
at low temperatures to increase enantioselectivity, the next step would be the 
synthesis and subsequent testing of chiral exocyclic catalysts under these conditions. 
The initial synthesis of such catalysts was started and is currently being continued 
within the group. 
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3.0 Experimental  
3.1 General Experimental 
 
All infrared spectra were obtained using a Perkin-Elmer Paragon 1000 FT-IR 
spectrophotometer; thin layer spectra were acquired using sodium chloride plates. 
 
All 1H and 13C NMR spectra recorded at Loughborough University were measured at 
400 and 100 MHz respectively, using a Bruker DXP 400 MHz spectrometer. The 
solvent used for NMR spectroscopy was CDCl3 (unless stated otherwise) using TMS 
(tetramethylsilane) as the internal reference. Chemical shifts are given in parts per 
million (ppm) and J values are given in Hertz (Hz).  
 
All 1H and 13C NMR spectra recorded at the University of East Anglia were 
measured at 300 and 75 MHz with a Varian Gemini 2000, at 400 MHz and 100 MHz 
with a Varian Unity+ in deuteriochloroform solution unless otherwise stated, using 
TMS (tetramethylsilane) as the internal reference. 
 
Microwave-assisted reactions were conducted using a CEM Discover apparatus set at 
a maximum power of 300 W. 
 
Mass spectra were recorded using a Jeol-SX102 instrument utilizing electron impact 
(E.I.), fast atom bombardment (F.A.B) and by the EPSRC national mass 
spectrometry service at the University of Wales, Swansea, utilizing electrospray 
(E.S.) ionization.  Mass spectra recorded at the University of East Anglia were 
recorded using a Shimadzu LCMS system. 
 
Melting points at Loughborough University were recorded using an Electrothermal-
IA 9100 melting point instrument and are uncorrected. 
 
Melting points at the University of East Anglia were recorded using a Büchi B-545 
melting point instrument and are uncorrected. 
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Optical rotation values recorded at Loughborough University were measured with an 
Optical Activity-polAAar 2001 instrument, operating at ë = 589 nm, corresponding 
to the sodium line, (D), at the temperatures indicated.  
 
Optical rotations recorded at the University of East Anglia were measured using a 
B&S ADP-440 spectrometer, operating at ë = 589 nm, corresponding to the sodium 
line, (D), at the temperatures indicated.  
 
The solvents in used in both universities were of spectrophotometric grade, and the 
solutions for these measurements were prepared in volumetric flasks for maximum 
accuracy.  
 
Microanalyses at Loughborough University were performed on a Perkin Elmer 
Elemental Analyser 2400 CHN. 
 
All chromagraphic manipulations used silica gel as the adsorbent. Reactions were 
monitored using thin layer chromatography (TLC). TLC plates were visualized by 
UV irradiation at a wavelength of 254 nm, or stained by exposure to an ethanolic 
solution of phosphomolybdic acid (acidified with concentrated sulfuric acid), 
followed by charring where appropriate. Purification by column chromatography 
used silica absorbent. 
 
The reactions requiring anhydrous conditions were carried out using glassware dried 
overnight at 150 oC, unless otherwise stated. Reaction solvents were obtained 
commercially dry, except light petroleum (b.p. 40-60 oC), which was distilled from 
calcium chloride prior to use; ethyl acetate, which was distilled from calcium sulfate 
or chloride; dichloromethane, which was distilled from calcium hydride; and 
tetrahydrofuran (THF), which was distilled under a nitrogen atmosphere, from the 
sodium/benzophenone ketyl radical. 
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(+)-(4S,5S)-N-Formyl-2,2-dimethyl-4-(4-(methylthio)phenyl)-5-amino-1,3-
dioxane57 
 
S
OH OH
NH2
S
O O
HN H
O
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(1S,2S)-(+)-2-Amino-1-(4-(methylthio)phenyl)-1,3-propandiol (10.0 g, 46.8 mmol) 
was dissolved in methanol (100 ml). Methyl formate (3.2 ml, 0.98 g/cm3, 51.5 mmol) 
was then added, followed by commercially available aqueous sodium methoxide (10 
mol%, 1 ml). The reaction mixture was stirred for 3.5 hours at room temperature and 
the solvent removed under reduced pressure. The resulting yellow oil was dissolved 
in acetone (500 ml) and 2,2-dimethoxypropane (60 ml, 0.84 g/cm3, 46.8 mmol) and 
para-toluenesulfonic acid (0.9 g, 10 mol%) was added. The reaction mixture was 
stirred for a further 4 hours at room temperature and monitored by TLC. The solvents 
were removed under reduced pressure and the residue re-dissolved in ethyl acetate, 
washed with saturated aqueous sodium hydrogen carbonate, dried (MgSO4), and the 
solvents removed under reduced pressure to give the product as a colourless oil, 
which was used without further purification (9.6 g, 73%), [á]D + 1.4° (c 1.26, 
CHCl3), ímax (film) / cm-1 3316, 3010, 2263, 1664, 1497, 1378, 1197, 1064, 956; äH 
(400 MHz; CDCl3) 1.55 (3H, s, CH3), 1.59 (3H, s, CH3), 2.44 (3H, s, SCH3, C16), 
3.87 (1H, dd, J 7.0, 1.0 Hz, upfield portion of ABX system C6, N-CHCHH-O), 4.25 
(1H, dd, J 7.0, 1.0 Hz, downfield portion of ABX system C6, N-CHCHH-O), 4.25-
4.29 (1H, m, NCH, C5), 5.17 (1H, d, J 1.0 Hz, CH, C4), 6.28 (1H, d, J 5.6 Hz, NH), 
7.21 (4H, s, 4 x CH arom.,), 7.99 (1H, s, NCHO, C18); äC (100 MHz; CDCl3) 15.8 
(SCH3, C16), 18.5 (CH3), 29.7 (CH3), 45.3 (NCH3), 64.6 (CH2), 71.4 (Ar-CH, C4), 
99.7 (C quat., C2), 125.9 (2 x CH
 
arom., C10,11), 126.4 (2 x CH
 
arom., C12,13), 
135.1 (C quat., arom., C14), 138.7 C quat., arom., C9), 161.0 (NCHO). 
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(−)-(4S,5S)-N-Formyl-2,2-dimethyl-4-(4-(methylsulfonyl)phenyl)-5-amino-1,3-
dioxane 57 
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(+)-(4S,5S)-N-[2,2-Dimethyl-4-(4-methylsulfanyl-phenyl)-[1,3]dioxan-5-yl]-
formamide (9.6 g, 34 mmol) was dissolved in dichloromethane (200 ml), and the 
solution cooled to 0 oC. A solution of m-CPBA (2.2 eq, 35.5 g, 0.103 mol) in 
chloroform (40 ml) was added dropwise over 15 min. The reaction mixture was 
stirred for 2 hours, transferred to a separating funnel, and washed with sat. sodium 
hydrogen carbonate (2 x 40 ml) and brine (2 x 40 ml), and dried (MgSO4). The 
solvent was then removed under reduced pressure to give colourless crystals (6.4 g, 
59%) m.p. 146-149 oC (lit  146-147 oC);57 [á]D - 11.4° (c 1.23, CHCl3),  ímax (film) 
/ cm-1 3055, 2991, 1654, 1514, 1386, 1301, 1234, 1200, 1149, 1086, 950; äH (400 
MHz; CDCl3) 1.55 (3H, s, CH3), 1.60 (3H, s, CH3), 3.05 (3H, s, SO2CH3, C16), 3.88 
(3H, dd, J 12.0, 2.0 Hz, upfield portion of ABX system, C6, N-CHCHH-O), 4.34 
(1H, dd, J 12.0, 1.8 Hz, downfield portion of ABX system, C6, N-CHCHH-O), 4.43 
(1H, dd, J 10.0, 1.8 Hz, NCH, C5), 5.28 (1H, s, CH, C4), 6.37 (1H, d, J 10.0 Hz, 
NH), 7.52 (2H, d, J 8.2 Hz, 2 x CH arom., C10,11), 7.85 (2H, d, J 8.2 Hz, 2 x CH 
arom., C12,13), 7.94 (1H, s, NCHO); äC (100 MHz; CDCl3) 18.7 (CH3), 29.8 (CH3), 
45.0 (SO2CH3, C16), 45.8 (NCH, C5), 65.1 (CH2, C6), 72.5 (Ar-CH, C4), 100.6 (C 
quat., arom., C2), 127.4 (2 x CH arom., C10,13), 127.9 (2 x CH arom., C11,12), 
140.2 (C quat., arom., C14), 144.9 (C quat., arom., C9), 161.1 (NCHO, C18). 
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(+)-(4S,5S)-5-amino-2,2-dimethyl-4-(4-(methylsulfonyl)phenyl)-1,3-dioxane 57 
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(−)-(4S,5S)-N-[4-(4-Methanesulfonyl-phenyl)-2,2-dimethyl-[1,3]dioxan-5-yl]-
formamide (6.4 g, 20 mmol) was dissolved in aqueous hydrazine hydrate (85%) (140 
ml) and the solution heated under reflux for 2.5 hours. The reaction mixture was 
allowed to cool to room temperature and extracted with ethyl acetate (3 x 40 ml). 
The organic layers were washed with water (2 x 50 ml), dried (MgSO4) and the 
solvents removed under reduced pressure to give colourless crystals (3.2 g, 55%); 
m.p. 124-126 oC (lit  120-122 oC);57 [á]D + 45° (c 1.10, CHCl3), ímax (film) / cm-1 
3372, 3001, 1602, 1370, 1197, 1065, 950; äH (400 MHz; CDCl3) 1.56 (6H, s, 2 x 
CH3, C7,8), 2.85 (1H, dd, J 3.6, 2.0 Hz, NH2CH, C5), 3.06 (3H, s, SO2CH3, C16), 
3.88 (1H, dd, J 12.0, 2.0 Hz, upfield portion of ABX system, C6, N-CHCHH-O), 
4.24 (1H, dd, J 12.0, 2.0 Hz, downfield portion of ABX system, C6, N-CHCHH-O), 
5.18 (1H, d, J 3.6 Hz, CH, C4), 7.55 (2H, d, J 8.0 Hz, 2 x CH, arom., C10,11), 7.95 
(2H, d, J 8.0 Hz, 2 x CH, arom., C12,13); äC (100 MHz; CDCl3) 19.0 (CH3), 30.1 
(CH3), 44.5 (SO2CH3), 50.1 (NCH, C5), 66.8 (CH2, C6), 73.6 (CH, C4), 100.1 (C 
quat., C2), 127.4 (2 x CH arom., C10,11), 127.9 (2 x CH arom., C12,13), 140.2 (C 
quat., arom., C14), 146.5 (C quat., arom., C9). 
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(+)-N-[(4S,5S)-2,2-Dimethyl-4-[4-(methylsulfonyl)phenyl]-1,3-dioxan-5-yl]-3,4-
dihydroisoquinolinium tetraphenylborate.57 
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(+)-(4S,5S)- 5-amino-2,2-dimethyl-4-(4-(methylsulfonyl)phenyl)-1,3-dioxane (5.2 g, 
18 mmol) in ethanol (30 ml) was added dropwise to ice cooled 2-(2-
bromoethyl)benzaldehyde (3.3 g, 1.3 eq). After the addition was complete the 
reaction flask was lightly stoppered to contain the hydrogen bromide generated 
temporarily in the reaction, and the reaction stirred overnight whilst attaining room 
temperature. A solution of sodium tetraphenylborate (1.2 eq) in acetonitrile (2 ml) 
was added in one portion to the reaction and stirred for a further 5 minutes, resulting 
in the formation of a yellow precipitate. The organic solvents were then removed 
under reduced pressure. The yellow solid was then washed with ethanol (20 ml) and 
water (20 ml) and the yellow crystals collected by suction filtration (4.2 g, 52%); 
m.p. 198-201 °C (lit  199-201 °C);57 [á]D + 124.7° (c 1.24 acetone); ímax (film) / 
cm-1 1636, 1602, 1507, 1478, 1370, 1266, 1202, 1197, 1065, 950; äH (400 MHz; 
acetone-d6) 1.56 (3H, s, CH3, C7, eq.), 1.60 (3H, s, CH3, C8, ax.), 2.55-2.60 (1H, m, 
Ar-CHH, isoq-4), 2.76-2.82 (1H, m, Ar-CHH, isoq-4), 2.89 (3H, s, S CH3), 3.65-3.70 
(1H, m, Ar-CHH, isoq-3), 4.12-4.25 (1H, m, Ar-CHH, isoq-3), 4.44 (1H, d, J 13.6 
Hz, upfield portion of ABX system, C6, N-CHCHH-O), 4.53 (1H, dd, J 2.6, 2.5 Hz, 
NCH, C5), 4.66 (1H, dd, J 13.6, 2.6 Hz, downfield portion of ABX system, C6, N-
CHCHH-O) 5.97 (1H, d, J 2.5, Ar-CH, C4 ), 6.77 (4H, t, J 7.4 Hz, 4 x CH arom., 
para in BPh4 group ), 6.80 (8H, t, J 7.2 Hz, 8 x CH arom., ortho in BPh4 group), 
7.18-7.21 (8H, m, 8 x CH arom., meta in BPh4 group), 7.40 (1H, t, J 7.6 Hz, CH 
arom., isoq-8), 7.73-7.83 (3H, m, 3 x CH arom., isoq-6,7,9), 7.82 (2H, d, J 8.2 Hz, 2 
x CH arom., C10,11), 7.95 (2H, d, J 8.2 Hz, 2 x CH arom., C12,13), 9.21 (1H, s, 
HC=N, isoq-1); äC (100 MHz; acetone-d6) 18.8 (CH3, C7), 25.4 (Ar-CH2, isoq-4), 
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29.4 (CH3, C8), 44.3 (SO2CH3), 52.3 (CH2N, isoq-3), 62.9 (CH2, C6), 66.1 (NCH), 
71.5 (Ar-CH, C4), 101.3 C quat., C2), 122.5 (8 x CH arom., ortho in BPh4), 125.9 (C 
quat., arom., isoq-10 ), 127.5 (2 x CH arom., C12,13 ), 128.6 (2 x CH arom., 
C10,11), 130.1 (4 x CH arom., para in BPh4), 130.5 (CH arom., isoq-7), 135.4 (CH 
arom., isoq-9), 137.0 (8 x CH arom., meta in BPh4), 137.9 (C quat., arom., C14), 
139.9 (C quat., arom., isoq-5), 143.2 (C quat., arom., C9), 165.0 (4 x C, quat., arom 
in BPh4), 169.1 (HC=N). 
 
2-Methylbut-3-yn-2-yl-acetate67 
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2-Methylbut-3-yn-2-ol (10 g, 0.10 mol) was placed in a 200 ml round bottomed 
flask, to this triethylamine (15 ml, 0.11 mol), acetic anhydride (11.6 ml, 0.12 mol) 
and DMAP (0.6 g, 4.91 mmol) were added with stirring. The reaction was then left 
stirring overnight at room temperature. The reaction was stopped when TLC showed 
no remaining starting material. The reaction was then dissolved in DCM and 
extracted with brine. All the organic layers were combined, dried (MgSO4) and the 
solvent removed under reduced pressure to yield the product as a dark yellow oil (9.6 
g, 73% yield); ímax (film) / cm-1 3090, 2954, 1610, 1578, 1476, 1355, 1339, 1268, 
1234, 1202, 1164, 1103, 1087, 1034, 956; äH (400 MHz; CDCl3) 1.66 (6H, s, 2 x 
CH3), 2.02 (3H, s, COCH3), 2.58 (1H, s, CH, C4); äC (100 MHz; CDCl3) 20.1 (2 x 
CH3), 25.8 (C quat., C2), 65.4 (COCH3), 72.2 (C quat., C3), 89.1 (CH, C4), 170.5 
(C=O). 
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2-Methylbut-3-yn-2-yl-aniline67 
 
N
H
H
 
140 
 
2-Methylbut-3-yn-2-yl-acetate (5.00 g, 39.5 mmol) and aniline (3.67 ml, 39.5 mmol) 
were placed in a dry flask containing CuCl (0.39 g, 10 mol%, 3.9 mmol) and 
magnetic flea under nitrogen. To this freshly distilled THF (100 ml), was added and 
a reflux condenser placed on the flask. The reaction was then heated under reflux 
under a nitrogen atmosphere for 3 hours. When the reaction was cool, ethyl acetate 
was added to the reaction and the organic layer extracted with brine. The organic 
layers were then combined, dried and the solvent removed under reduced pressure to 
yield the intermediate as an orange oil (5.6 g, 73%), which was used immediately 
without further purification; ímax (film) / cm-1 3324, 3010, 2245, 2140, 1620, 1499, 
1283, 1154, 1068; äH (400 MHz; CDCl3) 1.58 (6H, s, 2 x CH3), 2.37 (1H, s, CH, C4), 
4.50 (1H, s, broad NH), 6.77 (1H, t, J 8.0 Hz, CH arom., para on aniline), 6.93 (2H, 
d, J 9.6 Hz, 2 x CH, arom., ortho on aniline), 7.16 (2H, dd, J 9.6, 8.0 Hz, 2 x CH 
arom., meta on aniline); äC (100 MHz; CDCl3) 30.4 (2 x CH3), 48.2 (C quat., C2), 
71.6 (CH, C4), 87.9 (C quat., C3), 117.2 (2 x CH arom., ortho on aniline), 120.0 (CH 
arom., para on aniline), 128.8 (2 x CH arom., meta on aniline), 145.4 (C quat., 
CNHC(CH3)2). 
 
2,2-Dimethyl-1,2-dihydroquinoline67 
 
N
H
 
141 
 
2-Methylbut-3-yn-2-yl-aniline (5.63 g, 35.4 mmol) was placed into a dry round 
bottomed flask under nitrogen which already contained CuCl (0.43 g, 11 mol%, 4.3 
mmol). To this freshly distilled THF (100 ml) was added and the reaction heated 
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under reflux for 14 hours. The reaction was then allowed to cool and ethyl acetate 
(20 ml) added. The reaction was then extracted with brine and the organics 
combined, dried (MgSO4) and the solvent removed under reduced pressure to yield 
the crude product as a light orange oil (4.5 g, 73%). The compound was then purified 
using column chromatography (20:1 petroleum ether:ethyl acetate), yielding the final 
product as an orange oil (4.0 g, 71%); ímax (film) / cm-1 3012, 1701, 1623, 1547, 
1425, 1145, 1075; äH (400 MHz; CDCl3) 1.25 (6H, s, 2 x CH3), 4.50 (1H, br s, NH), 
5.44 (1H, d, J 9.6 Hz, CH, C3), 6.24 (1H, d, J 9.6 Hz, CH, C4), 6.39 (1H, d, J 8.0 
Hz, CH arom., C5), 6.55 (1H, dd, J 8.0, 6.0 Hz, CH arom., C7), 6.86 (1H, d, J 8.0 
Hz, CH arom., C8), 6.92 (1H, dd, J 8.0, 6.0 Hz, CH arom., C6); äC (100 MHz; 
CDCl3) 31.1 (2 x CH3), 52.1 (C quat., C2), 112.8 (CH arom., C5), 117.3 (CH arom., 
C7), 120.0 (C quat., C9), 123.7 (CH, alkene, C4), 126.6 (CH arom., C8), 128.5 (CH 
arom., C6), 130.9 (CH, alkene C3), 143.0 (C quat., C10). 
 
2-Methylbut-3-yn-2-yl-para-chloroaniline105 
 
N
H
H
Cl
 
142 
 
2-Methylbut-3-yn-2-yl-acetate (5.00 g, 39.5 mmol) and para-chloroaniline (4.96 g, 
39.5 mmol) were placed in a dry flask containing CuCl (0.39 g, 10 mol%, 3.9 mmol) 
and magnetic flea under nitrogen. To this freshly distilled THF (100 ml) was added 
and a reflux condenser placed on the flask. The reaction was then heated under reflux 
under a nitrogen atmosphere for 3 hours. When the reaction was cool, ethyl acetate 
was added to the reaction and the organic layer extracted with brine. The organic 
layers were then combined, dried and the solvent removed under reduced pressure to 
yield the intermediate as a yellow oil (6.2 g, 81%), which was used immediately 
without further purification; ímax (film) / cm-1 3334, 3014, 2255, 2146, 1626, 1489, 
1273, 1154, 1068; äH (400 MHz; CDCl3) 1.56 (6H, s, 2 x CH3), 2.38 (1H, s, CH, C4), 
5.02 (1H, s, broad NH), 6.84 (2H, d, J 8.5 Hz, 2 x CH arom., ortho on aniline), 7.10 
(2H, d, J 8.5 Hz, 2 x CH arom., meta on aniline); äC (100 MHz; CDCl3) 30.4 (2 x 
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CH3), 48.2 (C quat., C2), 71.6 (C quat., C3), 87.9 (CH, C4), 117.2 (CH arom., ortho 
on aniline), 128.8 (CH arom., meta on aniline), 141.2 (C quat., para on aniline) 145.4 
(C quat., CNHC(CH3)2). 
 
6-Chloro-2,2-dimethyl-1,2-dihydroquinoline105 
 
N
H
Cl
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2-Methylbut-3-yn-2-yl-para-chloroaniline (6.22 g, 32.1 mmol) was placed into a dry 
round bottomed flask under nitrogen which already contained CuCl (0.43 g, 11 
mol%, 4.3 mmol). To this freshly distilled THF (100 ml) was added and the reaction 
heated under reflux for 14 hours. The reaction was then allowed to cool and ethyl 
acetate (20 ml) added. The reaction was then extracted with brine and the organics 
combined, dried (MgSO4) and the solvent removed under reduced pressure to yield 
the crude product as a light yellow oil (5.2 g, 83%). The crude product was purified 
using column chromatography (20:1 petroleum ether:ethyl acetate), yielding the final 
product as a yellow oil (4.1g, 66%); ímax (film) / cm-1 3018, 1711, 1627, 1541, 
1426, 1155, 1075; äH (400 MHz; CDCl3) 1.2 (6H, s, 2 x CH3), 3.61 (1H, s, broad 
NH), 5.41 (1H, d, J 9.7 Hz, CH, C3), 6.10 (1H, d, J 9.7 Hz, CH, C4), 6.24 (1H, d, J 
8.4 Hz, CH arom., C8), 6.75 (1H, d, J 2.4 Hz, CH arom., C5), 6.80 (1H, dd, J 8.4, 2.4 
Hz, CH arom., C7); äC (100 MHz; CDCl3) 30.9 (2 x CH3), 52.2 (C quat., C2), 113.8 
(CH arom., C8), 123.4 (CH, alkene, C4), 125.9 (CH arom., C5), 127.9 (CH arom., 
C7), 129.4 (C quat., C9), 132.2 (CH, alkene, C3), 144.2 (C quat., C10), 144.9 (C 
quat., C6). 
 
2-Methylbut-3-yn-2-yl-para-methoxyaniline106 
 
N
H
H
O
 
144 
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2-Methylbut-3-yn-2-yl-acetate (5.00 g, 39.7 mmol) and para-aniside (4.89 g, 39.7 
mmol) were placed in a dry flask containing CuCl (0.39 g, 10 mol%, 3.9 mmol) and 
magnetic flea under nitrogen. To this THF (100 ml) straight from the still, was added 
and a reflux condenser placed on the flask. The reaction was then heated under reflux 
under a nitrogen atmosphere for 3 hours. When the reaction was cool, ethyl acetate 
was added to the reaction and the organic layer extracted with brine. The organic 
layers were then combined, dried and the solvent removed under reduced pressure to 
yield the intermediate as a dark yellow oil (4.9 g, 65%), which was used immediately 
without further purification; ímax (film) / cm-1 3314, 3008, 2235, 2120, 1615, 1495, 
1286, 1154, 1068; äH (400 MHz; CDCl3) 1.56 (6H, s, 2 x CH3), 2.38 (1H, s, CH, C4), 
5.0 (1H, s, broad NH), 6.84 (2H, d, J 8.8 Hz, 2 x CH arom., ortho on aniline), 7.10 
(2H, d, J 8.8 Hz, 2 x CH arom., meta on aniline); äC (100MHz; CDCl3) 30.4 (2 x 
CH3), 48.2 (C quat., C2), 71.6 (OCH3), 84.9 (CH, C4), 86.1 (C quat., C3), 117.2 (2 x 
CH arom., ortho on aniline), 128.8 (2 x CH arom., meta on aniline), 135.2 (C quat., 
para on aniline), 145.4 (C quat., CNHC(CH3)2). 
 
6-Methoxy-2,2-dimethyl-1,2-dihydroquinoline106 
 
N
H
O
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2-Methylbut-3-yn-2-yl-para-methoxyaniline (4.90 g, 25.9 mmol) was placed into a 
dry round bottomed flask under nitrogen which already contained CuCl (0.43 g, 11 
mol%, 4.3 mmol). THF (100 ml) was added straight from the still and the reaction 
heated under reflux for 14 hours. The reaction was then allowed to cool and ethyl 
acetate (20 ml) added. The reaction was then extracted with brine and the organics 
combined, dried (MgSO4) and the solvent removed under reduced pressure to yield 
the crude product as a dark yellow oil (5.2 g, 83%). The crude product was purified 
using column chromatography (20:1 petroleum ether:ethyl acetate), yielding the final 
product as a yellow oil ( 4.4 g, 75%); ímax (film) / cm-1 3018, 1698, 1633, 1540, 
1421, 1149, 1075; äH (400 MHz; CDCl3) 1.26 (6H, s, (2 x CH3), 3.42 (1H, s, broad 
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NH), 3.74 (3H, s, OCH3), 5.51 (1H, d, J 9.6 Hz, CH, C3), 6.22 (1H, d, J 9.6 Hz, CH, 
C4), 6.37 (1H, d, J 8.4 Hz, CH arom., C8), 6.51 (1H, d, J 2.4 Hz, CH arom., C5), 
6.56 (1H, dd, J 8.4, 2.4 Hz, CH arom., C7); äC (100 MHz; CDCl3) 30.2 (2 x CH3), 
52.0 (C quat., C2), 55.6 (OCH3), 112.0 (CH arom., C5), 114.5 (CH arom., C8), 114.7 
(CH arom., C7), 121.5 (C quat., C6), 123.6 (CH, alkene, C4), 132.3 (CH, alkene, 
C3), 137.3 (C quat., C9), 152.7 (C quat., C10) 
 
Epoxidation Techniques 
 
General procedure for the generation of racemic epoxides with m-CPBA. 
 
The alkene substrate (1 eq) was dissolved in chloroform and cooled to 0 oC. When 
cold, m-CPBA (1.5 eq) was added slowly. The reaction was then allowed to warm to 
room temperature, whilst being monitored via TLC. When complete consumption of 
the substrate was observed the reaction was extracted with NaOH (3 x 20 ml), the 
organics combined, dried and the solvent removed under reduced pressure to yield 
the epoxide product. 
 
General procedure for the epoxidation of alkenes mediated by iminium salts 
using Oxone®.49,50 
 
Sodium carbonate (4 eq) was dissolved in water and cooled in an ice bath. To this 
Oxone® (2 eq) was added, followed by the catalyst (10 mol%) dissolved in 
acetonitrile (2 ml) was added with stirring. The reaction was then left stirring, whilst 
being monitored by TLC. When all starting material was consumed, diethyl ether 
was added and the reaction extracted with brine. The organics were then combined, 
dried (MgSO4) and evaporated to yield the epoxide. 
 
Tetraphenylphosphonium monoperoxysulfate (TPPP).57 
 
Oxone® triple salt (2KHSO5:KHSO4:K2SO4) (15.0 g, 48.8 mmol w.r.t. KHSO5) was 
dissolved in deionized water (300 ml) and the solution stirred at 10-15 oC (water 
bath). A solution of tetraphenylphosphonium chloride (15.0 g, 40.0 mmol) in 
distilled dichloromethane (300 ml) was added over 5 min, and the reaction stirred for 
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an additional 30 min. The organic layer was then separated and the solvent removed 
under reduced pressure at room temperature. The colourless crude residue was then 
washed with distilled water (2 x 75 ml), dissolved in dichloromethane (180 ml) and 
dried (MgSO4). Hexane was added until cloudiness developed and the flask was then 
placed in the freezer (-20oC) overnight, producing a white precipitate of the salt 
about 82% pure in peroxide (14.2 g, 60%); äH (400 MHz; CDCl3) 7.64 (8H, m), 7.79 
(8H, m), 7.90 (4H, m), 9.10 (1H, s). 
 
General procedure for catalytic epoxidation of simple alkenes mediated by 
iminium salts using tetraphenylphosphonium monoperoxysulfate (TPPP).57 
 
Tetraphenylphosphonium monoperoxysulfate (2 eq with respect to the substrate) was 
dissolved in chloroform (2 ml per 0.1 g oxidant), and cooled to the required reaction 
temperature. Iminium salt (10 mol%) was dissolved in chloroform (0.5 ml per 0.1 g 
oxidant) and added dropwise to the solution of oxidant over 15-20 min; the reaction 
temperature was monitored throughout the addition, and any increase in temperature 
minimized. A solution of the alkene substrate in chloroform (0.5 ml per 0.1 g 
oxidant) was added in the same manner. The reaction was then stirred at the reaction 
temperature until the substrate was completely consumed. Diethyl ether was then 
added to induce precipitation of the remaining oxidant. The mixture was filtered 
through celite® and the solvent removed under reduced pressure to yield the epoxide. 
 
6-Chloro-2,2-dimethylbenzopyran oxide57 
 
O
OCl
O
Cl
 
        151 
 
Prepared by the general procedure for the generation of racemic epoxides and the 
general procedure for the catalytic epoxidation of simple alkenes mediated by 
iminium salts using tetraphenylphosphonium monoperoxysulfate (TPPP). 6-Chloro-
2,2-dimethylbenzopyran (0.194 g, 1.00 mmol) afforded 6-chloro-2,2-
dimethylbenzopyran oxide as a colourless oil (0.134 g, 62%); ímax (film) / cm-1 
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3090, 2954, 1610, 1578, 1476, 1355, 1339, 1268, 1234, 1202, 1164, 1103, 1087, 
1034, 956; äH (400 MHz; CDCl3) 1.22 (3H, s, CH3), 1.50 (3H, s, CH3), 3.48 (1H, d, J 
4.4 Hz, CH, C3), 3.84 (1H, d, J 4.4 Hz, CH, C4), 6.74 (1H, d, J 8.6 Hz, CH arom., 
C8), 7.17 (1H, dd, J 8.6, 2.6 Hz, CH arom., C7), 7.29 (1H, d, J 2.6 Hz, CH arom., 
C5); äC (100 MHz; CDCl3) 22.5 (CH3), 25.7 (CH3), 50.4 (CH, epoxide, C4) 60.4 
(CH, epoxide, C3), 72.6 (quat., C, C2), 119.2 (CH arom., C5), 120.6 (quat., C, C9), 
125.7 (quat., C, C6), 129.3 (CH arom., C7), 130.4 (CH arom., C8), 151.2 (quat., C, 
C10). 
 
General procedure for the acetate protection of 2,2-dimethyl-1,2-
dihydroquinoline compounds3 
 
N
H
R
N
R
O  
             
The appropriate dihydroquinoline compound (5 mmol) was dissolved in DCM (20 
ml) and acetyl chloride (5 mmol) and DMAP (5 mol%) added. The reaction was then 
stirred at room temperature overnight. Ethyl acetate was then added and the mixture 
extracted with brine. The organics were then dried (MgSO4) and reduced under 
vacuum, to yield the product as an off white oil.  
 
1-Acetyl-2,2-dimethyl-,1,2-dihydroquinoline105 
 
N
O
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Prepared via the general procedure for the acetyl protection of 2,2-dimethyl-1,2-
dihydroquinoline compounds. Product isolated as a yellow solid (0.74 g, 74%); ímax 
(film) / cm-1 3012, 1701, 1655, 1623, 1547, 1425, 1360, 1345, 1145, 1075; äH (400 
MHz; CDCl3) 1.22 (6H, s, 2 x CH3), 2.09 (3H, s, COCH3), 5.40 (1H, d, J 10.0 Hz, 
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CH, C3), 6.18 (1H, d, J 10.0 Hz, CH, C4), 6.34 (1H, d, J 7.6 Hz, CH arom., C8), 
6.48 (1H, dd, J 8.2, 7.6 Hz, CH arom., C6), 6.79 (1H, d, J 7.6 Hz, CH arom., C5), 
6.87 (1H, dd, J 8.2, 7.6 Hz, CH arom., C7); äC (100 MHz; CDCl3) 30.9 (2 x CH3), 
40.0 (COCH3), 52.1 (C quat., C2), 112.8 (CH arom., C8), 117.1 (CH arom., C6), 
120.0 (C quat., C9), 123.6 (CH, C4), 125.5 (CH, C3), 126.5 (CH arom., C5), 128.4 
(CH arom., C7), 166.4 (C quat., C10). 
 
1-Acetyl-6-chloro-2,2-dimethyl-1,2-dihydroquinoline105 
 
N
O
Cl
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Prepared via the general procedure for the acetyl protection of 2,2-dimethyl-1, 2-
dihydroquinoline compounds. Product isolated as a brown gum (0.84 g, 72%); ímax 
(film) / cm-1 3017, 1701, 1665, 1627, 1557, 1428, 1360, 1345, 1165, 1075; äH (400 
MHz; CDCl3) 1.40 (6H, s, 2 x CH3), 1.94 (3H, s, COCH3), 5.66 (1H, d, J 9.6 Hz, 
CH, C3), 6.19 (1H, d, J 9.6 Hz, CH, C4), 6.66 (1H, d, J 8.4 Hz, CH arom., C8), 6.93 
(1H, d, J 2.4 Hz, CH arom., C5), 7.00 (1H, dd, J 8.4, 2.4 Hz, CH arom., C7); äC (100 
MHz; CDCl3) 31.9 (2 x CH3), 42.1 (COCH3), 50.1 (C quat., C2), 111.7 (CH arom., 
C8), 120.6 (C quat., C9), 124.8 (CH, C4), 127.5 (CH, C3), 129.4 (CH arom., C5), 
132.1 (CH arom., C7), 134.2 (C quat., C6), 175.1 (C quat., C10). 
 
1-Acetyl-6-chloro-2,2-dimethyl-3,4-epoxy-1,2,3,4-tetrahydroquinoline using 
Oxone® system 
N
O
Cl O
 
155 
 
The reaction was performed via the general procedure for catalytic epoxidation of 
simple alkenes mediated by iminium salts using Oxone® and 1-acetyl-6-chloro-2,2-
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dimethyl-1,2-dihydroquinoline. After 6 hours, crude 1H NMR analysis revealed only 
slight epoxidation had occurred and after work up only starting material was 
recovered. 
 
1-Acetyl-6-chloro-2,2-dimethyl-3,4-epoxy-1,2,3,4-tetrahydroquinoline using m-
CPBA105 
N
O
Cl O
 
155 
 
Prepared using the general procedure for the generation of racemic epoxides using 
m-CPBA. 1-Acetyl-6-chloro-2,2-dimethyl-1,2-dihydroquinoline (0.20 g, 0.85 mmol) 
afforded 1-acetyl-6-chloro-2,2-dimethyl-3,4-epoxy-1,2,3,4-tetrahydroquinoline as a 
colourless oil (0.14 g, 72%); ímax (film) / cm-1 2985, 1745, 1610, 1584, 1486, 1385, 
1255, 1075; äH (400 MHz; CDCl3) 1.10 (3H, s, CH3), 1.83 (3H, s, CH3), 2.02 (3H, s, 
COCH3), 3.34 (1H, d, J 4.2 Hz, CH, C3), 3.73 (1H, d, J 4.2 Hz, CH, C4), 6.71 (1H, 
d, J 8.4 Hz, CH arom., C8), 7.17 (1H, dd, J 8.4, 2.4 Hz, CH arom., C7), 7.30 (1H, d, 
J 2.4 Hz, CH arom., C5); äC (100 MHz; CDCl3) 22.4 (CH3), 25.6 (CH3), 26.4 
(COCH3), 51.4 (CH, C4), 56.2 (C quat., C2), 66.8 (CH, C3), 126.7 (C quat., C9), 
128.8 (CH arom., C8), 129.1 (CH arom., C5), 131.5 (CH arom., C7), 135.1 (C quat., 
C6), 161.4 (C quat., C10). 
 
General procedure for the benzyl protection of 2,2-dimethyl-1,2-
dihydroquinoline compounds 
 
N
H
R
N
R
 
 
The required dihydroquinoline compound (5 mmol) was dissolved in DMF (20 ml). 
In a separate flask NaH (1.5 eq) was washed with petrol and then DMF (10 ml), the 
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flask was then cooled to -78oC. The dissolved dihydroquinoline compound was then 
added to the NaH slowly at a rate of 1 ml/min, followed by the slow addition of 
BnBr (1.1eq) also at a rate of 1 ml/min. The reaction was then left stirring overnight 
whilst warming to room temperature.  
 
1-Benzyl-6-chloro-2,2-dimethyl-1,2-dihydroquinoline 
 
N
Cl
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Prepared via the general method for the benzyl protection of 2,2-dimethyl-1,2-
dihydroquinoline compounds. Product isolated as a yellow oil (1.0 g, 72%). ímax 
(film) / cm-1 3012, 2912, 1698, 1601, 1586, 1456, 1262, 1054; äH (400 MHz; CDCl3) 
1.31 (6H, s, 2 x CH3), 4.40 (2H, s, NCH2Ph), 5.43 (1H, d, J 9.8 Hz, CH, C3), 6.03 
(1H, d, J 8.8 Hz, CH arom., C8), 6.14 (1H, d, J 9.8 Hz, CH, C4), 6.71 (1H, dd, J 8.8, 
2.4 Hz, CH arom., C7), 6.75 (1H, d, J 2.4 Hz, CH arom., C5), 7.047-7.147 (5H, m, 
CH2(C6H5); äC (100 MHz; CDCl3) 28.6 (2 x CH3), 33.6 (NCH2Ph), 57.6 (C quat., 
C2), 112.9 (CH, C4), 121.0 (C quat., C9), 122.7 (CH arom., C8), 126.7 (CH arom., 
C5), 127.8 (CH arom., C7), 128.6 (2 x CH arom., ortho on Ph), 128.9 (2 x CH arom., 
meta on Ph), 132.8 (CH arom., para on Ph), 137.8 (C quat., C10), 138.9 (C quat., 
NCH2C), 142.4 (C quat., C6). m/z: 283.11274; C18H18ClN requires 283.11278.  
 
(3,4,5-Trimethoxyphenyl)-methanol6, 107 
 
OHO
O
O
 
195 
 
3,4,5-Trimethoxybenzoic acid (9.0 g, 45 mmol) was placed in a flask with a stirrer, 
the flask was then dried and fitted with a nitrogen bubbler. To the flask dry THF (80 
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ml) was added, followed by the dropwise addition of LiAlH4 (40 ml, 40 mmol, 1.0 M 
in THF). The reaction was then stirred overnight, at which point hexane (80 ml) and 
NH4Cl (6 ml) was added. The reaction was stirred for a further hour, then filtered, 
dried (MgSO4) and evaporated to yield the product as a clear oil (6.8 g, 81%). ímax 
(film) / cm-1 3256, 3109, 2945, 1601, 1547, 1165, 1012; äH (400 MHz; CDCl3) 1.88 
(1H, s, OH), 3.83 (3H, s, para OCH3), 3.85 (6H, s, 2 x meta OCH3), 4.61 (2H, d, J 
5.2 Hz, CH2OH), 6.58 (2H, s, 2 x CH arom., C2,6); äC (100 MHz; CDCl3) 56.0 (2 x 
meta OCH3), 60.8 (para OCH3), 65.4 (CH2OH), 103.6 (2 x CH arom., C2,6), 136.8 
(C quat., OHCH2C), 137.1 (C quat., C4), 153.3 (2 x C quat., C3,5). 
 
3,4,5-Trimethoxybenzaldehyde6,108 
 
O
O
O
O
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(3,4,5-Trimethoxyphenyl)-methanol (3.0 g, 15 mmol) was placed in a dry flask under 
nitrogen, to this DCM (30 ml) was added. In a separate dry flask also under nitrogen 
was added PDC (2.7 g, 7.1 mmol) and 4Å molecular sieves. The DCM mixture was 
then added to the PDC and the reaction stirred at room temperature overnight. 
Diethyl ether (20ml) was then added to quench the reaction, and this was then run 
through silica to remove the chromium waste. The organics were then evaporated to 
yield the product as a white solid (1.9 g, 82%), m.p. 75-77 °C (lit  73-76 °C)6,108; 
ímax (film) / cm-1 3078, 2975, 2756, 1738, 1689, 1526, 1496, 1263, 1056; äH (400 
MHz; CDCl3) 3.89 (6H, s, 2 x OCH3, meta), 3.92 (3H, s, OCH3, para) 7.20 (2H, s, 2 
x CH arom., C2, 5), 9.90 (1H, s, CHO); äC (100 MHz; CDCl3) 62.1 (2 x OCH3, 
meta), 68.5 (1 x OCH3, para), 105.4 (C quat., C4), 132.5 (C 2 x quat., C3, 5), 145.1 
(2 x CH arom., C2, 6), 153.5 (C quat., CCHO), 178.9 (CHO).  
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Ethyl-(E)-3,4,5-trimethoxycinnamate6,109,110   
O
O
O
O
O
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3,4,5-Trimethoxy-benzaldehyde (1.0 g, 4.7 mmol) was dissolved under nitrogen in 
THF (10 ml). In a separate flask NaH (0.73 g, 18 mmol, 60% dispersion in mineral 
oil) was washed, and THF (10 ml) added, the flask was then cooled to -78oC. 
Triethylphosphonoacetate (1.4 ml, 1.2 eq) was added to this to form the ylid, at 
which point the aldehyde solution was added dropwise. The reaction was then slowly 
warmed up to room temperature and stirred. After 2 hours solid NaHCO3 (2 g) was 
added and the organic layer separated. The aqueous layer was further washed with 
ethyl acetate and the organics combined, dried (MgSO4) and evaporated to yield the 
product as an off white solid. This was further washed with hexane to remove any 
trace of the mineral oil and excess phosphonate reagent, yielding a clean product as a 
white solid (0.98 g, 77%); m.p. 69-70 °C (lit 68-69 °C)110; ímax (film) / cm-1 3050, 
2045, 1748, 1725, 1655, 1573, 1496, 1287, 1186, 1065; äH (400 MHz; CDCl3) 1.35 
(3H, t, J 9.6 Hz, CH2CH3), 3.81 (3H, s, OCH3, para), 3.86 (6H, s, 2 x OCH3, meta), 
4.12 (2H, q,  J 9.6 Hz, CH2CH3), 6.26 (1H, d, J 16.0 Hz, ArHC=CHCOOEt), 6.68 
(2H, s, CH arom., C2,6), 7.51 (1H, d, J 16.0 Hz, ArHC=CHCOOEt); äC (100 MHz; 
CDCl3) 14.3 (CH2CH3), 56.2 (2 x OCH3, meta), 56.9 (OCH3, para), 60.9 (CH2CH3), 
105.1 (2 x CH arom., C2,6), 111.2 (C quat., C4) 117.5 (CH=CH), 129.9 (C quat., 
C1), 144.5 (CH=CH), 153.4 (C quat., C3,5), 166.9 (C quat., COCH2CH3). 
 
General procedure for the acetalisation of aldehydes - route 173 
 
The required aldehyde (1 eq) was dissolved in the required alcohol (10 eq), the 
solution was then stirred at 0 oC under N2 and TiCl4 (1.0 M, 5 mol%) added to the 
solution with a syringe, in one portion. After 15 min, triethylamine (0.5eq) was 
added and the reaction stirred for a further 2 hours at room temperature. Water (2 ml 
for each 10 ml of alcohol) was then added and the solution extracted into DCM (3 x 
30 ml). The organics were then combined, dried (MgSO4) and evaporated to yield the 
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required product. The acetals were used directly after preparation without further 
purification due to the instability of the acetal on silica. 
 
General procedure for the acetalisation of aldehydes - route 274 
 
The aldehyde (1 eq) was dissolved in required alcohol (10 eq), to which was added 
triethyl orthoformate (1.2eq) and ammonium nitrate (0.1eq). The resultant solution 
was left stirring overnight at room temperature. The reaction was then checked by 
TLC and stopped upon complete consumption of the starting aldehyde. The liquid 
was removed under vacuum and the resulting oil re-dissolved in DCM and washed 
with NaHCO3 (3 x 50ml). The organic layers were then combined, dried (MgSO4) 
and evaporated to yield the product. The acetals were used directly after preparation 
without further purification due to the instability of the acetal on silica. 
 
1,1-Diethoxy-3-methyl-but-2-ene72 
 
O
O
 
230 
 
Prepared via the general procedure for the acetalisation of aldehydes routes 1 and 2, 
using ethanol (80 ml) as the alcohol. 3-Methyl-2-butenal (10 ml, 0.10 mol) yielded 
1,1-diethoxy-3-methyl-but-2-ene (15 g, 98%) as a yellow oil. ímax (film) / cm-1 
2976, 2932, 2915, 2880, 1680, 1447, 1377, 1358, 1348, 1206, 1146, 1115, 1086, 
1053, 1017, 991 cm-l, äH (400 MHz; CDCl3); 0.85-0.89 (6H, m, 2 x CH2CH3), 1.38, 
(3H, s, CH=CCH3, C4), 1.41 (3H, s, CH=CCH3, C5), 3.16-3.23 (4H, m, 2 x 
CH2CH3), 4.78 (1H, d, J 8.0 Hz, CH, C2), 4.93 (1H, d, J 8.0 Hz, CH, C1);  äC (100 
MHz; CDCl3) 14.8 (2 x CH2CH3), 17.0 (CH3, C4), 23.9 (CH3, C5), 58.8 (2 x 
CH2CH3), 101.0 (CH, C2), 122.9 (CH, C1), 137.3 (C quat., C3). 
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trans-1,1-Diethoxy-but-2-ene111 
O
O
 
159 
 
Prepared via the general procedure for the acetalisation of aldehydes routes 1 and 2, 
using ethanol (80 ml) as the alcohol. Crotonaldehyde (10 ml, 0.12 mol) yielded 1,1-
diethoxy-but-2-ene (17 g, 98%) as yellow oil. ímax (film) / cm-1 2846, 2810, 1677 
(w), 1661 (w), 1446, 1371, 1338, 1125 (s), 1052 (s), 996, 971. äH (400 MHz; CDCl3); 
1.30 (6H, t, J 7.2 Hz, 2 x CH2CH3), 1.64 (3H, dd, J 6.4, 1.6 Hz, CH3, C4), 3.37-3.45 
(2H, m, CH2), 3.52-3.61 (2H, m, CH2), 4.74 (1H, d, J 5.6 Hz, CH, C1 ), 5.43 (1H, 
ddq, J 15.6, 5.6, 1.6 Hz, CH=CHCH3, C2), 5.74 (1H, ddq, J 15.6, 6.4, 1.6 Hz, 
CH=CHCH3, C3); äC (100 MHz; CDCl3) 15.1 (2 x CH3 on acetal), 17.3 (CH3, C4), 
61.0 (2 x CH2, on acetal), 101.7 (CH, C1), 128.4 (CH, C2), 128.9 (CH, C3). 
 
trans-2-Hexenal Diethyl Acetal112 
O
O
 
160 
 
Prepared via the general procedure for the acetalisation of aldehydes route 2, using 
ethanol (80 ml) as the alcohol. The product was yielded as an orange oil (16 g, 88%); 
ímax (film) / cm-1 3105, 2799, 1587, 1491, 1301, 1255, 1087, äH (400 MHz; CDCl3); 
0.89-0.94 (3H, m, CH3, C6), 1.25-1.29 (6H, m, 2 x CH3, C7, 10), 1.42-1.45 (2H, m, 
CH2, C5), 2.01-2.04 (2H, m, CH2, C4), 3.51-3.56 (2H, m, CH2, C8), 3.58-3.64 (2H, 
m, CH2, C9), 4.82 (1H, d, J 6.2 Hz, C1), 5.52-5.56 (1H, m, CH, C3), 5.84-5.87 (1H, 
m, CH, C2); 
 
äC (100 MHz; CDCl3) 15.1 (C6), 18.5 (C7, 10), 23.4 (C5), 36.8 (C4), 
61.1 (C8, 9), 104.5 (C1), 128.4 (C3), 134.9 (C2).  
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trans-Cinnamaldehyde dimethylacetal74 
 
O
O
 
163 
 
Prepared via the general procedure for the acetalisation of aldehydes route 1, using 
methanol (80 ml) as the alcohol. trans-cinnamaldehyde (10 ml, 0.071 mol) yielded 
trans-cinnamaldehyde dimethylacetal (12 g, 88%) as a clear oil. ímax (film) / cm-1 
3095, 2847, 1567, 1495, 1275, 1150, 1087, äH (400 MHz; CDCl3); 3.95 (6H, s, 2 x 
CH3), 4.87 (1H, d, J 6.0 Hz, C1), 6.04 (1H, dd, J 15.8, 6.0 Hz, C2), 6.60 (1H, d, J 
15.8 Hz, C3), 7.1-7.48 (5H, m, Ph), 
 
äC (100 MHz; CDCl3) 52.7 (2 x CH3), 102.8 
(CH(OMe)2, C1), 125.6 (CHCH=CH, C2), 126.7 (CHCH=CHPh, C3), 128.8 (CH, 
para on Ph), 136.0 (2 x CH, ortho on Ph), 136.2 (2 x CH, meta on Ph), 152.8 
(CH=CHC, C4). 
 
trans-Cinnamaldehyde diethylacetal 74 
 
O
O
 
162 
 
Prepared via the general procedure for the acetalisation of aldehydes routes 1 and 2, 
using ethanol (80 ml) as the alcohol. trans-Cinnamaldehyde (10 ml, 0.071 mol) 
yielded trans-cinnamaldehyde diethylacetal (14 g, 96%) as a clear oil. ímax (film) / 
cm-1 3092, 2887, 1560, 1505, 1275, 1150, 1087, äH (400 MHz; CDCl3); 1.12 (6H, t, J 
7.4 Hz, 2 x CH3), 3.43 (2H, q, J 7.2 Hz, CH2), 3.58 (2H, q, J 7.2 Hz, CH2), 4.96 (1H, 
d, J 5.2 Hz, C1), 6.09 (1H, dd, J 16.0, 5.2 Hz, C2), 6.59 (1H, d, J 16.0 Hz, C3), 7.17-
7.48 (5H, m, Ph), 
 
äC (100 MHz; CDCl3) 15.3 (2 x CH3), 61.1 (2 x CH2), 101.5 
(CH(OEt)2, C1), 126.7 (CHCH=CH, C2), 128.5 (CHCH=CHPh, C3), 129.3 (CH, 
para on Ph), 135.5 (2 x CH, ortho on Ph), 136.2 (2 x CH, meta on Ph), 152.8 
(CH=CHC, C4). 
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4-Methyl-2-pentenal-diethyl acetal113 
 
O
O
 
161 
Prepared via the general procedure for the acetalisation of aldehydes routes 1 and 2, 
using ethanol (80 ml) as the alcohol. trans-2-Methyl-2-pentenal (10 ml, 0.083 mol) 
yielded 4-methyl-2-pentenal-diethyl acetal (13 g, 91%) as a yellow oil. ímax (film) / 
cm-1 3092, 2887, 1560, 1505, 1275, 1150, 1087, äH (400 MHz; CDCl3); 1.41 (6H, d, 
J 5.2 Hz, 2 x CH3, C5, 6), 1.65 (6H, t, J 6.8 Hz, 2 x CH3), 2.81 (1H, m, CH, C4), 
3.91 (2H, m, CH2), 4.05 (2H, m, CH2), 5.25 (1H, d, J 6.2 Hz, CH, C1), 5.90 (1H, dd, 
J 15.8, 5.5 Hz, CH=CH, C3), 6.20 (1H, dd, J 15.8, 6.2 Hz, CH=CH, C2); äC (100 
MHz; CDCl3) 15.3 (2 x CH3, C5, 6), 21.1 (2 x CH3), 30.1 (CH, C4), 61.1 (2 x CH2), 
110.5 (CH(OEt)2, C1), 120.7 (CH=CH, C3), 142.5 (CH=CH, C2).  
 
General procedure for the formation of chromenes74 
 
O R
R
 
 
The required acetalised aldehyde (1 eq) was dissolved in p-xylene (20 ml), the 
required phenol (2 eq) and 3-picolene (0.25 eq) were then added and the reaction 
heated under reflux overnight. The reaction was then left to cool and columned 
directly using either (i) a graded eluent from 100% petrol to 20:1 (petrol:ethyl 
acetate) or (ii) a petrol:toluene (1:1) mix. All of the products were obtained as either 
crystals or an oil. 
 
6-Chloro-2-methyl -2H-1-benzopyran114 
 
O
Cl
 
171 
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Prepared via the general procedure for the formation of chromenes using para 
chlorophenol (8.9 g, 69 mmol) as the required phenol, trans-1,1-diethoxy-3-methyl-
but-2-ene (5.0 ml, 34 mmol) as the required acetal and 3-picoline (0.8 ml, 0.25 eq). 
The product was columned directly using light petroleum:toluene (1:1). Product was 
obtained as a slight yellow liquid (4.7 g, 91% yield). ímax (film) / cm-1 3092, 2887, 
1560, 1505, 1275, 1150, 1087; äH (400 MHz; CDCl3); 1.40 ( 3H, d, J 6.6 Hz, CH3), 
4.95 (1H, dd, J 6.6, 3.2 Hz, CHMe, C2), 5.65 (1H, dd, J 9.6, 3.2 Hz, C3), 6.26 (1H, 
d, J 9.6 Hz, C4), 6.67 (1H, d, J 8.5 Hz, C8), 6.90 (1H, d, J 2.4 Hz, C5), 7.01 (1H, dd, 
J 8.5, 2.4 Hz, C7); äC (100 MHz; CDCl3) 22.4 (CH3), 75.6 (C2), 119.4 (C8), 125.2 
(quat., C, C9), 127.0 (C4), 128.3 (C3), 129.1 (C7), 129.2 (C5), 134.71 (quat., C, C6), 
152.02 (quat., C, C10); m/z 180.0338; C10H9ClO requires 180.0336. 
 
6-Nitro-2-methyl -2H-1-benzopyran114 
 
O
O2N
 
170 
 
Prepared via the general procedure for the formation of chromenes, using para 
nitrophenol (9.6 g, 69 mmol) as the required phenol, trans-1,1-diethoxy-3-methyl-
but-2-ene (5.0 ml, 34 mmol) as the required acetal and 3-picoline (0.8 ml, 0.25 eq). ). 
The product was columned directly using light petroleum:toluene (1:1) yielding the 
product as yellow crystals (4.7 g, 86% yield); m.p. 65 oC (lit. 66-66.5 oC);114 ímax 
(film) / cm-1 3065, 2972, 2936, 2224, 1485, 1464, 1368, 1279, 1269, 1215, 1167, 
961; äH (400 MHz; CDCl3); 1.49 (3H, d, J 6.8 Hz, CH3), 5.16 (1H, dd, J 6.8, 3.2 Hz, 
OCHMe, C2), 5.79 (1H, dd, J 10.0, 3.2 Hz, C3), 6.40 (1H, d, J 10.0 Hz, C4), 6.79 
(1H, d, J 8.8 Hz, C8), 7.97 (1H, d, J 2.4 Hz, C5), 8.0 (1H, dd, J 8.8, 2.4 Hz, C7); äC 
(100 MHz; CDCl3) 21.2 (CH3), 71.6 (C2), 117.3 (C8), 123.1 (quat., C, C9), 126.0 
(C4), 127.2 (C3), 128.3 (C5), 129.2 (C7), 145.7 (quat., C, C10), 162.1 (quat., C, C6). 
m/z: 191.05851; C10H9O3N requires 191.05824.  
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6-Cyano-2-methyl -2H-1-benzopyran75 
 
O
N
 
169 
Prepared via the general procedure for the formation of chromenes, using para 
cyanophenol (8.3 g, 69 mmol) as the required phenol, trans-1,1-diethoxy-3-methyl-
but-2-ene (5.0 ml, 35 mmol) as the required acetal and 3-picoline (0.80 ml, 0.25 eq).  
The product was columned directly using petrol:toluene (1:1) yielding the product as 
colourless crystals (4.7 g, 86% yield); m.p. 57 oC (lit. 55.5-56 oC);75 ímax (film) / 
cm-1 3020, 2972, 2936, 2324, 1485, 1468, 1379, 1269, 1215, 1167; äH (400 MHz; 
CDCl3); 1.37 (3H, d, J 6.8 Hz, CH3), 5.01 (1H, dd, J 6.8, 3.2 Hz, CH, C2), 5.66 (1H, 
dd, J 10.5, 3.2 Hz, C3), 6.24 (1H, d, J 10.5 Hz, C4), 6.70 1H, d, J 8.4 Hz, C8), 7.12 
(1H, d, J 2.0 Hz, C5), 7.27 (1H, dd, J 8.4, 2.0 Hz, C7); äC (100 MHz; CDCl3) 21.7 
(CH3), 72.5 (C2), 116.9 (C4), 120.4 (quat., C, C9), 122.1 (C3), 128.4 (C5), 129.2 
(quat., C, C6), 131.4 (C7), 133.3 (C8), 157.1 (quat., C, C10) 158.2 (quat., C, CN); 
m/z 171.0678; C11H9ON requires 171.0679. 
 
2,6-Dimethyl-2H-1-benzopyran115 
 
O
 
172 
 
Prepared via the general procedure for the formation of chromenes using para-cresol 
(1.87g, 17.3 mmol) as the required phenol, trans-1,1-diethoxy-3-methyl-but-2-ene (2 
ml, 11.5 mmol) as the required acetal and 3-picoline (0.30 ml, 0.25 eq.) The product 
was columned directly using toluene, yielding the product as a clear oil (1.49 g, 
80%yield); ímax (film) / cm-1 3020, 2972, 2936, 2324, 1485, 1468, 1379, 1269, 
1215, 1167; äH (400 MHz; CDCl3); 1.42 (3H, d, J 1.5 Hz, CH3, C11), 2.22 (3H, s, 
arom., CH3, C12), 4.91 (1H, dd, J 3.0, 1.5 Hz, OC(CH3)H, C2), 5.62 (1H, dd, J 9.7, 
3.0 Hz, CH=CH, C3), 6.32 (1H, d, J 9.7 Hz, CH=CH, C4), 6.66 (1H, d, J 8.1 Hz, 
arom., CH, C9), 6.75 (1H, s, arom., CH, C6), 6.88 (1H, d, J 8.1 Hz, arom., CH, C8); 
äC (100 MHz; CDCl3); 20.3 (CH3, C11), 21.0 (arom., CH3, C12), 71.2 (C2), 115.7 
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(C5), 121.6 (quat., C9), 123.9 (C4), 126.9 (C3), 128.4 (quat., C, C6), 129.5 (C7), 
129.8 (C8), 151.3 (quat., C10); m/z 160.2; C11H12O requires 160.2124. Mass spectra 
were obtained as low-resolution mass spectra after attempts to obtain high resolution 
spectra from Swansea failed due to decomposition during travel.  
 
6-Chloro-2-propyl-2H-1-benzopyran  
 
O
Cl
 
175 
 
Prepared via the general procedure for the formation of chromenes using para 
chlorophenol (7.4 g, 58 mmol) as the required phenol, trans-2-hexenal diethyl acetal 
(5.0 ml, 29 mmol) as the required acetal and 3-picoline (0.80 ml, 0.25 eq). The 
reaction was columned directly using toluene, yielding the product as a yellow oil 
(5.2 g, 86%); ímax (film) / cm-1 3065, 2950, 2736, 2224, 1585, 1464, 1368, 1315, 
991; äH (400 MHz; CDCl3) 0.95 (3H, t, J 7.4 Hz, CH3), 1.38-1.52 (4H, m, 2 x CH2), 
4.75-4.77 (1H, m, CH, C2), 5.63 (1H, dd, J 9.8, 3.5 Hz, C3), 6.23 (1H, d, J 9.8 Hz, 
C4), 6.65 (1H, d, J 8.5 Hz, C8), 6.84 (1H, d, J 2.5 Hz, C5), 6.95 (1H, dd, J 8.5, 2.5 
Hz, C7); äC (100 MHz; CDCl3) 14.2 (CH3), 37.4 (2 x CH2), 76.8 (C2), 117.2 (C5), 
123.0 (C4), 126.0 (C3), 127.1 (quat., C9), 127.3 (C8), 128.6 (C7), 134.7 (quat., C6), 
152.1 (quat., C10); m/z 208.06; C12H13ClO requires 208.0655. Mass spectra were 
obtained as low-resolution mass spectra after attempts to obtain high resolution 
spectra from Swansea failed due to decomposition during travel.  
 
6-Nitro-2-propyl-2H-1-benzopyran  
 
O
O2N
 
174 
 
Prepared via the general procedure for the formation of chromenes using para 
nitrophenol (8.0 g, 58 mmol) as the required phenol, trans-2-hexenal diethyl acetal 
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(5.0 ml, 29 mmol) as the required acetal and 3-picoline (0.80 ml, 0.25 eq). The 
reaction was columned directly using toluene, yielding the product as a yellow oil 
(5.7 g, 89%) ímax (film) / cm-1 3015, 2875, 2936, 2128, 1520, 1479, 1220, 1190, 
1068, 961; äH (400 MHz; CDCl3) 0.83 (3H, t, J 6.6 Hz, CH3), 1.32-1.43 (2H, m, CH2, 
CH2CH2CH3), 1.51-1.66 (2H, m, CH2, CH2CH2CH3), 4.87-4.90 (1H, m, CH, C2), 
5.66 (1H, dd, J 10.2, 3.2 Hz, C3), 6.26 (1H, d, J 10.2 Hz, C4), 6.67 (1H, d, J 9.5 Hz, 
C8), 7.65 (1H, d, J 2.8 Hz, C5), 7.82 (1H, dd, J 9.5, 2.8 Hz, C7); äC (100 MHz; 
CDCl3) 13.4 (CH3), 17.7 (2 x CH2), 77.0 (C2), 115.8 (C5), 121.9 (quat., C9), 123.0 
(C4), 124.9 (C3), 127.5 (C8), 130.0 (C7), 141.2 (quat., C6), 166.2 (quat., C10); m/z 
219.08985; C12H13NO3 requires 219.08959. 
 
6-Cyano-2-propyl-2H-1-benzopyran  
 
O
N
 
173 
 
Prepared via the general procedure for the formation of chromenes using para 
cyanophenol (6.9 g, 58 mmol) as the required phenol, trans-2-hexenal diethyl acetal 
(5.0 ml, 29 mmol) as the required acetal and 3-picoline (0.80 ml, 0.25 eq). The 
reaction was columned directly using toluene, yielding the product as a yellow oil 
(5.1 g, 89%). ímax (film) / cm-1 3024, 2854, 2251, 1444, 1268, 1169, 1167, 981; äH 
(400 MHz; CDCl3) 0.95 (3H, t, J 6.2 Hz, CH3), 1.47-1.62 (4H, m, 2 x CH2), 4.89-
4.91 (1H, m, CH, C2), 5.75 (1H, dd, J 10.6, 3.2 Hz, C3), 6.31 (1H, d, J 10.6 Hz, C4), 
6.76 (1H, d, J 8.1 Hz, C8), 7.18 (1H, d, J 2.0 Hz, C5), 7.33 (1H, dd, J 8.1, 2.0 Hz, 
C7); äC (100 MHz; CDCl3) 14.4 (CH3), 37.8 (2 x CH2), 75.9 (C2), 103.8 (quat., C9), 
116.7 (C5), 119.4 (quat., C6), 122.0 (C4), 122.3 (quat., C10), 127.5 (C3), 130.0 (C8), 
133.2 (C7), 158.7 (quat., CN); m/z 199.1; C13H13NO requires 199.0997. Mass spectra 
were obtained as low-resolution mass spectra after attempts to obtain high resolution 
spectra from Swansea failed due to decomposition during travel.  
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6-Chloro-2-phenyl-2H-1-benzopyran116 
 
O
Cl
 
177 
 
Prepared via the general procedure for the formation of chromenes using para 
chlorophenol (7.4 g, 58 mmol) as the required phenol, trans-cinnamaldehyde 
diethylacetal (5.0 ml, 29 mmol) as the required acetal and 3-picoline (0.70 ml, 0.25 
eq). Product yielded as a clear yellow oil (4.8 g, 68%); ímax (film) / cm-1 2992, 2956, 
1585, 1464, 1451, 1299, 1244, 1254, 1162; äH (400 MHz; CDCl3) 5.93 (1H, dd, J 
10.3, 3.6 Hz, C3), 6.00 (1H, dd, J 3.6, 1.6 Hz, CH, C2), 6.55 (1H, dd, J 10.3, 1.6 Hz, 
C4), 6.82 (1H, d, J 8.8 Hz, C8), 7.08 (1H, d, J 2.4 Hz, C5), 7.15 (1H, dd, J 8.8, 2.4 
Hz, C7), 7.44-7.50 (3H, m, arom., meta and para on phenyl substituent), 7.52-7.56 
(2H, m, arom., ortho on phenyl substituent); äC (100 MHz; CDCl3) 77.4 (C2), 117.4 
(C5), 122.7 (quat., C9), 123.2 (C4), 126.1 (C3), 126.2 (C8), 127.5 (2 x arom., ortho 
on phenyl substituent), 128.5 (2 x arom., meta on phenyl substituent), 128.7 (arom., 
para on phenyl substituent), 129.2 (C7), 134.7 (quat., C6), 140.3 (quat., C on phenyl 
substituent), 154.2 (quat., C10); m/z 242.7; C15H11ClO requires 242.0498. Mass 
spectra were obtained as low-resolution mass spectra after attempts to obtain high 
resolution spectra from Swansea failed due to decomposition during travel.  
 
6-Nitro-2-phenyl-2H-1-benzopyran116 
 
O
O2N
 
176 
 
Prepared via the general procedure for the formation of chromenes using para 
nitrophenol (8.0 g, 58 mmol) as the required phenol, trans-cinnamaldehyde 
diethylacetal (5.0 ml, 29 mmol) as the required acetal and 3-picoline (0.70 ml, 0.25 
eq). Product yielded as yellow oil (5.1 g, 70%); ímax (film) / cm-1 3024, 2104, 1585, 
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1564, 1486, 1298, 1278, 1155, 1067; äH (400 MHz; CDCl3) 5.94 (1H, dd, J 10.4, 3.2 
Hz, C3), 6.06 (1H,dd, J 3.2, 1.6 Hz, CH, C2), 6.59 1H, dd, J 10.4, 1.6 Hz, C4), 6.81 
(1H, d, J 8.8 Hz, C8), 7.35-7.42 (5H, m, phenyl substituent), 7.94 (1H, d, J 2.8 Hz, 
C5), 8.01 (1H, dd, J 8.8, 2.8 Hz, C7); äC (100 MHz; CDCl3) 78.4 (C2), 116.3 (C5), 
120.8 (quat., C9), 122.2 (C8), 122.3 (C4), 125.6 (C3), 126.3 (C7), 127.7 (3 x C 
arom., meta and para on phenyl substituent), 128.9 (2 x C arom., ortho on phenyl 
substituent), 139.4 (quat., C6), 158.4 (quat., C10), m/z: 253.07389; C15H11O3N 
requires 253.07389. 
 
6-Cyano-2-phenyl-2H-1-benzopyran  
 
O
N
 
164 
 
Prepared via the general procedure for the formation of chromenes using para-
cyanophenol (6.8 g, 58 mmol) as the phenol, trans-cinnamaldehyde diethylacetal 
(5.0 ml, 29 mmol) as the required acetal and 3-picoline (0.70 ml, 0.25 eq). Product 
yielded as clear crystals crystallized after column chromatography in light 
petroleum:ethyl acetate (10:1 to 1:1) and an off white oil (4.8 g, 71%) m.p. 118-120 
oC; ímax (film) / cm-1 3092, 2887, 1560, 1505, 1275, 1150, 1087, Found C, 82.14; 
H, 4.96; N, 5.87. C16H11NO requires C, 82.38; H, 4.75; N, 6.00; äH (400 MHz; 
CDCl3); 5.82 (1H, dd, J 9.6, 3.2 Hz, C3), 5.94 (1H, dd, J 3.2, 1.6 Hz, C2), 6.43 (1H, 
dd, J 9.6, 1.6 Hz, C4), 6.72 (1H, d, J 8.4 Hz, C8), 7.22 (1H, d, J 2.0 Hz, C5), 7.32-
7.38 (5H, m, phenyl substituent), 7.40 (1H, dd, J 8.4, 2.0 Hz, C7), äC (100 MHz; 
CDCl3) 77.4 (C2), 104.3 (C5), 116.9 (C quat., C9), 119.1 (C8), 121.6 (C4), 122.2 
(C3), 126.3 (CH arom., para on phenyl substituent), 127.0 (2 x CH arom., ortho on 
phenyl substituent), 130.3 (2 x CH arom., meta on phenyl substituent), 131.3 (C7), 
133.7 (C quat., on phenyl substituent), 138.4 (C quat., C6), 154.6 (C quat., C10), 
156.7 (CN); m/z 233.08406; C16H11NO requires 233.26461. Crystal structure 
obtained, see page 199. 
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6-Chloro-2-isopropyl-2H-1-benzopyran  
 
O
Cl
 
179 
 
Prepared via the general procedure for the formation of chromenes using para-
chlorophenol (7.4 g, 2 eq, 58 mmol) as the phenol, trans-4-methyl-2-pentenal-diethyl 
acetal (5.0 ml, 29 mmol) as the required acetal and 3-picoline (0.70 ml, 0.25 eq). 
Product yielded as clear white oil (3.5 g, 62%); ímax (film) / cm-1 3156, 2957, 1584, 
1498, 1286, 1304, 1087; äH (400 MHz; CDCl3); 1.00 (3H, d, J 9.1 Hz, CH3), 1.02 
(3H, d, J 9.1 Hz, CH3), 1.94-2.05 (1H, m, CH(CH3)2), 4.61-4.65 (1H, m, C2), 5.74 
(1H, dd, J 13.4, 4.4 Hz, C3), 6.35 (1H, d, J 13.4 Hz, C4), 6.69 (1H, d, J 8.4 Hz, C8), 
6.90 (1H, d, J 3.4 Hz, C5), 7.02 (1H, dd, J 8.4, 3.4, Hz, C7); äC (100 MHz; CDCl3) 
17.7 (CH3), 17.9 (CH3), 33.7 (CH(CH3)2), 80.3 (C2), 117.0 (C5), 123.4 (C4), 123.7 
(quat., C, C9), 125.4 (C3), 127.1 (C7), 134.8 (C8), 152.7 (quat., C, C6), 167.2 (quat., 
C, C10); m/z 208.6; C12H13ClO requires 208.6825. Mass spectra were obtained as 
low-resolution mass spectra after attempts to obtain high resolution spectra from 
Swansea failed due to decomposition during travel.  
 
6-Cyano-2-isopropyl-2H-1-benzopyran  
 
O
NC
 
178 
 
Prepared via the general procedure for the formation of chromenes using para-
cyanophenol (6.9 g, 2 eq, 58 mmol) as the phenol, trans-4-methyl-2-pentenal-diethyl 
acetal (5.0 ml, 29 mmol) as the required acetal and 3-picoline (0.70 ml, 0.25 eq). 
Product yielded a yellow oil (4.8 g, 84%), ímax (film) / cm-1 3053, 2785, 1596, 
1545, 1376, 1245, 1137; äH (400 MHz; CDCl3); 0.96 (3H, d, J 8.6 Hz, CH3), 0.99 
(3H, d, J 8.6 Hz, CH3), 1.91-2.01 (1H, m, CH(CH3)2), 4.86-4.93 (1H, m, C2), 5.65 
(1H, dd, J 12.5, 4.2 Hz, C3), 6.36 (1H, d, J 12.5 Hz, C4), 6.72 (1H, d, J 8.3 Hz, C8), 
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7.18 (1H, d, J 2.4 Hz, C5), 7.38 (1H, dd, J 8.3, 2.4 Hz, C7); äC (100 MHz; CDCl3) 
18.9 (CH3), 19.1 (CH3), 34.2 (CH(CH3)2), 82.1 (C2), 104.3 (quat., C, C9), 116.9 
(C5), 119.1 (quat., C, C6), 123.6 (quat., C, CN), 123.9 (C4), 126.5 (C3), 131.4 (C7), 
134.9 (C8), 158.7 (quat., C, C10); m/z 199.2; C13H13NO requires 199.2586. Mass 
spectra were obtained as low-resolution mass spectra after attempts to obtain high 
resolution spectra from Swansea failed due to decomposition during travel.  
 
6-Nitro-2-isopropyl-2H-1-benzopyran 
 
O
O2N
 
180 
 
Prepared via the general procedure for the formation of chromenes using para-
nitrophenol (8.0 g, 2 eq, 58 mmol) as the phenol, trans-4-methyl-2-pentenal-diethyl 
acetal (5.0 ml, 29 mmol) as the required acetal and 3-picoline (0.70 ml, 0.25 eq). 
Product yielded as yellow crystals (5.1 g, 80%) m.p. 124-126 oC; ímax (film) / cm-1 
3021, 2667, 1560, 1535, 1365, 1230, 1084; äH (400 MHz; CDCl3); 0.99 (3H, d, J 8.5 
Hz, CH3), 1.03 (3H, d, J 8.5 Hz, CH3), 1.95-2.06 (1H, m, CH(CH3)2), 4.83-4.87 (1H, 
m, C2), 5.78 (1H, dd, J 13.6, 4.3 Hz, C3), 6.45 (1H, d, J 13.6 Hz, C4), 6.79 (1H, d, J 
8.8 Hz, C8), 7.83 (1H, d, J 3.6 Hz, C5), 7.99 (1H, dd, J 8.8, 3.6 Hz, C7); äC (100 
MHz; CDCl3) 17.2 (CH3), 17.8 (CH3), 34.2 (CH(CH3)2), 81.5 (C2), 115.9 (C4), 
121.4 (C5), 122.2 (C3), 125.6 (C7), 129.1 (quat., C, C9), 129.7 (C8), 141.5 (quat., C, 
C6), 159.8 (quat., C, C10); m/z 220.0968; C12H13NO3 [+H+] requires 220.0968. 
 
5,7-Dimethyl-2-phenyl-2H-1-benzopyran117 
 
O
O
O
 
131 
 
 155 
Prepared via the general procedure for the formation of chromenes, using 3,5-
dimethoxyphenol (8.8 g, 58 mmol) as the required phenol, trans-cinnamaldehyde 
diethylacetal (5.0 ml, 29 mmol) as the required acetal and 3-picoline (0.70 ml, 0.25 
eq).. Product yielded as a yellow oil (1.9 g, 58%) ímax (film) / cm-1 3092, 2887, 
1560, 1505, 1275, 1150, 1087; äH (400 MHz; CDCl3); 3.78 (3H, s, OCH3 off C5), 
3.84 (3H, s, OCH3 off C7), 5.76 (1H, dd, J 9.9, 3.5 Hz, C3), 5.96 (1H, d, J 3.5, 1.8 
Hz, C2), 6.18 (1H, d, J 2.2 Hz, C6), 6.24 (1H, d, J 2.2 Hz, C8), 7.00 (1H, dd, J 9.9, 
1.8 Hz, C4), 7.42-7.49 (5H, m, Ph); äC (100 MHz; CDCl3) 55.3 (OCH3 off C5), 55.9 
(CH3 off C7), 77.8 (C2), 92.9 (C6), 94.7 (C8), 104.5 (C9), 119.0 (C4), 119.9 (C3), 
126.0 (2 x CH, ortho on phenyl substituent), 127.6 (CH, para on phenyl substituent), 
128.7 (2 x CH, meta on phenyl substituent), 141.1 (C quat., on phenyl substituent), 
155.3 (C5), 159.2 (C10), 161.5 (C7). 
 
2,2,8,8-Tetramethyl-2H,8H-pyrano[3,2-g]chromene118 
 
OO
 
221 
 
Prepared via the general procedure for the formation of chromenes using resorcinol 
(1.99 g, 18.1 mmol, 1 eq) as the required phenol, 3-methyl-2-butenal (5.7 ml, 36 
mmol, 2 eq) as the required acetal and 3-picoline (0.90 ml, 0.50 eq) yielding the 
product as a clear oil. ímax (film) / cm-1 3125, 2951, 2654, 2012, 1645, 1485, 1327, 
1240, 1058; äH (400 MHz; CDCl3) 1.37 (12H, s, (2 x CH3) x 2), 5.39 (2H, d, J 9.8 
Hz, CH x 2, alkene, C3,7), 6.18 (2H, d, J 9.8 Hz, CH x 2, alkene, C4,6), 6.30 (1H, s, 
CH arom., C5), 6.53 (1H, s, CH arom., C10); äC (100 MHz; CDCl3) 26.1 (4 x C of 
CH3), 103.6 (CH arom., C5), 115.6 (2 x quat., C2,8), 122.7 (CH x 2 alkene, C4,6), 
126.3, CH arom., C10), 127.0 (CH x 2 alkene, C3,7), 136.7 (2 x quat., C12,13), 
159.4 (2 x quat., C11,14).  
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The Epoxides - Prepared Via The General Epoxidation Routes Described 
Earlier (See pages 135-136). 
 
6-Chloro-2-methyl-benzopyran oxide 
 
O
Cl O
 
183 
 
Prepared by the epoxidation routes described above. The product epoxide was 
obtained as a clear oil with a cis:trans ratio of 50:50 when using m-CPBA and 1:10 
when using the chiral TPPP conditions with catalyst (132). ímax (film) / cm-1 2922, 
2853, 2226, 1462; äH (400 MHz; CDCl3) 1.18 (3H, d, J 6.8 Hz, Me on trans 
epoxide), 1.46 (3H, d, J 6.4 Hz, Me on cis epoxide), 3.48 ( 1H, dd, J 14.4, 7.4 Hz, 
C3, epox CH on trans epoxide), 3.54 (1H, d, J 11.8, 7.4 Hz, C3, epox CH on cis 
epoxide), 3.71 (1H, d, J 7.4 Hz, C4, epox CH on trans epoxide), 3.75 (1H, d, J 7.4 
Hz, C4, epox CH on cis epoxide), 4.13 (1H, dd, J 11.8, 6.4 Hz, C2, CH on cis 
epoxide), 4.63 (1H, dd, J 14.4, 6.8 Hz, C2, CH on trans epoxide), 6.66 (2H, d, J 8.4 
Hz, C8 on cis and trans epoxide), 7.08 (2H, d, J 2.8 Hz, C5 on cis and trans 
epoxide), 7.21 (2H, dd, J 8.4, 2.8 Hz, C7 on cis and trans epoxide); äC (100 MHz; 
CDCl3) 16.1 (CH3, on trans epoxide), 18.6 (CH3, on cis epoxide), 48.6 (epox CH on 
trans epoxide, C3), 50.0 (epox CH on cis epoxide, C3), 59.2 (epox CH on trans 
epoxide, C4), 59.6 (epox CH on cis epoxide, C4), 68.7 (CH, on trans epoxide, C2), 
69.0 (CH, on cis epoxide, C2), 119.1 (2 x CH arom., on cis and trans epoxide, C5), 
125.7 (2 x quat., on cis and trans epoxide, C9), 128.6 (2 x CH arom, on cis and trans 
epoxide, C6), 129.3 (2 x CH arom., on cis and trans epoxide, C8), 150.1 (2 x quat., 
on cis and trans epoxide, C10), 152.6 (2 x quat., on cis and trans epoxide, C6); m/z 
196.01; C10H9ClO2 requires 196.0291. Mass spectra were obtained as low-resolution 
mass spectra after attempts to obtain high resolution spectra from Swansea failed due 
to decomposition during travel.  
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6-Nitro-2-methyl-benzopyran oxide 
 
O
O2N
O
 
182 
 
Prepared by the epoxidation routes described above. The product epoxide was 
obtained as a clear oil with a cis:trans ratio of 50:50 when using m-CPBA and 1:20 
when using the chiral TPPP conditions with catalyst (132). ímax (film) / cm-1 2915, 
2758, 2375, 1480, 1425, 1211 äH (400 MHz; CDCl3) 1.28 (3H, d, J 6.8 Hz, Me on 
trans epoxide), 1.50 (3H, d, J 6.4 Hz, Me on cis epoxide), 3.59 (1H, dd, J 13.8, 7.2 
Hz, C3, epox CH on trans epoxide), 3.65 (1H, dd, J 12.2, 7.4 Hz, C3, epox CH on cis 
epoxide), 3.88 (1H, d, J 7.2 Hz, C4, epox CH on trans epoxide ), 3.92 (1H, d, J 7.4 
Hz, C4, epox CH on cis epoxide), 4.35 (1H, dd, J 12.2, 6.4 Hz, C2, CH on cis 
epoxide), 4.79 (1H, dd, J 13.8, 6.8 Hz, C2, CH on trans epoxide), 6.81 (1H, dd, J 8.8 
Hz, C8 on cis and trans epoxide), 8.03 (1H, d, J 1.2 Hz, C5 on cis and trans 
epoxide), 8.20 (1H, dd, J 8.8, 1.2 Hz, C7 on cis and trans epoxide); äC (100 MHz; 
CDCl3) 17.1 (CH3, on trans epoxide), 18.9 (CH3, on cis epoxide), 49.9 (epox CH on 
trans epoxide, C3), 52.2 (epox CH on cis epoxide, C3), 60.2 (epox CH on trans 
epoxide, C4), 60.4 (epox CH on cis epoxide, C4), 69.7 (CH, on trans epoxide, C2), 
70.0 (CH, on cis epoxide, C2), 120.1 (2 x CH arom., cis and trans epoxide, C6), 
126.4 (2 x quat., cis and trans epoxide, C9), 128.9 (2 x CH arom., cis and trans 
epoxide, C8), 130.7 (2 x CH arom., cis and trans epoxide, C7), 152.8 (2 x quat., cis 
and trans epoxide, C10), 154.1 (2 x quat., cis and trans epoxide, C6); m/z 208.06072, 
C10H9NO4 requires 207.05316 (+H = 208.06098). 
 
6-Cyano-2-methyl-benzopyran oxide75 
 
O
NC O
 
181 
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Prepared by the epoxidation routes described above. The product epoxide was 
obtained as clear crystals with a cis:trans ratio of 50:50 when using m-CPBA and 
1:15 when using the chiral TPPP conditions with catalyst (132). m.p. 52 oC (lit 55-56 
oC)13; ímax (film) / cm-1 2230, 1620, 1585; äH (400 MHz; CDCl3) 1.35 (3H, d, J 7.0 
Hz, Me on trans epoxide), 1.60 (3H, d, J 6.5 Hz, Me on cis epoxide), 3.65 (1H, d, J 
14.2, 6.4 Hz,  epox CH on trans epoxide, C3), 3.71 (1H, d, J 11.8, 6.4 Hz, epox CH 
on cis epoxide, C3), 3.89 (1H, d, J 6.4 Hz, epox CH on trans epoxide, C4), 3.94 (1H, 
d, J 6.4 Hz, epox CH on cis epoxide, C4), 4.39 (1H, dd, J 11.8, 6.5 Hz, CH on cis 
epoxide, C2), 4.84 (1H, dd, J 14.2, 7.0 Hz, CH on trans epoxide, C2), 6.89 (1H, d, J 
8.5 Hz, on trans and cis epoxide cis and trans, C8), 7.53 (1H, dd, J 8.5, 2.0 Hz, on 
trans and cis epoxide, C7), 7.65 (1H, d, J 2.0 Hz, on trans epoxide, C5), 7.68 (1H, d, 
J 2.0 Hz, on cis epoxide, C5); äC (100 MHz; CDCl3) 16.1 (CH3, on trans epoxide), 
17.5 (CH3, on cis epoxide), 48.4 (epox CH on trans epoxide, C3), 51.4 (epox CH on 
cis epoxide, C3), 58.2 (epox CH on trans epoxide, C4), 59.4 (epox CH on cis 
epoxide, C4), 67.5 (CH, on trans epoxide, C2), 69.1 (CH, on cis epoxide, C2), 119.4 
(2 x CH arom., on trans and cis epoxide, C5), 124.5 (2 x quat., on trans and cis 
epoxide, C9), 125.8 (2 x CH arom., on trans and cis epoxide, C8), 129.7 (2 x CH 
arom., on trans and cis epoxide, C7), 134.6 (quat., C, CN, on trans and cis epoxide), 
152.8 (2 x quat., on trans and cis epoxide, C6), 153.1 (2 x quat., on trans and cis 
epoxide, C10). 
 
6-Chloro-2-propyl-benzopyran oxide 
 
O
Cl O
 
185 
 
Prepared by the epoxidation routes described above. The product epoxide was 
obtained as a clear oil with a cis:trans ratio of 40:60 when using m-CPBA and 1:14 
when using the chiral TPPP conditions with catalyst (132). ímax (film) / cm-1 2853, 
2226, 1508, 1462, 1358; äH (400 MHz; CDCl3) 0.85 (3H, t, J 7.2 Hz, CH3 on trans 
epoxide), 0.92 (3H, t, J 6.8 Hz, CH3 on cis epoxide), 1.38-1.42 (4H, m, 2 x CH2 on 
trans epoxide), 1.42-1.53 (4H, m, 2 x CH2 on cis epoxide), 3.50 (1H, dd, J 14.4, 4.2 
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Hz, epox CH on trans epoxide, C3), 3.58 (1H, d, J 11.4, 4.4 Hz, epox CH on cis 
epoxide, C3), 3.71 (1H, d, J 4.2 Hz, epox CH on trans epoxide, C4), 3.73 (1H, d, J 
4.4 Hz, epox CH on cis epoxide, C4), 3.96-3.99 (1H, m, CH, on cis epoxide, C2), 
4.44-4.47 (1H, m, CH, on trans epoxide, C2), 6.65-6.68 (1H, m, CH arom., on trans 
and cis epoxide, C5), 7.06-7.09 (1H, m, CH arom., on trans and cis epoxide, C8), 
7.19-7.22 (1H, m, CH arom., on trans and cis epoxide, C7); äC (100 MHz; CDCl3) 
13.8 (CH3, on trans epoxide), 14.1 (CH3, on cis epoxide), 18.3 (CH2, on trans and cis 
epoxide), 32.5 (CH2, on trans and cis epoxide), 48.8 (epox., CH on trans epoxide, 
C3), 49.7 (epox., CH on cis epoxide, C3), 58.8 (epox., CH on trans epoxide, C4), 
58.9 (epox., CH on cis epoxide, C4), 70.5 (on cis epoxide, C2), 72.1 (on trans 
epoxide, C2), 119.4 (arom CH, on trans and cis epoxide, C5), 128.1 (arom CH, on 
trans and cis epoxide, C8), 130.3 (arom CH, on trans and cis epoxide, C7), 134.6 
(quat., on trans and cis epoxide, C9), 153.1 (quat., on trans and cis epoxide, C6), 
164.4 (quat., on trans and cis epoxide, C10); m/z 224; C12H13ClO2 requires 224.0604. 
Mass spectra were obtained as low-resolution mass spectra after attempts to obtain 
high resolution spectra from Swansea failed due to decomposition during travel.  
 
6-Nitro-2-propyl-benzopyran oxide 
 
O
O2N
O
 
184 
 
Prepared by the epoxidation routes described above. The product epoxide was 
obtained as a clear oil with a cis:trans ratio of 40:60 when using m-CPBA and 1:25 
when using the chiral TPPP conditions with catalyst (132). ímax (film) / cm-1 2922, 
2226, 1542, 1462, 1154; äH (400 MHz; CDCl3) 0.88 (3H, t, J 9.5 Hz, CH3 on trans 
epoxide), 0.96 (3H, t, J 9.0 Hz, CH3 on cis epoxide), 1.45-1.55 (4H, m, 2 x CH2, on 
trans epoxide), 1.65-1.72 (4H, m, 2 x CH2, on cis epoxide), 3.61 (1H, d, J 14.2, 4.4 
Hz, epox CH on trans epoxide, C3), 3.70 (1H, d, J 11.6, 4.4 Hz, epox CH on cis 
epoxide, C3), 3.88 (1H, d, J 4.4 Hz, epox CH on trans epoxide, C4), 3.91 (1H, d, J 
4.4 Hz, epox CH on cis epoxide, C4), 4.19-4.22 (1H, m, CH, on cis epoxide, C2), 
4.27-4.48 (1H, m, CH, on trans epoxide, C2), 6.83 (1H, d, J 9.2 Hz, arom CH, on 
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trans and cis epoxide, C8), 8.04-8.08 (1H, m, arom CH, on trans and cis epoxide, 
C5), 8.20-8.23 (1H, m, arom CH, on trans and cis epoxide, C7); äC (100 MHz; 
CDCl3) 11.8 (on trans epoxide), 12.0 (on cis epoxide) , 16.3 (CH3, on trans epoxide), 
17.0 (CH3, on cis epoxide) , 27.3 (2 x CH2, on trans epoxide), 31.1 (2 x CH2, on cis 
epoxide) , 46.5 (epox., CH on trans epoxide, C3), 47.3 (epox., CH on cis epoxide, 
C3) , 56.3 (epox., CH on trans and cis epoxide, C4) , 71.2 (on cis epoxide, C2) , 71.5 
(on trans epoxide, C2), 116.6 (arom CH, on trans and cis epoxide, C5), 124.0 (arom 
CH, on trans and cis epoxide, C8), 125.3 (arom CH, on trans and cis epoxide, C7), 
139.2 (quat., on trans and cis epoxide, C9), 155.8 (quat., on trans and cis epoxide, 
C10), 157.6 (quat., on trans and cis epoxide, C6); m/z 235; C14H19NO4 requires 
235.0845. Mass spectra were obtained as low-resolution mass spectra after attempts 
to obtain high resolution spectra from Swansea failed due to decomposition during 
travel.  
 
6-Chloro-2-phenyl-benzopyran oxide 
 
O
Cl O
 
188 
 
Prepared by the epoxidation routes described above. The product epoxide was 
obtained as a clear oil with a cis:trans ratio of 20:80 when using m-CPBA and 1:20 
when using the chiral TPPP conditions with catalyst (132). ímax (film) / cm-1 2922, 
2754, 2126, 1462; äH (400 MHz; CDCl3) 3.82 (1H, dd, J 4.4, 1.2 Hz, epox CH on 
trans epoxide, C3), 3.84 (1H, d, J 4.4 Hz, epox CH on cis epoxide, C3), 3.90 (1H, d, 
J 4.4 Hz, epox CH on cis epoxide, C4), 3.91 (1H, d, J 4.4 Hz, epox CH on trans 
epoxide, C4), 4.99 (1H, s, CH, on cis epoxide, C2), 5.54 (1H, d, J 1.2 Hz, CH, on 
trans epoxide, C2), 6.69 (1H, d, J 8.8 Hz, arom CH, on trans and cis epoxide, C8), 
7.13 (1H, dd, J 8.8, 2.4 Hz, arom CH, on trans and cis epoxide, C7), 7.24-7.27 (5H, 
m, phenyl substituent, on trans and cis epoxide), 7.30 (1H, d, J 2.8 Hz, arom CH, on 
trans and cis epoxide, C5); äC (100 MHz; CDCl3) 48.7 (epox., CH on trans epoxide, 
C3), 50.0 (epox., CH on cis epoxide, C3) , 58.0 (epox., CH on trans epoxide, C4 ), 
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59.9 (epox., CH on cis epoxide, C4), 75.4 (on trans and cis epoxide, C2), 125.3 
(quat., on trans and cis epoxide, C9), 126.0 (arom CH, on trans and cis epoxide, C8), 
126.6 (arom CH, on trans and cis epoxide, C5), 127.1 (arom CH, on trans and cis 
epoxide, C7), 127.5 (2 x arom., ortho on phenyl substituent), 128.5 (2 x arom., meta 
on phenyl substituent), 128.7 (arom., para on phenyl substituent), 136.0 (quat., on 
trans and cis epoxide, on phenyl substituent), 141.6 (quat., on trans and cis epoxide, 
C6), 157.8 (quat., on trans and cis epoxide, C10); m/z 258; C15H11ClO2 requires 
258.0448. Mass spectra were obtained as low-resolution mass spectra after attempts 
to obtain high resolution spectra from Swansea failed due to decomposition during 
travel.  
 
6-Nitro-2-phenyl-benzopyran oxide 
 
O
O2N
O
 
187 
 
Prepared by the epoxidation routes described above. The product epoxide was 
obtained as a clear oil with a cis:trans ratio of 20:80 when using m-CPBA. The 
reaction did not proceed when using the TPPP conditions with catalyst (132). ímax 
(film) / cm-1 2820, 2226, 1442, 1385; äH (400 MHz; CDCl3) 3.84 (1H, d, J 4.8 Hz, 
epox CH on trans epoxide, C3), 3.90 (1H, d, J 4.4 Hz, epox CH on cis epoxide, C3), 
4.02-4.05 (1H, d, epox CH, J 4.8 Hz on trans and J 4.4 Hz on cis epoxide, C4), 5.14 
(1H, s, CH, on cis epoxide, C2), 5.64 (1H, s, CH, on trans epoxide, C2), 6.81 (1H, d, 
J 8.8 Hz, arom CH, on trans epoxide, C8), 6.91 (1H, d, J 8.8 Hz, arom CH, on cis 
epoxide, C8), 8.06-8.08 (2H, m, arom CH, on trans and cis epoxide, ortho on phenyl 
substituent), 8.26-8.28 (3H, m, arom CH, on trans and cis epoxide, meta and para on 
phenyl substituent), 8.05 (1H, dd, J 8.8, 2.4 Hz, on trans and cis epoxide, C7), 8.25 
(1H, d, J 2.4 Hz, C5 on trans epoxide), 8.28 (1H, d, J 2.4 Hz, C5 on cis epoxide); äC 
(100 MHz; CDCl3) 48.7 (epox., CH on trans epoxide, C3), 50.0 (epox., CH on cis 
epoxide, C3) , 58.0 (epox., CH on trans epoxide, C4), 59.9 (epox., CH on cis 
epoxide, C4), 75.4 (on trans and cis epoxide, C2), 125.3 (quat., on trans and cis 
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epoxide, C9), 126.0 (arom CH, on trans and cis epoxide, C8), 126.6 (arom CH, on 
trans and cis epoxide, C7), 127.1 (arom CH, on trans and cis epoxide, C5), 128.5 (2 
x arom., ortho on phenyl substituent), 129.5 (2 x arom., meta on phenyl substituent), 
129.7 (arom., para on phenyl substituent), 136.0 (quat., on trans and cis epoxide, on 
phenyl substituent), 141.6 (quat., on trans and cis epoxide, C10), 157.8 (quat., on 
trans and cis epoxide, C6); m/z 269; C15H11NO4 requires 269.0688. Mass spectra 
were obtained as low-resolution mass spectra after attempts to obtain high resolution 
spectra from Swansea failed due to decomposition during travel.  
 
6-Cyano-2-phenyl-benzopyran oxide 
 
O
NC O
 
186 
 
Prepared by the epoxidation routes described above. The product epoxide was 
obtained as a clear oil with a cis:trans ratio of 20:80 when using m-CPBA and 1:24 
when using the chiral TPPP conditions with catalyst (132). ímax (film) / cm-1 2822, 
2653, 2226, 1554, 1462; äH (400 MHz; CDCl3) 3.83 (1H, dd, J 4.4, 1.2 Hz, epox CH 
on trans epoxide, C3), 3.90 (1H, d, J 4.4 Hz, epox CH on cis epoxide, C3), 3.96-3.97 
(1H, d, epox CH, J 4.4 Hz on both trans and cis epoxide, C4), 5.14 (1H, s, CH, on cis 
epoxide, C2), 5.64 (1H, d,  J 1.2 Hz, CH, on trans epoxide, C2), 6.81 (1H, d, J 8.5 
Hz, arom CH, on trans epoxide, C8), 6.91 (1H, d, J 8.5 Hz, arom CH, on cis epoxide, 
C8), 8.06-8.08 (2H, m, arom CH, on trans and cis epoxide, ortho on phenyl 
substituent), 8.26-8.28 (3H, m, arom CH, on trans and cis epoxide, meta and para on 
phenyl substituent), 7.55 (1H, dd, J 8.5, 2.0 Hz, C7 on trans and cis epoxide), 7.70 
(1H, d, J 2.0 Hz, C5 on trans epoxide), 7.74 (1H, d, J 2.0 Hz, C5 on cis epoxide); äC 
(100 MHz; CDCl3) 47.4 (epox., CH on trans epoxide, C3), 50.0 (epox., CH on cis 
epoxide, C3) , 58.0 (epox., CH on trans epoxide, C4), 60.9 (epox., CH on cis 
epoxide, C4), 75.8 (CH on trans and cis epoxide, C2), 126.3 (quat.,quat., on trans 
and cis epoxide, C9), 126.5 (2 x arom., ortho on phenyl substituent), 127.0 (arom 
CH, on trans and cis epoxide, C8), 127.6 (arom CH, on trans and cis epoxide, C7), 
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128.1 (arom CH, on trans and cis epoxide, C5), 129.5 (2 x arom., meta on phenyl 
substituent), 129.7 (arom., para on phenyl substituent), 134.0 (quat., on trans and cis 
epoxide, on phenyl substituent), 140.6 (quat.,, on trans and cis epoxide, C6), 148.2 
(quat., CN), 155.8 (quat., on trans and cis epoxide, C10); m/z 249; C16H11NO2 
requires 249.0790. Mass spectra were obtained as low-resolution mass spectra after 
attempts to obtain high resolution spectra from Swansea failed due to decomposition 
during travel. Crystal structure obtained by slow evaporation from ethanol, see page 
203. 
 
6-Chloro-2-isopropyl-benzopyran oxide 
 
O
Cl O
 
190 
 
Prepared by the epoxidation routes described above. The product epoxide was 
obtained as a clear oil with a cis:trans ratio of 20:80 when using m-CPBA and 1:26 
when using the chiral TPPP conditions with catalyst (132). ímax (film) / cm-1 2822, 
2653, 2226, 1554, 1462; äH (400 MHz; CDCl3) 1.92 (3H, d, J 8.0 Hz, on trans 
epoxide , CH3), 1.94 (3H, d, J 8.0 Hz, on cis epoxide, CH3), 1.12 (6H, d, J 8.0 Hz, on 
trans and cis epoxide, 2 x CH3), 1.25-1.29 (1H, m, CH on cis epoxide, CH(CH3)2), 
2.90-2.98 (1H, m, CH on trans epoxide , CH(CH3)2), 3.61 (1H, dd, J 8.2, 2.4 Hz, 
epox CH on trans epoxide, C3), 3.69 (1H, dd, J 7.8, 2.4 Hz, epox CH on cis epoxide, 
C3), 3.77 (1H, d, J 7.8 Hz, epox CH on cis epoxide, C4), 3.81 (1H, d, J 8.2 Hz, epox 
CH on trans epoxide, C4), 3.84 (1H, d, J 2.4 Hz, CH on cis epoxide, C2), 4.21 (1H, 
d, J 2.4 Hz, CH on trans epoxide, C2), 6.77 (1H, d, J 8.2 Hz, on trans and cis 
epoxide, C8), 7.15 (1H, dd, J 8.2, 2.4 Hz, on trans and cis epoxide, C7), 7.22 (1H, d, 
J 2.4 Hz, on trans and cis epoxide, C5); äC (100 MHz; CDCl3) 17.3 (CH3, on trans 
and cis epoxide), 18.0 (CH3, on trans and cis epoxide), 31.8 (CH(CH3)2, on trans and 
cis epoxide), 46.2 (C3, on trans and cis epoxide), 55.4 (C4, on trans and cis 
epoxide), 77.8 (C2, on trans and cis epoxide), 117.1 (C5, on trans and cis epoxide), 
125.4 (quat., C9, on trans and cis epoxide), 126.1 (C7, on trans and cis epoxide), 
127.9 (C8, on trans and cis epoxide), 137.1 (quat., C, C6, on trans and cis epoxide), 
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152.7 (quat., C, C10, on trans and cis epoxide); m/z 224.6, C12H13ClO2 requires 
224.06. Mass spectra were obtained as low-resolution mass spectra after attempts to 
obtain high resolution spectra from Swansea failed due to decomposition during 
travel.  
 
6-Nitro-2-isopropyl-benzopyran oxide 
 
O
O2N
O
 
191 
 
Prepared by the m-CPBA epoxidation route described above. Racemic epoxide was 
obtained as a clear oil in a cis:trans ratio of 20:80. ímax (film) / cm-1 3102, 2822, 
2653, 2226, 1554, 1462; äH (400 MHz; CDCl3) 1.94 (3H, d, J 7.9 Hz, on trans 
epoxide, CH3), 1.95 (3H, d, J 8.0 Hz, on cis epoxide, CH3), 1.01 (3H, d, J 7.9 Hz, on 
trans epoxide, CH3), 1.02 (3H, d, J 8.0 Hz, on cis epoxide, CH3), 2.90-2.98 (1H, m, 
CH on trans epoxide, CH(CH3)2), 2.05-2.11 (1H, m, CH on cis epoxide, CH(CH3)2), 
3.66 (1H, dd, J 9.2, 2.8 Hz, epox CH on trans epoxide, C3), 3.79 (1H, dd, J 8.8, 2.8 
Hz, epox CH on cis epoxide, C3), 3.87 (1H, d, J 8.8 Hz, epox CH on cis epoxide, 
C4), 3.91 (1H, d, J 9.2 Hz, epox CH on trans epoxide, C4), 3.94 (1H, d, J 2.8 Hz, 
CH on cis epoxide, C2), 4.38 (1H, d, J 2.8 Hz, CH on trans epoxide, C2), 6.89 (1H, 
d, J 8.4 Hz, on trans and cis epoxide, C8), 8.08 (1H, dd, J 8.4, 2.2 Hz, on trans and 
cis epoxide , C7), 8.22 (1H, d, J 2.2 Hz, on trans and cis epoxide, C5); äC (100 MHz; 
CDCl3) 19.1 (CH3, on trans and cis epoxide), 19.6 (CH3, on trans and cis epoxide), 
32.4 (CH(CH3)2, on trans and cis epoxide), 49.5 (C3, on trans and cis epoxide), 58.4 
(C4, on trans and cis epoxide), 79.3 (C2, on trans and cis epoxide), 119.4 (C5, on 
trans and cis epoxide), 126.1 (quat., C9, on trans and cis epoxide), 126.5 (C7, on 
trans and cis epoxide), 128.7 (C8, on trans and cis epoxide), 157.1 (quat., C, C6, on 
trans and cis epoxide), 162.7 (quat., C, C10, on trans and cis epoxide); m/z 
236.0917, C12H13NO4 requires 236.0917. 
 
 
 
 165 
6-Cyano-2-isopropyl-benzopyran oxide 
 
O
NC O
 
189 
 
Prepared by the m-CPBA epoxidation route described above. Racemic epoxide was 
obtained as a clear oil in a cis:trans ratio of 20:80. ímax (film) / cm-1 2822, 2653, 
2226, 1554, 1462; äH (400 MHz; CDCl3) 1.94 (3H, d, J 7.9 Hz, on trans epoxide, 
CH3), 1.95 (3H, d, J 8.0 Hz, on cis epoxide, CH3), 1.01 (3H, d, J 7.9 Hz, on trans 
epoxide, CH3), 1.02 (3H, d, J 8.0 Hz, on cis epoxide, CH3), 2.90-2.98 (1H, m, CH on 
trans epoxide, CH(CH3)2), 2.05-2.11 (1H, m, CH on cis epoxide, CH(CH3)2), 3.66 
(1H, dd, J 9.2, 2.5 Hz, epox CH on trans epoxide, C3), 3.79 (1H, dd, J 8.8, 2.5 Hz, 
epox CH on cis epoxide, C3), 3.87 (1H, d, J 8.8 Hz, epox CH on cis epoxide, C4), 
3.91 (1H, d, J 9.2 Hz, epox CH on trans epoxide, C4), 3.94 (1H, d, J 2.5 Hz, CH on 
cis epoxide, C2), 4.38 (1H, d, J 2.5 Hz, CH on trans epoxide, C2), 6.89 (1H, d, J 8.4 
Hz, on trans and cis epoxide, C8), 8.08 (1H, dd, J 8.4, 2.2 Hz, on trans and cis 
epoxide, C7), 8.22 (1H, d, J 2.2 Hz, on trans and cis epoxide, C5); äC (100 MHz; 
CDCl3) 18.1 (CH3, on trans and cis epoxide), 18.9 (CH3, on trans and cis epoxide), 
33.4 (CH(CH3)2, on trans and cis epoxide), 47.5 (C3, on trans and cis epoxide), 56.5 
(C4, on trans and cis epoxide), 75.3 (C2, on trans and cis epoxide), 115.1 (C5, on 
trans and cis epoxide), 128.1 (quat., C9, on trans and cis epoxide), 128.9 (C7, on 
trans and cis epoxide), 129.7 (C8, on trans and cis epoxide), 137.1 (quat., C, C6, on 
trans and cis epoxide), 144.2 (quat., CN), 152.7 (quat., C, C10, on trans and cis 
epoxide); m/z 215; C13H13NO2 requires 215.0946. Mass spectra were obtained as 
low-resolution mass spectra after attempts to obtain high resolution spectra from 
Swansea failed due to decomposition during travel.  
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1-(3,4,5-Trimethoxy-phenyl)-prop-2-yn-1-ol78 
 
O
O
O
OH
 
201 
 
3,4,5-Trimethoxybenzaldehyde (2.0 g, 0.012 mol) was placed under N2 in a round-
bottomed flask containing THF (100ml). The solution was then cooled to 0 °C and 
ethynyl magnesium bromide (27 ml, 0.013 mol, 1.3 eq) added. The reaction was then 
stirred at room temperature for 2 hours at which point sat. aqueous ammonium 
chloride (20 ml) was added. The solvent was evaporated and the aqueous layer 
washed with EtOAc (3 x 20 ml). The combined organics were washed with brine, 
dried (MgSO4) and evaporated to yield the title compound as a yellow oil (2.1 g, 
89%); ímax (film) / cm-1 3425, 2956, 1585, 1464, 1451, 1299, 1244, 1254, 1162; äH 
(400 MHz; CDCl3) 2.46 (1H, s, broad, OH), 2.65 (1H, s, alkyne CH), 3.80 (3H, s, 1 x 
OCH3 para on ring), 3.84 (6H, s, 2 x OCH3, meta on ring), 5.37 (1H, s, CHOH), 6.75 
(2H, s, CH arom., C2, 6); äC (100 MHz; CDCl3) 56.3 (2 x OCH3, meta on ring), 60.2 
(OCH3, para on ring), 66.1 (OHCH), 75.7 (CHCCH, alkyne), 83.6 (C quat., 
CHCCH, alkyne), 105.3 (2 x CH arom., C2, 6), 136.1 (C quat., C4), 138.8 (C quat., 
C1), 153.6 (2 x C quat., C3, 5). 
 
1-(3,4,5-Trimethoxy-phenyl)-propynone78 
 
O
O
O
O
 
202 
 
1-(3,4,5-Trimethoxy-phenyl)-prop-2-yn-1-ol (1.36 g, 6.11 mmol) was placed in a 
round bottomed flask in EtOAc (100ml) equipped with a reflux condenser. To this 
IBX (3.43 g, 12.0 mmol, 2 eq) was added. The reaction was then heated to 80 °C and 
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stirred overnight. The solution was then cooled, filtered through celite and 
evaporated to yield the title compound as a clear oil (1.05 g, 78%); ímax (film) / cm-
1
 2822, 2653, 2226, 1654, 1462; äH (400 MHz; CDCl3) 3.78 (1H, s, alkyne CH), 3.82 
(6H, s, 2 x OCH3, meta on ring), 3.87 (3H, s, 1 x OCH3 para on ring), 7.37 (2H, s, 
arom., CH, C2, 6); äC (100 MHz; CDCl3) 56.0 (2 x OCH3, meta on ring), 56.2 
(OCH3, para on ring), 80.0 (CHCCH, alkyne), 80.3 (C quat., CHCCH, alkyne), 
110.1 (2 x CH arom., C2, 6), 126.1 (C quat., C4), 129.7 (C quat., C1), 149.1 (C quat., 
C3), 154.7 (C quat., C5), 176,0 (C=O).  
 
5,7-Dimethoxy-2-(3,4,5-trimethoxy-phenyl)-chromenylium-
hexafluorophosphate78 
 
O
O
O O
O
O
-PF6
 
200 
 
1-(3,4,5-Trimethoxy-phenyl)-propynone (1.0 g, 4.5 mmol) and 3,5-dimethoxyphenol 
(0.69 g, 4.5 mmol, 1 eq) were placed in a round bottomed flask in the minimum of 
acetic acid (5 ml). An excess of aq. hexafluorophosphoric acid (50% in H2O) was 
then added and the reaction turned bright red. The reaction was then stirred for 48 
hours after which it was plunged into diethyl ether (50 ml) causing the salt to 
precipitate out. The solid was filtered off and washed with more diethyl ether (3 x 10 
ml) and dried, yielding the title compound as bright red crystals (1.9 g, 83%). M.p. 
215 oC (lit 216-218 oC);78 ímax (film) / cm-1 2822, 2653, 2226, 1554, 1462; äH (400 
MHz; CD3CN) 3.98 (3H, s, CH3), 4.00 (6H, s, 2 x OCH3, meta on phenyl 
substituent), 4.09 (3H, s, OCH3, para on phenyl substituent), 4.11 (3H, s, OCH3, off 
C5), 4.85 (3H, s, OCH3, off C7), 6.85 (1H, d, J 8.2 Hz, C3), 7.41 (1H, d, J 8.2 Hz, 
C4), 7.59 (2H, s, CH arom., ortho on phenyl substituent), 8.21 (1H, d, J 4.2 Hz, C8), 
9.18 (1H, d, J 4.2 Hz, C6); äC (100 MHz; CD3CN) 55.9 (OCH3, para on phenyl 
substituent), 57.0 (OCH3, off C5), 57.2 (OCH3, off C7), 57.6 (2 x OCH3, meta on 
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phenyl substituent), 93.4 (C6), 99.8 (C8), 111.3 (C3), 113.4 (quat., C, C9), 120.8 
(quat., C, on phenyl substituent), 131.9 (2 x CH arom., ortho on phenyl substituent), 
148.7 (C4), 158.8 (quat., C, C2), 159.0 (quat., C, C5), 165.2 (2 x quat., C, meta on 
phenyl substituent), 167.0 (quat., C, C7), 171.4 (quat., C, para on phenyl 
substituent), 171.7 (quat., C, C10). 
 
5,7-Dimethoxy-2-(3,4,5-trimethoxy-phenyl)-4H-chromene119  
 
O
O
O O
O
O
 
204 
 
5,7-Dimethoxy-2-(3,4,5-trimethoxy-phenyl)-4H-chromene (0.502 g, 1 mmol) was 
placed in a round bottomed flask in the oven at 100 °C for 24 hours. Dry THF was 
then added under N2 and the flask cooled to - 70 °C. Lithium aluminium hydride 
(2M, 0.5 ml, 1 mmol, 1 eq) was then added slowly and the temperature raised until 
the solvent began to boil. The reaction was then refluxed for a further 2 hours at 
which point the reaction was cooled and the solvent removed. The residue was then 
treated with wet ether (20 ml) and aq. potassium sodium tartrate tetrahydrate (20 ml). 
The aqueous layer was washed with ether (3 x 10 ml) and the combined organics 
washed with further potassium sodium tartrate tetrahydrate (3 x 10 ml). The organic 
layers were then dried (MgSO4) and evaporated to yield the title compound as slight 
pink powder (0.25 g, 69% yield), m.p. 145-147 °C (lit 147-148 °C)119; ímax (film) / 
cm-1 2822, 2653, 2226, 1554, 1462; äH (400 MHz; CD3CN) 3.31 (2H, d, J 8.4 Hz, 
CH2, C4), 3.77 (3H, s, OCH3, off C5), 3.80 (3H, s, OCH3, off C7), 3.82 (3H, s, 
OCH3, para on phenyl substituent), 3.79 (6H, s, 2 x OCH3, meta on phenyl 
substituent
 
), 5.42 (1H, t, J 8.4 Hz, CH, C3), 6.12 (1H, d, J 7.8 Hz, CH arom., C8), 
6.19 (1H, d, J 7.8 Hz, CH arom., C6), 6.84 (2H, s, CH arom., ortho on phenyl 
substituent); äC (100 MHz; CD3CN) 18.3 (CH2, C4), 56.1 (OCH3, off C5), 56.4 (3 x 
OCH3, on phenyl substituent), 56.7 (OCH3, off C5), 62.4 (OCH3, off C7), 95.3 (CH, 
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C3), 95.8 (CH, arom., C6), 96.4 (CH arom., C8), 103.2 (quat., C, C9), 105.2 (2 x CH 
arom., ortho on phenyl substituent), 128.1 (quat., C, C1 on phenyl substituent), 131.5 
(quat., C, para on phenyl substituent) 145 (2 x quat., C, meta on phenyl substituent), 
150.1 (quat., C, C2), 158.2 (quat., C, C10), 160.2 (quat., C, C7), 165.3 (quat., C, C5).  
 
3,4,5-Tris-(tert-butyl-dimethyl-silanyloxy)-benzoic acid methyl ester120,121 
 
O
O
O
O
Si
Si
Si
O
 
207 
 
Methyl gallate (9.2 g, 0.051 mol), tert-butyldimethylsilyl chloride (30.1 g, 0.202 
mol) and imidazole (24 g, 0.36 mol) were stirred in dimethyl formamide (100 ml) for 
20 h. The reaction mixture was then cast into NaHCO3 (200 ml, 5% solution) and 
extracted with hexane (3 x 50 ml). The organics were then dried (Na2SO4) and 
evaporated to yield a green oil. This was then diluted with methanol (ca. 100 ml) and 
then placed in the fridge. The compound was yielded as white crystals (21.3 g, 92% 
yield), m.p. 68-70 oC (lit. 68-68.5 oC);20 ímax (film) / cm-1 2955, 2925, 1718, 1490, 
1423, 1224, 1101, 840, 826; äH (400 MHz; CDCl3) 0.11 (6H, s, para Si-(CH3)2), 0.21 
(12H, s, meta 2 x Si-(CH3)2), 0.92 (18H, s, meta 2 x Si-t-Bu), 0.96 (9H, s, para Si-t-
Bu), 3.83 (3H, s, OCH3), 7.18 (2H, s, arom CH, C2, 6); äC (100 MHz; CDCl3) 0.09 (2 
x meta Si-(CH3)2), 18.1 (quat., C, para Si-t-Bu), 19.4 (2 x quat., C, meta Si-t-Bu), 
22.0 (para Si-(CH3)2), 29.5 (para Si-t-Bu), 30.2 (2 x meta Si-t-Bu), 56.4 (OCH3), 
119.1 (2 x CH arom., C2, 6), 125.4 (quat., C, C1), 147.6 (2 x quat., C, meta on ring, 
C3, 5), 153.9 (quat., C, para on ring, C4), 171.1 (quat., C, C=O). 
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[3,4,5-Tris-(tert-butyl-dimethyl-silanyloxy)-phenyl]-methanol120,122 
 
O
O
O
Si
Si
Si
OH
 
208 
 
3,4,5-Tris-(tert-butyl-dimethyl-silanyloxy)-benzoic acid methyl ester (2.0 g, 3.8 
mmol) was dissolved in dry THF (100 ml) and added to a solution of LiAlH4 (1.9 ml, 
2M solution in THF, 3.8 mmol) in THF (100 ml) at such a rate as to maintain a 
gentle reflux. The reaction was then refluxed for a further 3 h, at which point it was 
cooled to room temperature and diluted with diethyl ether (200 ml). The mixture was 
then stirred rapidly whilst adding NaOH (1N, 10 ml) and filtered through celite. The 
filtrate was then washed with brine (3 x 50 ml), dried (Na2SO4) and evaporated to 
yield the crude product as a pale green oil which was used without further 
purification (1.1.g, 60% yield); ímax (film) / cm-1 3410, 2930, 1580, 1100, 840, 830; 
äH (400 MHz; CDCl3) 0.09 (6H, s, para Si-(CH3)2), 0.18 (12H, s, meta 2 x Si-
(CH3)2), 0.91 (18H, s, meta Si-t-Bu), 0.97 (9H, s, para Si-t-Bu), 1.42 (1H, t, J 5.9 
Hz, OH), 4.46 (2H, d, J 5.9 Hz, CH2), 6.47 (2H, s, arom., CH, C2, 6); äC (100 MHz; 
CDCl3) 0.20 (2 x meta Si-(CH3)2), 16.1 (quat., C, para Si-t-Bu), 18.9 (2 x quat., C, 
meta Si-t-Bu), 23.4 (para Si-(CH3)2), 29.5 (para Si-t-Bu), 30.2 (2 x meta Si-t-Bu), 
66.4 (CH2), 111.9 (2 x CH arom., C2, 6), 121.4 (quat., C, C1), 145.1 (2 x quat., C, 
meta on ring, C3, 5), 151.2 (quat., C, para on ring, C4). 
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3,4,5-Tris-(tert-butyl-dimethyl-silanyloxy)-benzaldehyde120 
 
O
O
O
O
Si
Si
Si
 
209 
 
Pyridinium chlorochromate (3.5 g, 0.016 mol) was placed in dry round bottomed 
flask under N2 containing dry DCM (20 ml). A solution of [3,4,5-tris-(tert-butyl-
dimethyl-silanyloxy)-phenyl]-methanol (6.9 g, 0.016 mol) in dry DCM (20 ml) was 
added in one portion under efficient stirring. The reaction was then stirred at room 
temperature for 2 hours, whilst monitoring by TLC (3:7 acetone:hexane). When no 
starting material remained Et2O was added and the reaction filtered through celite 
and evaporated to yield the product as a white powder. Mp 67-69 oC (lit 68-70 oC)120; 
ímax (film) / cm-1 3060, 2950, 2930, 2780, 2700, 1695, 1255, 1100 ; äH (400 MHz; 
CDCl3) 0.13 (6H, s, para Si-(CH3)2), 0.23 (12H, s, meta 2 x Si-(CH3)2), 0.93 (18H, s, 
meta Si-t-Bu), 0.97 (9H, s, para Si-t-Bu), 7.00 (2H, s, arom., CH, C2, 6), 9.70 (1H, s, 
CHO); äC (100 MHz; CDCl3) 0.07 (2 x Si-(CH3)2), 14.8 (quat., C, para Si-t-Bu), 17.2 
(2 x quat., C, meta Si-t-Bu), 21.5 (para Si-(CH3)2), 25.1 (para Si-t-Bu), 28.9 (2 x 
meta Si-t-Bu), 122.1 (2 x CH arom., C2, 6), 128.1 (quat., C, C1), 149.0 (2 x quat., C, 
meta on ring, C3, 5), 158.2 (quat., C, para on ring, C4), 189.1 (CHO) 
 
3,4,5-Tris-benzyloxy-benzoic acid methyl ester123,124 
 
O
O
BnO
BnO
OBn
 
215 
 
Methyl 3,4,5-trihydroxybenzoate (5.00 g, 27.1 mmol) was placed in a round 
bottomed flask under N2 followed by DMF (50 ml) and K2CO3 (15.0 g, 109 mmol, 4 
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eq.). Benzyl bromide (13.9 g, 9.72 ml, 3 eq.) was then added dropwise and the 
reaction stirred overnight. The reaction was then poured into water (100 ml) and the 
solid filtered off and dried, yielding the title compound as a white solid (10.6 g, 
86%), m.p. 104-105 °C (lit. 102-102.5 °C);22 ímax (film) / cm-1 1615; m.p. 98-99 °C 
(lit. 99-100 °C);124  äH (400 MHz; CDCl3) 3.88 (3H, s, OCH3), 5.11 (2H, s, CH2Ph, 
off C4), 5.13 (4H, s, 2 x CH2Ph, off C3 and 5), 7.18 (2H, s, 2 x CH arom., C2, 6), 
7.20-7.42 (15H, m, 3 x C6H5); äC (100 MHz; CDCl3) 52.2 (OCH3), 71.2 (CH2Ph, off 
C4), 75.4 (2 x CH2Ph, off C3 and 5), 109.1 (2 x CH arom., C2, 6), 125.2 (quat., C, 
C1), 127.9 (2 x CH arom., para on meta OBn groups), 128.0 (CH arom., para on 
para OBn), 128.1 (4 x CH arom., meta on meta OBn groups), 128.4 (2 x CH arom., 
meta on para OBn), 128.5 (4 x CH arom., ortho on meta OBn groups), 129.1 (2 x 
CH arom., ortho on para OBn), 136.6 (quat., C, on para OBn), 137.4 (2 x quat., C, 
on meta OBn), 142.4 (quat., C, C4), 152.5 (quat., C, C3, 5), 166.6 (quat., C=O). 
 
2,6-dibenzyloxy-4-hydroxyacetophenone123 
 
O
OBnHO
OBn
 
219 
 
2,4,6-Trihydroxyacetophenone (3.2 g, 17 mmol) and anhydrous K2CO3 (4.9 g, 35 
mmol) were placed in a round bottomed flask under N2. HMPA (20 ml) was then 
added, followed by BnBr (6.4 g, 37 mmol). The reaction was then stirred at 80 °C for 
1 hour. The reaction was then cooled and filtered to remove any solid and washed 
with diethyl ether (3 x 10 ml). The organics were combined and further washed with 
water (3 x 10 ml) and brine (3 x 10 ml), dried (MgSO4) and evaporated to yield the 
crude product as a yellow oil (5.2 g, 85%). ímax (film) / cm-1 3310, 1615, 1563, 
1210; äH (400 MHz; CDCl3) 1.42 (1H, s, OH), 2.26 (3H, s, CH3), 4.98 (4H, s, 2 x 
CH2Ph, off C2 and 6), 5.97 (1H, d, J 2.4 Hz, CH arom., C3), 6.01 (1H, d, J 2.4 Hz, 
CH arom., C5), 7.10-7.22 (10H, m, 2 x C6H5); äC (100 MHz; CDCl3) 33.2 (CH3), 
70.1 (2 x CH2Ph), 71.0 (CH2Ph), 94.6 (2 x CH arom., C3, 5), 106.2 (quat., C, COH), 
127.5 (2 x CH, para on OBn), 127.9 (4 x CH arom., meta on OBn), 128.2 (4 x CH 
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arom., ortho on OBn), 135.8 (2 x quat., C, on OBn), 165.0 (quat., C, COH, C4), 
167.5 (2 x quat., C, CCH2Ph, C2, 6), 203.1 (quat., C, C=O). 
 
3,4,5-Tribenzyloxy-phenylmethanol123 
BnO
BnO
OBn
OH
 
216 
 
A solution of LiAlH4 in THF was placed in a flask equipped with a reflux condenser 
under N2 at 0 °C. To this a solution of 3,4,5-tris-benzyloxy-benzoic acid methyl ester 
(10 g, 0.022 mol) in THF (20 ml) was added dropwise at such rate as to maintain a 
gentle reflux. The reaction was then further refluxed for 3 hours, cooled and diluted 
with diethyl ether (40 ml). NaOH (10 ml) was then added whilst stirring rapidly and 
the reaction filtered through celite. The filtrate was washed with brine (3 x 10 ml), 
dried (MgSO4) and evaporated to yield the product as a clear oil (7.8 g, 83%). ímax 
(film) / cm-1 3351, 3258, 2954, 1547, 1456, 1210; äH (400 MHz; CDCl3) 1.75 (1H, s, 
br OH), 4.55 (2H, s, CH2), 5.02 (2H, s, CH2Ph, off C4), 5.08 (4H, s, 2 x CH2Ph, off 
C3 and 5), 6.68 (2H, s, 2 x CH arom., C2, 6), 7.23-4.41 (15H, m, OBn); äC (100 
MHz; CDCl3) 65.5 (CH2Ph, off C4), 71.4 (2 x CH2Ph, off C3 and 5), 75.5 (CH2OH), 
106.6 (quat., C, C1), 127.9 (2 x CH arom., para on meta OBn groups), 128.0 (CH 
arom., para on para OBn), 128.1 (4 x CH arom., meta on meta OBn groups), 128.4 
(2 x CH arom., meta on para OBn), 128.5 (4 x CH arom., ortho on meta OBn 
groups), 129.1 (2 x CH arom., ortho on para OBn), 137.0 (2 x quat., C, on meta OBn 
groups), 137.4 (quat., C, on para OBn), 142.4 (2 x quat., C, C3, 5), 152.5 (quat., C, 
C4). 
 
3,4,5-Tribenzyloxy-benzaldehyde123 
 
BnO
BnO
OBn
O
 
217 
 174 
 
Pyridinium chlorochromate (3.5 g, 0.016 mol) was placed in dry round bottomed 
flask under N2 containing dry DCM (20 ml). A solution of (3,4,5-tris-benzyloxy-
phenyl)-methanol (6.9 g, 0.016 mol) in dry DCM (20 ml) was added in one portion 
under efficient stirring. The reaction was then stirred at room temperature for 2 
hours, whilst being monitored by TLC (3:7 acetone:hexane). When no starting 
material remained Et2O was added and the reaction filtered through celite and 
evaporated to yield the product as a white powder (4.9 g, 73%), m.p. 105-106 °C (lit. 
103-104 °C)123; ímax (film) / cm-1 2678, 2367, 1876, 1567, 1290; äH (300 MHz; 
CDCl3); 5.16 (6H, s, 3 x CH2), 7.26 (2H, s, 2 x CH arom., C2, 6), 7.25-7.27 (3H, m, 
3 x CH arom., para on OBn groups), 7.34-7.45 (12H, m, remaining CH arom on 
OBn groups), 9.80 (1H, s, CHO); äC (100 MHz; CDCl3) 72.1 (2 x CH2), 109.5 (quat., 
C, C1), 127.9 (3 x CH arom., para on OBn), 128.4 (6 x CH arom., ortho on OBn), 
129.8 (6 x CH arom., meta on OBn), 136.4 (quat., C, C3, 5), 155.4 (quat., C, C4), 
172.1 (CHO). 
 
3,4,5-Tribenzyloxy-benzaldehyde123,125 
BnO
BnO
OBn
O
 
217 
 
(3,4,5-Tris-benzyloxy-phenyl)-methanol (1.79 g, 4.20 mmol) was placed in a flask 
containing EtOAc (20 ml) and IBX (2.35 g, 8.40 mmol, 2 eq, 45% IBX) and was 
equipped with a reflux condenser. The reaction was then heated at 80 °C overnight, 
at which point the reaction was cooled, filtered to remove the insoluble by-products 
and evaporated to yield the product as a white solid. All data as previously obtained. 
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2-Hydroxy-4,6,3,4,5-pentabenzyloxy-chalcone123,126 
 
 
BnO
BnO
OBn
O
HO
OBn
OBn
 
220 
 
To a solution of 1-(2,6-bis-benzyloxy-4-hydroxy-phenyl)-ethanone (4.00 g, 11.5 
mmol) in DMF (20 ml) was added NaH (0.55 g, 23 mmol, 2 eq.). A solution of 3,4,5-
tris-benzyloxy-benzaldehyde (5.1 g, 12.0 mmol, 1.05 eq.) in DMF (20 ml) was then 
added dropwise, and the reaction stirred for a further 2 hours at room temperature. 
Water (20 ml) was then added to quench any unreacted NaH, followed by removal of 
DMF by vacuum evaporation. The resulting residue was dissolved in DCM (20 ml), 
washed with water (3 x 10 ml) and brine (3 x 10 ml), the organics were then 
combined, dried (MgSO4) and evaporated to yield the product as a yellow solid (6.8 
g, 75%); m.p. 147-149 °C (lit. 148-149 °C).126 ímax (film) / cm-1 äH (300 MHz; 
CDCl3) 4.87 (4H, s, 2 x CH2Ph), 5.12 (6H,  s, 3 x CH2Ph), 6.18 (1H, d, J 2.5 Hz, CH 
arom., C3), 6.25 (1H, d, J 2.5 Hz, CH arom C5), 6.70 (2H, s, 2 x CH arom., C2, 6), 
7.19-7.45 (m, 25H, arom CH on OBn), 7.66 (1H, d, J 12.5 Hz, CH), 7.78 (1H, d, J 
12.5 Hz, CH), OH not observed; äC (100 MHz; CDCl3) 70.3 (CH2), 71.2 (2 x CH2), 
75.2 (CH2), 75.8 (CH2), 93.0 (CH arom.,), 95.2 (CH arom.,), 102.5 (C quat.,), 108.4 
(2 x CH arom.,), 127.1 (5 x CH arom., para on OBn), 127.2 (10 x CH arom., ortho 
on OBn), 128.8 (10 x CH arom., meta on OBn), 130.8 (CH alkene), 135.8 (C quat.,), 
135.9 (C quat.,), 136.2 (C quat.,), 136.8 (5 x C quat., on OBn), 142.4 (CH alkene), 
152.9 (C quat.,), 161.5 (C quat.,), 165.2 (C quat.,), 168.1 (C quat.,), 192.6 (C=O). 
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5,7,3,4,5-Pentabenzyloxyflav-3-ene123,126 
 
BnO
BnO
OBn
O
OBn
OBn
 
213 
 
1-(2,4-Bis-benzyloxy-6-hydroxy-phenyl)-3-(3,4,5-tris-benzyloxy-phenyl)-propenone 
(2.0 g, 2.6 mmol) was dissolved in THF:EtOH (2:1, 30 ml total volume) in a round 
bottomed flask equipped with a reflux condenser. NaBH4 (0.1 g, 2.6 mmol, 1 eq.) 
was then added in one portion and the reaction refluxed overnight at 65-70 °C. The 
reaction was then cooled, evaporated and the resulting residue redissolved in DCM, 
dried (MgSO4) and evaporated to yield the title compound as an off white solid 0.25 
g, 13%); m.p. 106-109 °C (lit. 105-107 °C);126 ímax (film) / cm-1 2789, 2500, 2109, 
1699, 1687, 1567, 1205, 1060; äH (300 MHz; CDCl3) 5.00 (2H, s, CH2Ph), 5.06 (2H, 
s, CH2Ph), 5.09 (2H, s, CH2Ph), 5.11 (2H, s, CH2Ph), 5.15 (2H, s, CH2Ph), 5.58 (1H, 
dd, J 6.9, 1.2 Hz, C2), 5.76 (1H, dd, J 9.8, 6.9 Hz, C3), 6.19 (1H, d, J 2.1, C6), 6.23 
(1H, d, J 2.1, C8), 6.83 (2H, s, 2 x CH arom., ortho on phenyl substituent), 6.91-6.93 
(1H, dd, J 9.8, 1.2 Hz, C4), 7.29-7.47 (25H, m, 5 x OBn); äC (100 MHz; CDCl3) 78.4 
(CH2), 79.2 (2 x CH2), 80.3 (CH2), 82.8 (CH2), 86.4 (CH), 98.1 (CH arom.,), 101.2 
(CH arom.,), 102.5 (C quat.,), 112.4 (2 x CH arom.,), 124.8 (CH alkene), 126.4 (CH 
alkene), 128.0 (5 x CH arom., para on OBn), 128.5 (10 x CH arom., ortho on OBn), 
129.8 (10 x CH arom., meta on OBn), 135.8 (C quat.,), 135.9 (C quat.,), 136.2 (C 
quat.,), 136.8 (5 x C quat., on OBn), 152.9 (C quat.,), 161.5 (C quat.,), 165.2 (C 
quat.,), 168.1 (C quat.,). 
 
Seselin127,128 
O O O
 
223 
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7-Hydroxycoumarin (1.00 g, 6.17 mmol) was dissolved in p-xylene (20 ml). 1,1 
Diethoxy-3-methyl-2-butene (1.47 ml, 7.40 mmol) and 3-picoline (0.15 mL, 1.50 
mmol) were added, and the reaction mixture was heated under reflux for 24 h. 
Dichloromethane (20 ml) was added to the reaction mixture, the solution was filtered 
through a pad of silica gel and Celite, and the pad was rinsed with ethyl acetate (3 × 
20 ml). The combined organic solvents were removed under reduced pressure, and 
the residue was purified by column chromatography on silica gel using ethyl 
acetate/toluene (1:1) as eluent to give seselin as a yellow solid (1.03 g, 73%): mp 
119-120 °C (lit. 117-120 °C);128 ímax (film) /cm-1 2976, 2361, 1734, 1597, 1485, 
1152; äH (400 MHz; CDCl3) 1.45 (6H, s, 2 × CH3), 5.71 (1H, d, J 10.1 Hz), 6.20 
(1H, d, J 9.5 Hz), 6.70 (1H, d, J 8.5 Hz), 6.86 (1H, d, J 10.1 Hz), 7.20 (1H, d, J 8.5 
Hz), 7.59 (1H, d, J 9.5 Hz); äC (100 MHz; CDCl3) 28.3 (2 × CH3), 53.4, 109.4, 
112.7, 113.7, 115.1, 120.2, 127.9, 130.9, 144.1, 150.2, 156.4, 161.2. 
 
(+)-(3′S,4′S)-Seselin Epoxide87,127,128  
OO O
O
 
235 
 
Seselin (0.50 g, 2.2 mmol) was dissolved in chloroform (30 ml) and the solution 
cooled to -30 °C. The sulfone catalyst (132) (0.16 g, 0.22 mmol) and TPPP (2.0 g, 
4.38 mmol) were added, and the mixture was stirred at -30 °C for 24 h. Diethyl ether 
(50 ml) was added to the mixture and the resulting cloudy solution filtered through 
Celite. The solvents were removed under reduced pressure, and the residue was 
purified by column chromatography on silica gel using petroleum ether/ethyl 
acetate/triethylamine (3:1:0.1) as eluent to give (+)- (3′S,4′S)-seselin epoxide as a 
colourless solid (0.35 g, 65%) of 97% ee (HPLC conditions: hexane/2-propanol 
(90:10), oven temp 20 °C, column Eurocel 01 250 × 4.6 mm, 5 ìm particle size, flow 
rate 1 ml/min): mp 143-144 °C (lit. mp 144-146 °C);87,128 [á]D +7.2° (c 0.1 CHCl3); 
ímax (film) / cm-1 2950, 2256, 1729, 1698, 1587, 1423, 1120; äH (400 MHz; CDCl3) 
1.24 (3H, s, CH3), 1.53 (3H, s, CH3), 3.49 (1H, d, J 6.0 Hz), 4.53 (1H, d, J 6.0 Hz), 
6.19 (1H, d, J 12.7 Hz), 6.65 (1H, d, J 11.7 Hz), 7.24 (1H, d, J 11.7 Hz), 7.55 (1H, d, 
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J 12.7 Hz); äC (100 MHz; CDCl3) 23.1 (CH3), 25.8 (CH3), 44.2 (epox., C9), 62.1 
(quat., C(CH3)2), 75.0 (epox., C8), 108.4 (CH, C6), 113.1 (CH, á C of á,â system), 
113.8 quat., C11), 115.8 (quat., C12), 129.4 (CH, C5), 144.2 (CH, â C of á,â 
system), 155.1 (quat., C13), 156.2 (quat., C10), 161.2 (ketone). 
 
(-)-(3′S)-Lomatin89,127 
OO
OH
O
 
226 
 
(+)-(3′S,4′S)-Seselin epoxide (20 mg, 0.080 mmol) was dissolved in tetrahydrofuran 
(3 ml) and the solution cooled to 0 °C. Boron trifluoride etherate (7 ìL, 0.12 mmol) 
was added. Sodium cyanoborohydride (0.0050 g, 0.12 mmol) was added in one 
portion and the mixture stirred for 30 min. Water (1 ml) and dichloromethane (3 ml) 
were added to the reaction mixture, and the organic phase was separated. The 
aqueous layer was extracted with dichloromethane (2 × 3 ml), and the organic layers 
were combined and dried over magnesium sulfate. The solvents were removed under 
reduced pressure, and the residue was purified by column chromatography on silica 
gel using petroleum ether/ethyl acetate (7:3) as eluent to give to give (-)-(3′S)-
lomatin as a yellow solid (19 mg, 94%) of 97% ee (HPLC conditions: hexane/2-
propanol (99:1), oven temp 20 °C, column Eurocel 01 250 × 4.6 mm, 5 ìm particle 
size, flow rate 0.5 mL/ min): mp 164-165 °C (lit. mp 163-165 °C);89 [á]D -52 (c 0.4, 
EtOH), lit. [á]D -51° (c 0.5, EtOH); 89 ímax (film) /cm-1 3452, 2935, 1723, 1604, 
1405, 1117; äH (400 MHz; CDCl3) 1.32 (3H, s, CH3), 1.38 (3H, s, CH3), 2.94 (1H, 
dd, J 17.6, 5.0 Hz), 3.11 (1H, dd, J 17.6, 5.0 Hz), 3.88 (1H, dd, J 5.0, 5.0 Hz), 6.19 
(1H, d, J 9.4 Hz), 6.75 (1H, d, J 8.6 Hz), 7.22 (1H, d, J 8.6 Hz), 7.59 (1H, d, J 9.4 
Hz); äC (100 MHz; CDCl3) 22.3 (CH3), 24.8 (CH3), 25.9 (CH2, C9), 68.5 (alcohol, 
C8), 78.3 (quat., C(CH3)2), 107.6 (quat., C11), 112.3 (quat., C12), 112.5 (CH, C6), 
114.5 (CH, á C of á,â system), 126.8 (CH, C5), 144.2 (CH, â C of á,â system), 153.7 
(quat., C13), 156.5 (quat., C10), 161.6 (quat., ketone). 
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(+)-(3′S,4′R)-trans-khellactone127,130 
 
OO
OH
O
OH
 
228 
 
Seselin epoxide (20 mg, 0.080 mmol) was dissolved in acetone (1 ml) at room 
temperature. Aqueous sulfuric acid (1M, 0.5 ml) was added to the solution, and the 
mixture was stirred for 1 h. The reaction mixture was neutralized to pH 7 using 
sodium hydrogen carbonate. Dichloromethane (3 ml) was added to the reaction 
mixture and the organic phase separated. The aqueous layer was extracted with 
dichloromethane (2 × 3 mL), and the organic layers were combined and dried over 
magnesium sulfate. The solvents were removed under reduced pressure, and the 
residue was purified by column chromatography on silica gel using petroleum 
ether/ethyl acetate (2:1) as eluent to give to give (+)- (3′S,4′R)-trans-khellactone as a 
colourless solid (20 mg, 95%) of 97% ee (HPLC conditions: hexane/2-propanol 
(99.5:0.5), oven temp 20 °C, column Eurocel 01 250 × 4.6 mm, 5 ìm particle size, 
flow rate 1 mL/min): mp 182-184 °C (lit. mp 181-185 °C);130 [á]D +19° (c 1.7, 
CHCl3), (lit. [á]D +19.6° (c 0.6, CHCl3);130 ímax (film) /cm-1 3418, 1715, 1605, 
1491, 1245; äH (300 MHz; CDCl3) 1.30 (3H, s, CH3), 1.51 (3H, s, CH3), 3.08-3.35 
(1H, s, OH), 3.85 (1H, d, J 6.9 Hz, CHOH), 4.09-4.46 (1H, br s, OH), 5.00 (1H, d, J 
6.9 Hz, CHOH), 6.25 (1H, d, J 9.6 Hz, CH), 6.78 (1H, d, J 8.4 Hz, arom., CH), 7.32 
(1H, d, J 8.4 Hz, arom., CH), 7.66 (1H, d, J 9.6 Hz, CH); äC (75 MHz; CDCl3) 19.9 
(CH3), 25.4 (CH3), 66.5 (quat., C(CH3)2), 74.8 (alcohol., CH), 79.3 (alcohol., CH), 
111.6 (quat., C11), 112.2 (CH, C6), 112.5 (quat., C12), 114.8 (CH, á C of á,â 
system), 128.6 (CH, C5), 144.4 (CH, â C of á,â system), 154.4 (quat., C13), 156.3 
(quat., C10), 161.2 (quat., C, ketone). 
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4,5-Dihydro-3H-benzo[b]oxepin-2-one75 
 
O
O
 
238 
 
To a solution of m-CPBA (7.6 g, 34 mmol, 2 eq), in chloroform (50 ml) at 0 oC, was 
added á-tetralone (2.5 g , 17 mmol, 1 eq) as a solution in chloroform. After the 
addition was complete the reaction mixture was allowed to warm to room 
temperature. Stirring was continued for 5 days until complete consumption of the 
starting material was observed by TLC. Saturated aqueous sodium carbonate (100 
ml) was carefully added and the mixture extracted further with saturated aqueous 
sodium bicarbonate and water, dried over MgSO4 and concentrated in vacuo, to yield 
the product as an off white solid (2.3 g, 83%). No further purification was required. 
m.p. 35 oC (lit - 34-36 oC)75; ímax (film) / cm-1 2987, 2508, 1653, 1535, 1478, 1211, 
1087; äH (400 MHz; CDCl3) 2.13-2.22 (2H, m, CH2, C5), 2.42-2.49 (2H, m, CH2, 
C3), 2.77-2.84 (2H, m, CH2, C3), 7.07-7.30 (4H, m, arom., CH); äC (100 MHz; 
CDCl3) 22.6 (CH2), 28.2 (CH2), 31.0 (CH2), 119.2 (arom., CH), 125.9 (arom., CH), 
128.3 (arom., CH), 129.7 (arom., CH) 130.3 (quat.,), 151.7 (quat.,), 171.6 (quat.,). 
 
5-(2-hydroxyphenyl)-2-methyl-2-hydroxypentane75 
 
OH
HO
 
239 
 
To a stirred solution of methylmagnesium iodide (3M soln. in ether, 22 ml, 67 mmol) 
in diethyl ether (50 ml) at 0 oC was added a solution of 4,5-dihydro-3H-
benzo[b]oxepin-2-one (5.0 g, 31 mmol) in diethyl ether over a 90 min period. The 
mixture was then stirred for 1 hr at room temperature and then poured into aq. 
ammonium chloride (50 ml) and extracted with dichloromethane (3 x 20 ml). The 
combined organics were dried (MgSO4) and evaporated to give the title compound 
(5.8 g, 96%) as an off white solid, m.p. 77 oC (lit 78-79 oC)75, which was used 
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without further purification. ímax (film) / cm-1 3400, 3100, 1654, 1589, 1245, 1085; 
äH (400 MHz; CDCl3) 1.22 (6H, s, 2 x CH3), 1.50-1.56 (2H, m, CH2, C4), 1.66-1.72 
(2H, m, CH2, C3), 2.64 (2H, t, J 7.2 Hz, CH2, C2), 6.78-6.85 (2H, m, 2 x arom CH), 
7.04-7.09 (2H, m, 2 x arom., CH), OH protons not observed; äC (100 MHz; CDCl3) 
25.7 (CH2), 29.4 (2 x CH3), 31.7 (CH2), 42.0 (CH2), 72.1 (quat.,), 115.6 (arom CH), 
120.4 (arom CH), 129.5 (quat.,), 126.9 (arom CH), 130.3 (arom CH), 154.1 (quat.,). 
 
2,2-Dimethyl-2,3,4,5-tetrahydro-benzo[b]oxepine75 
 
O
 
240a 
 
A mixture of 2-(3-hydroxy-3-methyl-butyl)-phenol (4.0 g, 21 mmol) and PTSA 
(catalytic 0.2 g) in toluene (100 ml) was heated under reflux with a Dean and Stark 
head for 18 hrs. The solvent was then evaporated under reduced pressure yielding a 
green solid. 1H NMR data did not confirm the expected product. 
 
General procedure for the new system of catalytic oxidation of alcohols with 2-
iodobenzoic acid and TPPP developed by the Page group.131  
 
2-Iodobenzoic acid (0.1 eq) and TPPP (3 eq) were dissolved in dichloroethane (DCE) 
(20 ml). To this the required alcohol (1 eq) was added. The reaction was then 
warmed to 80 oC and the reaction monitored by TLC. Upon consumption of the 
starting material the reaction was cooled and diethyl ether added to precipitate out 
any excess TPPP. The reaction was then filtered through a pad of celite to yield the 
carbonyl compound. 
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Benzo[1,3]dioxole-5-carbaldehyde132 
 
O
O
O
 
269 
 
Prepared as the general procedure for the oxidation of alcohols with 2-iodobenzoic 
acid and TPPP using piperonyl alcohol (0.079 g, 0.50 mmol). Product yielded as a 
white solid (0.071 g, 94%). m.p. 37 oC (lit. 35-37 oC)132; ímax (film) / cm-1 1778, 
1567, 1234; äH (400 MHz; CDCl3) 6.07 (2H, s, CH2), 6.92 (1H, d, J 7.6 Hz, C3), 7.31 
(1H, d, J 1.6 Hz, C6), 7.40 (1H, dd, J 7.6, 1.6 Hz, C2), 9.80 (1H, s, aldehyde); äC 
(100 MHz; CDCl3) 102.1 (CH2), 106.8 (CH arom., C6), 108.3 (CH arom., C3), 128.7 
(CH arom., C2), 131.8 (quat., C, C1), 148.6 (quat., C, C4), 153.1 (quat., C, C5), 
190.3 (CH, aldehyde). 
 
Trans-cinnammaldehyde133  
 
O
  
272 
 
Prepared as the general procedure for the oxidation of alcohols with 2-iodobenzoic 
acid and TPPP using cinnamyl alcohol (0.067 g, 0.50 mmol). Product yielded as a 
yellow liquid (0.055 g, 83%); ímax (film) / cm-1 1749, 1601, 1578, 1471, 1156; äH 
(400 MHz; CDCl3) 6.68 (1H, q, J 12.5), 7.45 (4H, m, 3 x arom., CH, 1 x alkene CH), 
7.54 (2H, m, arom CH), 9.68 (1H, d, J 10.5); äC (100 MHz; CDCl3) 128.2 (2 x ortho 
arom CH), 129.3 (2 x meta arom CH), 130.7 (para arom CH), 131.5 (alkene CH), 
133.9 (quat., C, on phenyl), 153.0 (alkene CH), 193.7 (CH, aldehyde). 
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3-Methyl-but-2-enal134 
 
O
  
275 
 
Prepared as the general procedure for the oxidation of alcohols with 2-iodobenzoic 
acid and TPPP using prenyl alcohol (0.043 g, 0.50 mmol). Product yielded as a clear 
liquid (0.039 g, 92%); ímax (film) / cm-1 1787, 1599, 1501, 1467; äH 1.99 (3H, s, 
CH3), 2.18 (3H, s, CH3), 5.88 (1H, d, J 8.0 Hz, CH, C2), 9.95 (1H, d, J 8.0 Hz, CHO, 
C1); äC (100 MHz; CDCl3) 18.8 (CH3), 27.1 (CH3), 128.3 (CH, C2), 160.9 (C quat., 
C3), 191.2 (CH, aldehyde). 
 
Acetophenone135 
O
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Prepared as the general procedure for the oxidation of alcohols with 2-iodobenzoic 
acid and TPPP using alpha-methylbenzyl alcohol (0.061 g, 0.50 mmol). Product 
yielded as a clear liquid (0.055 g, 91%); ímax (film) / cm-1 1724, 1589, 1525, 1367; 
äH (400 MHz; CDCl3) 2.52 (3H, s, CH3), 7.38 (2H, t, J 15.0 Hz, CH arom., C3,5), 
7.46 (1H, t, J 7.5 Hz, CH arom., C4), 7.88 (2H, d, J 9.5 Hz, CH arom., C2,6); äC (100 
MHz; CDCl3) 25.5 (CH3), 126.7 (2 x CH arom., C3,5), 127.9 (2 x CH arom., C2,6), 
139.9 (CH arom., C4), 136.4 (C quat., C1), 197.1 (quat., C, ketone). 
 
Cyclohexane-1,2-dione136  
 
O
O
  
274 
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Prepared as the general procedure for the oxidation of alcohols with 2-iodobenzoic 
acid and TPPP using cyclohexane-1,2-diol (0.058 g, 0.50 mmol). Product yielded as 
a clear liquid (0.049 g, 87%); ímax (film) / cm-1 3378, 1689, 1576, 1435,1167; äH 
(400 MHz; CDCl3) 1.99-2.03 (2H, m, CH2), 2.39-2.40 (2H, m, CH2), 2.52-2.55 (2H, 
m, CH2), 6.06 (1H, s, broad enol OH), 6.14-6.17 (1H, m, enol CH); äC (100 MHz; 
CDCl3) 23.3 (CH2, C3), 23.8 (CH2, C4), 36.4 (CH2, C6), 118.5 (CH2, C3), 147.0 (C 
quat., C2), 195.6 (C quat., C1). 
  
Benzaldehyde137 
O
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Prepared as the general procedure for the oxidation of alcohols with 2-iodobenzoic 
acid and TPPP using benzyl alcohol (0.054 g, 0.50 mmol). Product yielded as a 
yellow liquid (0.041 g, 78%); ímax (film) / cm-1 1767, 1602, 1588, 1421, 1215; äH 
(400 MHz; CDCl3) 7.46-7.48 (2H, m, 2 x CH arom., meta, C3,5), 7.54-7.56 (1H, m, 
CH arom., para, C4), 7.81-7.84 (2H, m, 2 x CH arom., ortho, C2,6), 9.96 (1H, s, 
aldehyde, CH); äC (100 MHz; CDCl3) 128.4 (2 x CH meta, C3,5), 129.8 (2 x CH 
ortho, C2,6), 134.4 (CH para, C4), 136.3 (C quat., C1), 192.6 (aldehyde, C). 
 
Cyclohexanone138 
O
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Prepared as the general procedure for the oxidation of alcohols with 2-iodobenzoic 
acid and TPPP using cyclohexanol (0.050 g, 0.50 mmol). Product yielded as a clear 
oil (0.042 g, 86%); ímax (film) / cm-1 1765, 1505, 1201, 1166, 1042; äH (400 MHz; 
CDCl3) 1.70-1.76 (2H, m, CH2 para, C4), 1.83-1.90 (4H, m, 2 x CH2, meta, C3,5), 
2.32-2.35 (4H, m, 2 x CH2, ortho, C2,6); äC (100 MHz; CDCl3) 21.7 (CH2, para, 
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C4), 27.0 (2 x CH2, meta, C3,5), 41.7 (2 x CH2, ortho, C2,6), 211.8 (C quat., ketone, 
C1). 
 
1-Cyclohexylidene-pyrrolidinium tetraphenyl borate46 
 
N+
-BPh4
 
282 
 
Pyrrolidine (2.00 ml, 23.9 mmol) and cyclohexanone (2.48 ml, 23.9 mmol) were 
dissolved in toluene (20 ml) and hydrochloric acid (6.00 ml, 23.9 mmol, 4M in 
dioxane) was added to this. The flask was then connected to Dean Stark apparatus 
and refluxed overnight. Analysis by TLC showed no trace of the starting materials, 
so sodium tetraphenylborate (8.00 g, 23.9 mmol) was added to achieve ion exchange. 
The reaction was stirred for a further 30 minutes, then diethyl ether was added and 
the product precipitated out of the reaction. This could then be filtered off and 
washed with more diethyl ether. The product was then re-crystalised from DCM with 
diethyl ether. The product was obtained as a white crystalline solid (9.2 g, 70%). 
M.p, 190-192oC (lit. 191-192 °C)46; ímax (film) / cm-1 3050, 2996, 1653, 1578, 
1477, 1426, 1264, 1030; äH (400 MHz; CD3CN); 1.641-1.697 (2H, m, CH2), 1.802-
1.905 (4H, m, 2 x CH2), 2.05 (4H, m, 2 x CH2), 2.612-2.645 (4H, m, 2 x CH2), 
3.764-3.782 (4H, m, 2 x CH2), 6.88 (4H, m, BPh4), 7.015-7.054 (8H, m, BPh4), 
7.295-7.321 (8H, m, BPh4); äC (100 MHz; CD3CN) 22.54 (CH2, para on cycl.), 23.61 
(2 x CH2, pyr.), 24.29 (2 x CH2, meta on cycl.), 33.45 (2 x CH2, ortho on cyclo.), 
53.51 (2 x CH2, pyr.), 121.45 (4 x CH, para on Ph), 125.25 (8 x CH, ortho on Ph), 
135.40 (8 x CH, meta on Ph); m/z anion 319.1, cation 152.2.  
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Ethyl-2-[(R)-1-phenylethyl]iminoethanoate139 
 
N
COOEt
 
293 
A cooled (0 °C) solution of ethyl glyoxylate (2.0 ml, 19.6 mmol) in Et2O (40 ml) was 
treated by the slow addition of (R)-1-phenylethylamine (2.50 ml, 19.6 mmol), 
followed by the addition of MgSO4 (4.0 g, 1.8 eq). The reaction mixture was stirred 
overnight at ambient temperature; the solids were then filtered off and washed with 
Et2O. The filtrate was concentrated to yield the expected product as a yellow oil (3.9 
g, 95%); ímax (film) / cm-1 3050, 2996, 1653, 1578, 1477, 1426, 1264, 1030; äH (400 
MHz; CDCl3) 1.31 (3H, t, J 7.0 Hz, CH2CH3), 1.59 (3H, d, J 6.7 Hz, CH3CH), 4.31 
(2H, q, J 7.0 Hz, CH2CH3), 4.58 (1H, q, J 6.7 Hz, CHCH3), 7.20-7.38 (5H, m, CH 
arom., on phenyl substituent), 7.72 (1H, s, CH=N); äC (100 MHz; CDCl3) 14.2 
(CH2CH3), 23.8 (PhCCH3), 61.8 (PhCCH3), 69.7 (CH2CH3), 128.7 (CH, para on Ph), 
127.6 (2 x CH, ortho on Ph), 128.9 (2 x CH, meta on Ph), 142.8 (quat., C, on phenyl 
substituent), 152.4 (COOEt), 163.3 (C=N). 
 
1-Phenyl-6-oxa-bicyclo[4.1.0]heptane49-54,56,57 
 
O
 
286 
 
Prepared via the general procedure for the epoxidation of alkenes mediated by TPPP, 
using the achiral, exocyclic catalyst (282). Product isolated as a colourless oil, (0.095 
g, 55%); ímax (film) / cm-1 3034, 2929, 2827, 1604, 1498, 1438, 1343, 1065; äH (400 
MHz; CDCl3) 1.568-1.597 (4H, m, 2 x CH2), 1.856-1.912 (2H, m, CH2), 1.998-2.087 
(2H, m, CH2), 2.992-3.000 (1H, m, epox CH), 7.176-7.274 (5H, m, arom); äC (100 
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MHz; CDCl3) 20.4 (CH2 meta to Ph), 23.4 (CH2 para to Ph), 26.1 (CH2 meta to Ph 
and next to epox), 34.1 (CH2 ortho to Ph), 64.8 (epox. CH, ortho to Ph), 75.4 (epox. 
C, PhC), 125.7 (CH, para on Ph), 126.4 (2 x CH, ortho on Ph), 128.4 (2 x CH, meta 
on Ph), 144.5 (quat., C, on phenyl substituent). 
 
(E)-2,3-Diphenyloxirane49-54,56,57 
O
 
284 
 
Prepared via the general procedure for the epoxidation of alkenes mediated by 
iminium salts using Oxone®, using achiral exocyclic catalyst (282) with the reaction 
being performed at both 0 oC and 25 oC; Product isolated as a colourless solid (at 0 
oC - 0.115 g, 59%; at 25 oC - 0.121 g, 62%); mp 64-66 oC, (lit. mp 61-63 oC);1,5 ímax 
(film) / cm-1 1605, 1511, 1490, 1289, 1195, 1140, 1085, 1036; äH (400 MHz; CDCl3) 
3.851 (2H, s, PhCH-O), 7.278-7.369 (10H, m, arom., 2 x Ph gp.); äC (100 MHz; 
CDCl3) 63.2 (2 x epox. CH), 125.4 (4 x CH arom., ortho to epox.), 127.9 (2 x CH 
arom., para to epox.), 129.4 (4 x CH arom., meta to epox.), 138.1 (2 x quat., C on 
phenyl substituents). 
 
(E)-2,3-Diphenyloxirane49-54,56,57 
 
O
 
284 
 
Prepared via the method used by Komatsu; NaHCO3 (4 eq) was placed in a round 
bottomed flask with water (12 ml per 1.5 g carbonate). Oxone® (1 eq) was then 
added, and the reaction stirred until the effervescence had stopped. The catalyst (282) 
(10 mol%) was dissolved in MeCN (6 ml per 1.5 g carbonate) and added to the flask. 
The alkene (1 eq) was then added and the reaction stirred at room temperature, whilst 
being monitored via TLC. Product isolated as a colourless solid (0.133 g, 68%); mp 
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65-67oC, (lit. mp 61-63oC);1,5 ímax (film) / cm-1 1600, 1501, 1489, 1286, 1190, 
1148, 1090, 1036; äH (400 MHz; CDCl3) 3.851 (2H, s, PhCH-O), 7.278-7.369 (10H, 
m, arom., 2 x Ph gp.); äC (100 MHz; CDCl3) 63.2 (2 x epox. CH), 125.4 (4 x CH 
arom., ortho to epox.), 127.9 (2 x CH arom., para to epox.), 129.4 (4 x CH arom., 
meta to epox.), 138.1 (2 x quat., C on phenyl substituents). 
 
2H-benzopyran140 
 
O
 
241 
 
4-chrominol (1.31 g, 8.73 mmol) was added to a round bottomed flask containing 
toluene (40 ml), pTSA (1.66 g, 1 eq) and hydroquinone (0.0080 g, cat.). The flask 
was equipped with a reflux condenser and the reaction refluxed until TLC confirmed 
no starting material remained. The reaction was then passed through a short pad of 
silica and the filtrate concentrated under vacuum, yielding the product as a clear oil 
(1.08 g, 93%). ímax (film) / cm-1 2854, 2054, 1685, 1456, 1397, 1186, 1036; äH (400 
MHz; CDCl3) 4.54-4.58 (2H, m, CH2, C2), 5.85-5.89 (1H, m, CH, C3), 6.52-6.55 
(1H, m, CH, C4), 6.75 (1H, dd, J 8.4, 2.1 Hz, C8), 6.84 (1H, dd, J 8.8, 2.2Hz, C6), 
6.97 (1H, dd, J 8.4, 2.1 Hz, C7), 7.02 (1H, dd, J 8.8, 2.2 Hz, C5); äC (100 MHz; 
CDCl3) 65.1 (C2), 115.2 (C4), 118.4 (C3), 121.2 (quat., C, C9), 124.3 (C5), 125.1 
(C7), 125.2 (C6), 126.5 (C8), 131.2 (quat., C, C10). 
 
2H-benzopyran oxide 
 
O
O
 
244 
 
Prepared by the TPPP epoxidation route described previously, yielding the title 
compound as a clear oil (0.11 g, 74%). ímax (film) / cm-1 3051, 3025, 1685, 1454;  
äH (400 MHz; CDCl3) 3.42-3.45 (1H, m, CH, C3), 3.78-3.81 (1H, m, CH, C4), 4.10-
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4.15 (2H, m, CH2, C2), 6.78 (1H, dd, J 8.6, 2.4 Hz, C8), 6.88 (1H, dd, J 8.7, 2.5 Hz, 
C6), 7.05 (1H, dd, J 8.6, 2.4 Hz, C7), 7.10 (1H, dd, J 8.7, 2.5 Hz, C5); äC (100 MHz; 
CDCl3) 68.2 (C2), 75.3 (C3), 79.5 (C4), 119.2 (quat., C, C9), 125.1 (C5), 125.2 (C7), 
125.7 (C6), 128.5 (C8), 132.0 (quat., C, C10). 
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Table 1.  Crystal data and structure refinement for pcbp62. 
 
Identification code  pcbp62 
Chemical formula  C16H11NO 
Formula weight  233.26 
Temperature  120(2) K 
Radiation, wavelength  MoK, 0.71073 Å 
Crystal system, space group  monoclinic, P21/c 
Unit cell parameters a = 5.70970(10) Å  = 90° 
 b = 8.8774(3) Å  = 94.203(2)° 
 c = 23.3732(9) Å  = 90° 
Cell volume 1181.54(6) Å3 
Z 4 
Calculated density  1.311 g/cm3 
Absorption coefficient  0.082 mm1 
F(000) 488 
Crystal colour and size colourless, 0.46  0.04  0.03 mm3 
Reflections for cell refinement 2688 ( range 2.91 to 27.48°) 
Data collection method Bruker-Nonius 95mm CCD camera on -
goniostat 
  &  scans 
 range for data collection 3.48 to 27.54° 
Index ranges h 7 to 7, k 11 to 11, l 30 to 30 
Completeness to  = 27.54° 98.6 %  
Intensity decay 0% 
Reflections collected 13408 
Independent reflections 2692 (Rint = 0.0379) 
Reflections with F2>2 2295 
Absorption correction semi-empirical from equivalents 
Min. and max. transmission 0.858 and 0.998 
Structure solution direct methods 
Refinement method Full-matrix least-squares on F2 
Weighting parameters a, b 0.0452, 0.5563 
Data / restraints / parameters 2692 / 0 / 164 
Final R indices [F2>2] R1 = 0.0462, wR2 = 0.1129 
R indices (all data) R1 = 0.0555, wR2 = 0.1188 
Goodness-of-fit on F2 1.079 
Extinction coefficient 0.017(5) 
Largest and mean shift/su 0.000 and 0.000 
Largest diff. peak and hole 0.272 and 0.224 e Å3 
 
Table 2.  Atomic coordinates and equivalent isotropic displacement parameters (Å2) 
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for pcbp62.  Ueq is defined as one third of the trace of the orthogonalized Uij tensor. 
 
      x      y      z      Ueq 
 
O(1) 0.36053(16) 0.77756(10) 0.11147(4) 0.0249(3) 
C(1) 0.3094(2) 0.61650(15) 0.10537(6) 0.0226(3) 
C(2) 0.0914(3) 0.58442(16) 0.06769(6) 0.0246(3) 
C(3)  0.0665(2) 0.68902(15) 0.05235(6) 0.0230(3) 
C(4)  0.0263(2) 0.84484(15) 0.06985(5) 0.0202(3) 
C(5)  0.1869(2) 0.95932(15) 0.05695(5) 0.0214(3) 
C(6)  0.1362(2) 1.10777(15) 0.07338(6) 0.0218(3) 
C(7) 0.0772(2) 1.14215(15) 0.10364(6) 0.0235(3) 
C(8) 0.2396(2) 1.02932(15) 0.11656(6) 0.0228(3) 
C(9) 0.1890(2) 0.88177(15) 0.09965(5) 0.0204(3) 
C(10) 0.2965(2) 0.54828(15) 0.16452(6) 0.0238(3) 
C(11) 0.1059(3) 0.5789(2) 0.19626(7) 0.0357(4) 
C(12) 0.0947(3) 0.5186(2) 0.25071(7) 0.0488(5) 
C(13) 0.2705(4) 0.4251(2) 0.27324(7) 0.0506(5) 
C(14) 0.4581(4) 0.3923(2) 0.24197(8) 0.0482(5) 
C(15) 0.4723(3) 0.45409(18) 0.18756(7) 0.0341(4) 
C(16)  0.3035(2) 1.22461(15) 0.05812(6) 0.0244(3) 
N(1)  0.4378(2) 1.31736(15) 0.04560(6) 0.0322(3) 
 
 
 
Table 3.   Bond lengths [Å] and angles [°] for pcbp62. 
 
O(1)C(9)  1.3609(16) O(1)C(1)  1.4640(16) 
C(1)C(2)  1.499(2) C(1)C(10)  1.5161(18) 
C(2)C(3)  1.325(2) C(3)C(4)  1.4559(18) 
C(4)C(5)  1.3872(18) C(4)C(9)  1.4062(18) 
C(5)C(6)  1.3970(19) C(6)C(7)  1.3972(19) 
C(6)C(16)  1.4370(19) C(7)C(8)  1.3832(19) 
C(8)C(9)  1.3925(18) C(10)C(15)  1.385(2) 
C(10)C(11)  1.388(2) C(11)C(12)  1.386(2) 
C(12)C(13)  1.377(3) C(13)C(14)  1.371(3) 
C(14)C(15)  1.393(2) C(16)N(1)  1.1486(18) 
 
C(9)O(1)C(1) 120.58(10) O(1)C(1)C(2) 113.19(11) 
O(1)C(1)C(10) 108.91(11) C(2)C(1)C(10) 111.47(11) 
C(3)C(2)C(1) 123.04(13) C(2)C(3)C(4) 119.96(13) 
C(5)C(4)C(9) 118.47(12) C(5)C(4)C(3) 123.15(12) 
C(9)C(4)C(3) 118.35(12) C(4)C(5)C(6) 120.74(12) 
C(5)C(6)C(7) 120.03(12) C(5)C(6)C(16) 119.49(12) 
C(7)C(6)C(16) 120.47(12) C(8)C(7)C(6) 119.89(12) 
C(7)C(8)C(9) 119.82(12) O(1)C(9)C(8) 116.77(12) 
O(1)C(9)C(4) 122.14(12) C(8)C(9)C(4) 121.04(12) 
C(15)C(10)C(11) 118.99(14) C(15)C(10)C(1) 120.89(13) 
C(11)C(10)C(1) 120.11(13) C(12)C(11)C(10) 120.38(17) 
C(13)C(12)C(11) 120.15(17) C(14)C(13)C(12) 120.01(16) 
C(13)C(14)C(15) 120.19(17) C(10)C(15)C(14) 120.26(16) 
N(1)C(16)C(6) 179.51(17)  
 
Table 4.   Hydrogen coordinates and isotropic displacement parameters (Å2) for pcbp62. 
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      x       y       z       U 
 
H(1) 0.4443 0.5684 0.0874 0.027 
H(2) 0.0651 0.4845 0.0542 0.029 
H(3)  0.2059 0.6623 0.0299 0.028 
H(5)  0.3330 0.9365 0.0367 0.026 
H(7) 0.1107 1.2428 0.1153 0.028 
H(8) 0.3853 1.0524 0.1369 0.027 
H(11)  0.0176 0.6415 0.1806 0.043 
H(12)  0.0346 0.5418 0.2725 0.059 
H(13) 0.2619 0.3834 0.3105 0.061 
H(14) 0.5787 0.3272 0.2575 0.058 
H(15) 0.6030 0.4315 0.1662 0.041 
 
 
 
Table 5.  Torsion angles [°] for pcbp62. 
 
C(9)O(1)C(1)C(2) 19.69(16) C(9)O(1)C(1)C(10)  104.89(13) 
O(1)C(1)C(2)C(3)  14.53(18) C(10)C(1)C(2)C(3) 108.65(15) 
C(1)C(2)C(3)C(4) 3.1(2) C(2)C(3)C(4)C(5)  177.88(13) 
C(2)C(3)C(4)C(9) 4.22(19) C(9)C(4)C(5)C(6)  0.22(19) 
C(3)C(4)C(5)C(6)  178.12(12) C(4)C(5)C(6)C(7)  0.61(19) 
C(4)C(5)C(6)C(16) 178.38(12) C(5)C(6)C(7)C(8) 0.9(2) 
C(16)C(6)C(7)C(8)  178.06(12) C(6)C(7)C(8)C(9)  0.4(2) 
C(1)O(1)C(9)C(8) 168.38(11) C(1)O(1)C(9)C(4)  14.04(18) 
C(7)C(8)C(9)O(1) 177.13(11) C(7)C(8)C(9)C(4)  0.5(2) 
C(5)C(4)C(9)O(1)  176.71(11) C(3)C(4)C(9)O(1) 1.30(18) 
C(5)C(4)C(9)C(8) 0.77(19) C(3)C(4)C(9)C(8) 178.77(12) 
O(1)C(1)C(10)C(15)  108.08(14) C(2)C(1)C(10)C(15) 126.33(14) 
O(1)C(1)C(10)C(11) 72.41(16) C(2)C(1)C(10)C(11)  53.18(17) 
C(15)C(10)C(11)C(12) 1.4(2) C(1)C(10)C(11)C(12)  179.06(15) 
C(10)C(11)C(12)C(13)  1.4(3) C(11)C(12)C(13)C(14) 0.4(3) 
C(12)C(13)C(14)C(15) 0.5(3) C(11)C(10)C(15)C(14)  0.5(2) 
C(1)C(10)C(15)C(14) 179.96(14) C(13)C(14)C(15)C(10)  0.4(3) 
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Table 1.  Crystal data and structure refinement for pcbp75. 
 
Identification code  pcbp75 
Chemical formula  C16H11NO2 
Formula weight  249.26 
Temperature  150(2) K 
Radiation, wavelength  MoK, 0.71073 Å 
Crystal system, space group  orthorhombic, Pca21 
Unit cell parameters a = 25.5445(17) Å  = 90° 
 b = 5.8327(4) Å  = 90° 
 c = 16.5222(11) Å  = 90° 
Cell volume 2461.7(3) Å3 
Z 8 
Calculated density  1.345 g/cm3 
Absorption coefficient  0.090 mm1 
F(000) 1040 
Crystal colour and size colourless, 0.46  0.43  0.09 mm3 
Reflections for cell refinement 3765 ( range 2.94 to 21.88°) 
Data collection method Bruker APEX 2 CCD diffractometer 
  rotation with narrow frames 
 range for data collection 1.59 to 27.20° 
Index ranges h 32 to 32, k 7 to 7, l 21 to 21 
Completeness to  = 27.20° 100.0 %  
Intensity decay 0% 
Reflections collected 22235 
Independent reflections 2841 (Rint = 0.0525) 
Reflections with F2>2 2442 
Absorption correction semi-empirical from equivalents 
Min. and max. transmission 0.960 and 0.992 
Structure solution direct methods 
Refinement method Full-matrix least-squares on F2 
Weighting parameters a, b 0.0322, 0.3228 
Data / restraints / parameters 2841 / 1 / 344 
Final R indices [F2>2] R1 = 0.0327, wR2 = 0.0676 
R indices (all data) R1 = 0.0428, wR2 = 0.0721 
Goodness-of-fit on F2 1.031 
Extinction coefficient 0.0016(4) 
Largest and mean shift/su 0.000 and 0.000 
Largest diff. peak and hole 0.147 and 0.128 e Å3 
Absolute structure was not determined from the data. Friedels were merged. 
 
Table 2.  Atomic coordinates and equivalent isotropic displacement parameters (Å2) 
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for pcbp75.  Ueq is defined as one third of the trace of the orthogonalized Uij tensor. 
 
      x      y      z      Ueq 
 
O(1) 0.49309(6)  0.0721(3) 0.27694(9) 0.0343(4) 
C(1) 0.43773(8)  0.0974(4) 0.26338(13) 0.0303(5) 
C(2) 0.47468(8)  0.2332(4) 0.21565(13) 0.0271(5) 
C(3) 0.48317(8)  0.1594(4) 0.13094(12) 0.0240(4) 
C(4) 0.46518(8) 0.0555(4) 0.10721(12) 0.0237(4) 
O(2) 0.44182(6) 0.2033(2) 0.16031(9) 0.0302(3) 
C(5) 0.41044(9) 0.1008(4) 0.22438(13) 0.0291(5) 
C(6) 0.50774(8)  0.2992(4) 0.07479(13) 0.0250(5) 
C(7) 0.51433(8)  0.2218(4)  0.00435(13) 0.0268(5) 
C(8) 0.49705(9)  0.0046(4)  0.02740(13) 0.0281(5) 
C(9) 0.47219(8) 0.1332(4) 0.02820(13) 0.0271(5) 
C(10) 0.53815(9)  0.3684(4)  0.06426(14) 0.0308(5) 
N(1) 0.55626(9)  0.4824(4)  0.11320(12) 0.0414(5) 
C(11) 0.35713(9) 0.0368(4) 0.19242(13) 0.0310(5) 
C(12) 0.31596(10) 0.1894(5) 0.20189(16) 0.0430(6) 
C(13) 0.26676(11) 0.1401(6) 0.1721(2) 0.0593(8) 
C(14) 0.25782(11)  0.0613(5) 0.1311(2) 0.0541(7) 
C(15) 0.29820(11)  0.2146(5) 0.11971(19) 0.0517(7) 
C(16) 0.34756(9)  0.1655(5) 0.15087(16) 0.0413(6) 
O(3) 0.60284(7) 0.4493(3) 0.46576(10) 0.0419(4) 
C(17) 0.59421(10) 0.4759(4) 0.38067(15) 0.0361(5) 
C(18) 0.63367(9) 0.6164(4) 0.42122(15) 0.0351(5) 
C(19) 0.68902(9) 0.5566(4) 0.40752(13) 0.0316(5) 
C(20) 0.70079(9) 0.3441(4) 0.37290(14) 0.0309(5) 
O(4) 0.66230(6) 0.1870(3) 0.35621(10) 0.0360(4) 
C(21) 0.61175(9) 0.2769(4) 0.32973(15) 0.0354(6) 
C(22) 0.72918(9) 0.7061(4) 0.42550(14) 0.0319(5) 
C(23) 0.78079(9) 0.6454(4) 0.40880(14) 0.0325(5) 
C(24) 0.79204(9) 0.4320(4) 0.37492(15) 0.0343(5) 
C(25) 0.75213(10) 0.2827(4) 0.35626(14) 0.0333(5) 
C(26) 0.82236(10) 0.8084(4) 0.42339(16) 0.0362(5) 
N(2) 0.85530(8) 0.9394(4) 0.43215(15) 0.0452(5) 
C(27) 0.61424(8) 0.3291(4) 0.24028(14) 0.0317(5) 
C(28) 0.59957(9) 0.1601(4) 0.18558(15) 0.0350(6) 
C(29) 0.60579(9) 0.1931(4) 0.10328(15) 0.0373(6) 
C(30) 0.62668(9) 0.3952(4) 0.07479(16) 0.0366(6) 
C(31) 0.64064(9) 0.5669(4) 0.12815(16) 0.0388(6) 
C(32) 0.63449(9) 0.5348(4) 0.21103(16) 0.0349(5) 
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Table 3.   Bond lengths [Å] and angles [°] for pcbp75. 
 
O(1)C(1)  1.439(3) O(1)C(2)  1.459(3) 
C(1)C(2)  1.463(3) C(1)C(5)  1.496(3) 
C(2)C(3)  1.480(3) C(3)C(6)  1.385(3) 
C(3)C(4)  1.392(3) C(4)O(2)  1.367(2) 
C(4)C(9)  1.393(3) O(2)C(5)  1.456(3) 
C(5)C(11)  1.507(3) C(6)C(7)  1.393(3) 
C(7)C(8)  1.395(3) C(7)C(10)  1.443(3) 
C(8)C(9)  1.376(3) C(10)N(1)  1.145(3) 
C(11)C(12)  1.387(3) C(11)C(16)  1.387(3) 
C(12)C(13)  1.380(4) C(13)C(14)  1.375(4) 
C(14)C(15)  1.378(4) C(15)C(16)  1.392(4) 
O(3)C(17)  1.432(3) O(3)C(18)  1.453(3) 
C(17)C(18)  1.462(3) C(17)C(21)  1.502(3) 
C(18)C(19)  1.474(3) C(19)C(22)  1.379(3) 
C(19)C(20)  1.398(3) C(20)O(4)  1.372(3) 
C(20)C(25)  1.387(3) O(4)C(21)  1.461(3) 
C(21)C(27)  1.510(3) C(22)C(23)  1.393(3) 
C(23)C(24)  1.395(3) C(23)C(26)  1.445(3) 
C(24)C(25)  1.376(3) C(26)N(2)  1.146(3) 
C(27)C(28)  1.389(3) C(27)C(32)  1.393(3) 
C(28)C(29)  1.383(4) C(29)C(30)  1.377(4) 
C(30)C(31)  1.381(4) C(31)C(32)  1.391(4) 
 
C(1)O(1)C(2) 60.63(13) O(1)C(1)C(2) 60.35(13) 
O(1)C(1)C(5) 116.49(18) C(2)C(1)C(5) 119.14(18) 
O(1)C(2)C(1) 59.02(13) O(1)C(2)C(3) 114.95(17) 
C(1)C(2)C(3) 116.53(19) C(6)C(3)C(4) 119.40(19) 
C(6)C(3)C(2) 121.9(2) C(4)C(3)C(2) 118.69(19) 
O(2)C(4)C(3) 122.09(18) O(2)C(4)C(9) 116.89(19) 
C(3)C(4)C(9) 121.0(2) C(4)O(2)C(5) 116.61(16) 
O(2)C(5)C(1) 111.96(17) O(2)C(5)C(11) 110.14(17) 
C(1)C(5)C(11) 112.37(18) C(3)C(6)C(7) 119.5(2) 
C(6)C(7)C(8) 120.8(2) C(6)C(7)C(10) 120.2(2) 
C(8)C(7)C(10) 119.0(2) C(9)C(8)C(7) 119.6(2) 
C(8)C(9)C(4) 119.6(2) N(1)C(10)C(7) 178.3(3) 
C(12)C(11)C(16) 117.9(2) C(12)C(11)C(5) 119.1(2) 
C(16)C(11)C(5) 122.9(2) C(13)C(12)C(11) 121.1(3) 
C(14)C(13)C(12) 120.3(3) C(13)C(14)C(15) 119.8(3) 
C(14)C(15)C(16) 119.6(3) C(11)C(16)C(15) 121.2(3) 
C(17)O(3)C(18) 60.89(15) O(3)C(17)C(18) 60.29(16) 
O(3)C(17)C(21) 114.9(2) C(18)C(17)C(21) 119.0(2) 
O(3)C(18)C(17) 58.82(14) O(3)C(18)C(19) 116.0(2) 
C(17)C(18)C(19) 117.3(2) C(22)C(19)C(20) 119.3(2) 
C(22)C(19)C(18) 122.1(2) C(20)C(19)C(18) 118.6(2) 
O(4)C(20)C(25) 117.7(2) O(4)C(20)C(19) 121.3(2) 
C(25)C(20)C(19) 120.9(2) C(20)O(4)C(21) 117.00(17) 
O(4)C(21)C(17) 111.91(19) O(4)C(21)C(27) 109.16(19) 
C(17)C(21)C(27) 113.9(2) C(19)C(22)C(23) 120.1(2) 
C(22)C(23)C(24) 120.1(2) C(22)C(23)C(26) 119.7(2) 
C(24)C(23)C(26) 120.2(2) C(25)C(24)C(23) 120.1(2) 
C(24)C(25)C(20) 119.5(2) N(2)C(26)C(23) 177.6(3) 
C(28)C(27)C(32) 119.0(2) C(28)C(27)C(21) 118.9(2) 
C(32)C(27)C(21) 121.9(2) C(29)C(28)C(27) 120.7(2) 
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C(30)C(29)C(28) 120.0(2) C(29)C(30)C(31) 120.2(2) 
C(30)C(31)C(32) 120.1(2) C(31)C(32)C(27) 120.0(2) 
 
Table 4.   Hydrogen coordinates and isotropic displacement parameters (Å2) for pcbp75. 
 
      x       y       z       U 
 
H(1) 0.4177  0.1816 0.3060 0.036 
H(2) 0.4775  0.4006 0.2279 0.033 
H(5) 0.4052 0.2204 0.2670 0.035 
H(6) 0.5200  0.4467 0.0901 0.030 
H(8) 0.5024 0.0479  0.0812 0.034 
H(9) 0.4599 0.2806 0.0128 0.033 
H(12) 0.3217 0.3303 0.2293 0.052 
H(13) 0.2389 0.2458 0.1800 0.071 
H(14) 0.2239  0.0947 0.1107 0.065 
H(15) 0.2924  0.3529 0.0907 0.062 
H(16) 0.3752  0.2726 0.1436 0.050 
H(17) 0.5612 0.5546 0.3639 0.043 
H(18) 0.6252 0.7820 0.4299 0.042 
H(21) 0.5854 0.1517 0.3371 0.043 
H(22) 0.7216 0.8506 0.4493 0.038 
H(24) 0.8273 0.3896 0.3647 0.041 
H(25) 0.7597 0.1386 0.3321 0.040 
H(28) 0.5851 0.0204 0.2049 0.042 
H(29) 0.5956 0.0764 0.0664 0.045 
H(30) 0.6315 0.4166 0.0183 0.044 
H(31) 0.6545 0.7072 0.1082 0.047 
H(32) 0.6441 0.6530 0.2477 0.042 
 
Table 5.  Torsion angles [°] for pcbp75. 
 
C(2)O(1)C(1)C(5)  110.0(2) C(1)O(1)C(2)C(3) 107.2(2) 
C(5)C(1)C(2)O(1) 105.7(2) O(1)C(1)C(2)C(3)  104.5(2) 
C(5)C(1)C(2)C(3) 1.2(3) O(1)C(2)C(3)C(6) 128.1(2) 
C(1)C(2)C(3)C(6)  165.65(19) O(1)C(2)C(3)C(4)  52.8(3) 
C(1)C(2)C(3)C(4) 13.4(3) C(6)C(3)C(4)O(2)  178.34(18) 
C(2)C(3)C(4)O(2) 2.5(3) C(6)C(3)C(4)C(9)  0.9(3) 
C(2)C(3)C(4)C(9) 179.98(18) C(3)C(4)O(2)C(5)  33.6(3) 
C(9)C(4)O(2)C(5) 148.89(18) C(4)O(2)C(5)C(1) 45.5(2) 
C(4)O(2)C(5)C(11)  80.3(2) O(1)C(1)C(5)O(2) 39.9(2) 
C(2)C(1)C(5)O(2)  29.3(3) O(1)C(1)C(5)C(11) 164.51(18) 
C(2)C(1)C(5)C(11) 95.3(2) C(4)C(3)C(6)C(7) 0.4(3) 
C(2)C(3)C(6)C(7) 179.47(19) C(3)C(6)C(7)C(8) 0.7(3) 
C(3)C(6)C(7)C(10)  177.77(19) C(6)C(7)C(8)C(9)  1.4(3) 
C(10)C(7)C(8)C(9) 177.2(2) C(7)C(8)C(9)C(4) 0.9(3) 
O(2)C(4)C(9)C(8) 177.84(19) C(3)C(4)C(9)C(8) 0.3(3) 
O(2)C(5)C(11)C(12)  94.8(2) C(1)C(5)C(11)C(12) 139.7(2) 
O(2)C(5)C(11)C(16) 82.7(3) C(1)C(5)C(11)C(16)  42.9(3) 
C(16)C(11)C(12)C(13) 1.1(4) C(5)C(11)C(12)C(13) 178.6(2) 
C(11)C(12)C(13)C(14)  1.0(5) C(12)C(13)C(14)C(15) 0.0(5) 
C(13)C(14)C(15)C(16) 0.9(5) C(12)C(11)C(16)C(15)  0.1(4) 
C(5)C(11)C(16)C(15)  177.6(2) C(14)C(15)C(16)C(11)  0.9(4) 
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C(18)O(3)C(17)C(21) 110.5(2) C(17)O(3)C(18)C(19)  107.5(2) 
C(21)C(17)C(18)O(3)  103.7(2) O(3)C(17)C(18)C(19) 105.4(2) 
C(21)C(17)C(18)C(19) 1.6(3) O(3)C(18)C(19)C(22)  129.6(2) 
C(17)C(18)C(19)C(22) 163.8(2) O(3)C(18)C(19)C(20) 52.4(3) 
C(17)C(18)C(19)C(20)  14.3(3) C(22)C(19)C(20)O(4) 178.0(2) 
C(18)C(19)C(20)O(4)  3.9(3) C(22)C(19)C(20)C(25)  0.2(3) 
C(18)C(19)C(20)C(25) 177.8(2) C(25)C(20)O(4)C(21)  146.5(2) 
C(19)C(20)O(4)C(21) 35.2(3) C(20)O(4)C(21)C(17)  45.0(3) 
C(20)O(4)C(21)C(27) 82.0(2) O(3)C(17)C(21)O(4)  41.9(3) 
C(18)C(17)C(21)O(4) 26.5(3) O(3)C(17)C(21)C(27)  166.3(2) 
C(18)C(17)C(21)C(27)  97.9(3) C(20)C(19)C(22)C(23) 0.3(3) 
C(18)C(19)C(22)C(23)  177.7(2) C(19)C(22)C(23)C(24)  0.9(3) 
C(19)C(22)C(23)C(26) 176.4(2) C(22)C(23)C(24)C(25) 1.4(3) 
C(26)C(23)C(24)C(25)  175.8(2) C(23)C(24)C(25)C(20)  1.3(4) 
O(4)C(20)C(25)C(24)  177.6(2) C(19)C(20)C(25)C(24) 0.7(3) 
O(4)C(21)C(27)C(28) 91.4(2) C(17)C(21)C(27)C(28)  142.7(2) 
O(4)C(21)C(27)C(32)  83.7(3) C(17)C(21)C(27)C(32) 42.2(3) 
C(32)C(27)C(28)C(29) 1.2(3) C(21)C(27)C(28)C(29)  174.0(2) 
C(27)C(28)C(29)C(30) 0.0(4) C(28)C(29)C(30)C(31)  1.1(4) 
C(29)C(30)C(31)C(32) 1.1(4) C(30)C(31)C(32)C(27) 0.0(4) 
C(28)C(27)C(32)C(31)  1.2(3) C(21)C(27)C(32)C(31) 173.9(2) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
